[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_99b9ffee-d77f-44e1-ba10-e8c984ac1672":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:99b9ffee-d77f-44e1-ba10-e8c984ac1672,\"}":117},{"code":4,"data":5,"meta":24},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":26,"manageAffiliations":51,"indexDatabases":75,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},"99b9ffee-d77f-44e1-ba10-e8c984ac1672","2023-05-29T10:52:17.667+00:00","2025-11-21T10:03:30.516+00:00",[],"Hypertension-Research",{"country":12,"issn":14,"introduce":16,"eissn":18,"title":20},{"VOID":13},"GB",{"VOID":15},"13484214",{"EN":17},"Hypertension Research is the official publication of the Japanese Society of Hypertension. The journal publishes papers reporting original clinical and experimental research that contribute to the advancement of knowledge in the field of hypertension and related cardiovascular diseases. The journal publishes Review Articles, Articles, Correspondence and Comments. Manuscripts submitted to Hypertension Research will be accepted on the understanding that the author must not have previously submitted the paper to another journal or have published the material elsewhere.",{"VOID":19},"09169636",{"EN":21},"Hypertension Research","PUBLISHER","PENDING",null,0,[27,35,43],{"id":28,"createTime":29,"updateTime":30,"relativeEntities":31,"label":32,"description":34,"parentId":24,"standard":24,"scholarHubFieldId":24},"2e748c70-3f53-41a9-99c9-1e3e45a3dc6d","2023-05-29T10:24:06.277+00:00","2023-11-21T08:07:05.812+00:00",[],{"EN":33},"Cardiology and Cardiovascular Medicine",{},{"id":36,"createTime":37,"updateTime":38,"relativeEntities":39,"label":40,"description":42,"parentId":24,"standard":24,"scholarHubFieldId":24},"77761c13-d9ff-4113-b615-60dad0c16000","2023-05-29T10:24:33.231+00:00","2023-11-21T06:06:57.205+00:00",[],{"EN":41},"Internal Medicine",{},{"id":44,"createTime":45,"updateTime":46,"relativeEntities":47,"label":48,"description":50,"parentId":24,"standard":24,"scholarHubFieldId":24},"317b242e-4e36-43ab-821e-f9755e22375e","2023-05-29T10:24:14.083+00:00","2023-11-21T05:26:08.510+00:00",[],{"EN":49},"Physiology",{},[52,64],{"id":53,"createTime":54,"updateTime":55,"relativeEntities":56,"slug":57,"properties":58,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"url":24,"parentIds":62,"statistic":24},"8e7fce10-23c9-4f81-8998-abcf28ea16a0","2024-04-11T20:35:34.338+00:00","2025-11-21T10:07:28.515+00:00",[],"Springer-Nature",{"title":59},{"EN":60},"Springer Nature","AFFILIATION",[63],"9a7c7208-b28a-42c2-a634-5a7f90eee3ab",{"id":65,"createTime":66,"updateTime":67,"relativeEntities":68,"slug":69,"properties":70,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":73,"url":24,"parentIds":74,"statistic":24},"ae54b068-a7dd-4746-b752-b7b24439de47","2023-05-29T10:24:12.391+00:00","2025-11-21T09:53:50.486+00:00",[],"Nature-Publishing-Group",{"title":71},{"EN":72},"Nature Publishing Group",6,[],[76,95],{"id":77,"indexDatabase":78,"url":92,"indexYears":24,"academicFieldIds":93,"indexDatabaseRanking":24},"b348207a-9955-48ae-bbfd-673214d81a99",{"id":79,"createTime":80,"updateTime":81,"relativeEntities":82,"label":83,"description":85,"key":88,"publicationTags":89,"standard":24},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":84,"VI":84},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":86,"EN":87},"Cơ sở dữ liệu SCIE","SCIE database","scie",[90,91],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0916-9636",[94],"0ddd214e-2317-43ae-8737-4f5747adc536",{"id":96,"indexDatabase":97,"url":109,"indexYears":110,"academicFieldIds":111,"indexDatabaseRanking":115},"9af7048b-46a9-45fa-96fa-ab0b3c629ae2",{"id":98,"createTime":99,"updateTime":100,"relativeEntities":101,"label":102,"description":104,"key":106,"publicationTags":107,"standard":24},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":103,"VI":103},"Scopus - Elsevier",{"EN":103,"VI":105},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[108],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F23752","1992-2025",[112,113,114],"7e7a8be0-3213-4ad0-b9db-1ab0e7d051c8","f845e4fe-178d-4593-b013-715b3c1cc81c","d44e3b1d-4abe-47f2-b4aa-783c24a9f903","SCOPUS__Q1","https:\u002F\u002Fwww.nature.com\u002Fhr\u002F",{"meta":118,"data":120},{"total":119},"32",[121,540,1297,1632,1965,2378,2592,2988,3294,3585],{"id":122,"createTime":123,"updateTime":123,"relativeEntities":124,"slug":125,"properties":126,"entityType":139,"verifyStatus":140,"verifyTime":123,"verifyNote":141,"syncStatus":23,"languages":142,"translateLanguages":24,"viewCount":25,"primaryUrl":144,"fullTextUrl":24,"authors":145,"publicationType":288,"publisherRelationship":289,"citationCount":322,"citationInfo":323,"publishDate":325,"publishYear":326,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":327,"isForceReanalyzing":539},"e1e2b8f0-1265-4f7b-a09f-5ed04bd004e2","2024-09-02T22:55:44.620+00:00",[],"Blood-pressure-decreasing-effect-of-etamicastat-alone-and-in-combination-with-antihypertensive-drugs-in-the-spontaneously-hypertensive-rat",{"mag":127,"keywords":129,"openalex":130,"abstract":132,"title":133,"pm":135,"doi":137},{"VOID":128},"2001504124",{},{"VOID":131},"W2001504124",{},{"EN":134},"Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat",{"VOID":136},"25298210",{"VOID":138},"10.1038\u002Fhr.2014.143","PUBLICATION","VERIFIED","Auto Verify",[143],"EN","https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fhr2014143",[146,169,187,204,222,255,272],{"id":147,"sortIndex":148,"researcher":24,"roles":149,"affiliations":150,"properties":162},"d2d85291-8f78-4b3c-9a2a-dc6782699ad7",3,[],[151],{"id":152,"sortIndex":25,"affiliation":153,"properties":24},"1bb36ce6-9399-42e4-886f-14f52cd128e2",{"id":154,"createTime":155,"updateTime":156,"relativeEntities":157,"slug":158,"properties":159,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"81a6f502-b7a9-4cc9-8bd7-cd92b65e87c0","2024-01-13T23:12:44.862+00:00","2024-09-02T22:55:44.629+00:00",[],"Department-of-Research-and-Development-BIAL-Portela-C%C2%AA-S-A-S-Mamede-do-Coronado-Portugal",{"title":160},{"VI":161},"Department of Research and Development, BIAL – Portela & Cª, S.A., S. Mamede do Coronado, Portugal",{"openalex":163,"orcid":165,"title":167},{"VOID":164},"A5100644387",{"VOID":166},"https:\u002F\u002Forcid.org\u002F0000-0002-4676-8475",{"EN":168},"Ana I. Loureiro",{"id":170,"sortIndex":171,"researcher":24,"roles":172,"affiliations":173,"properties":180},"0c1342e5-a878-43ab-b546-65f1603c2581",4,[],[174],{"id":175,"sortIndex":25,"affiliation":176,"properties":24},"d23db065-d6ac-4528-b968-a6695b743d3c",{"id":154,"createTime":155,"updateTime":156,"relativeEntities":177,"slug":158,"properties":178,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":179},{"VI":161},{"openalex":181,"orcid":183,"title":185},{"VOID":182},"A5083074131",{"VOID":184},"https:\u002F\u002Forcid.org\u002F0000-0002-7508-0792",{"EN":186},"Carlos Fernandes‐Lopes",{"id":188,"sortIndex":25,"researcher":24,"roles":189,"affiliations":190,"properties":197},"c179e264-17d8-4a07-90c5-41c8c1af5e95",[],[191],{"id":192,"sortIndex":25,"affiliation":193,"properties":24},"88252a7e-afe7-4967-83cb-ee6d17bca57b",{"id":154,"createTime":155,"updateTime":156,"relativeEntities":194,"slug":158,"properties":195,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":196},{"VI":161},{"openalex":198,"orcid":200,"title":202},{"VOID":199},"A5007191545",{"VOID":201},"https:\u002F\u002Forcid.org\u002F0000-0003-1896-4388",{"EN":203},"Bruno Igreja",{"id":205,"sortIndex":206,"researcher":24,"roles":207,"affiliations":208,"properties":215},"52f01728-1651-4ed9-a550-bc5bacc90572",2,[],[209],{"id":210,"sortIndex":25,"affiliation":211,"properties":24},"3c7e53d7-f95e-42be-9222-7bc318696db3",{"id":154,"createTime":155,"updateTime":156,"relativeEntities":212,"slug":158,"properties":213,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":214},{"VI":161},{"openalex":216,"orcid":218,"title":220},{"VOID":217},"A5064879720",{"VOID":219},"https:\u002F\u002Forcid.org\u002F0000-0002-4782-4686",{"EN":221},"Maria João Bonifácio",{"id":223,"sortIndex":73,"researcher":24,"roles":224,"affiliations":225,"properties":248},"a9a5d675-90ce-47d5-a725-5304b7341c11",[],[226,236],{"id":227,"sortIndex":25,"affiliation":228,"properties":24},"8e8ad259-a337-4f50-9117-216ddb84f021",{"id":229,"createTime":230,"updateTime":231,"relativeEntities":232,"slug":158,"properties":233,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"8256d9f7-5611-42f8-adb3-9e7cc123832e","2023-12-20T02:18:38.127+00:00","2024-09-02T22:55:44.698+00:00",[],{"title":234},{"VI":235},"Department of Research and Development, BIAL-Portela & Cª, S.A., S. Mamede do Coronado, Portugal",{"id":237,"sortIndex":238,"affiliation":239,"properties":24},"32bb1b73-ecd3-4925-84dc-b8816bc79ac8",1,{"id":240,"createTime":241,"updateTime":242,"relativeEntities":243,"slug":244,"properties":245,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"3d8e4444-557c-47a8-ae03-f18a82ec5462","2023-12-23T12:06:30.578+00:00","2024-09-02T22:55:44.700+00:00",[],"MedInUP-Center-for-Drug-Discovery-and-Innovative-Medicines-University-of-Porto-Porto-Portugal",{"title":246},{"VI":247},"MedInUP-Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal",{"openalex":249,"orcid":251,"title":253},{"VOID":250},"A5078712323",{"VOID":252},"https:\u002F\u002Forcid.org\u002F0000-0002-2446-5078",{"EN":254},"Patrício Soares‐da‐Silva",{"id":256,"sortIndex":238,"researcher":24,"roles":257,"affiliations":258,"properties":265},"b3f3e4b0-f297-4ad0-b17c-cfe336db5bf2",[],[259],{"id":260,"sortIndex":25,"affiliation":261,"properties":24},"0e542fb4-3284-4d92-b03b-4ba08e481b00",{"id":154,"createTime":155,"updateTime":156,"relativeEntities":262,"slug":158,"properties":263,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":264},{"VI":161},{"openalex":266,"orcid":268,"title":270},{"VOID":267},"A5057581263",{"VOID":269},"https:\u002F\u002Forcid.org\u002F0000-0001-5244-8550",{"EN":271},"Nuno Pires",{"id":273,"sortIndex":274,"researcher":24,"roles":275,"affiliations":276,"properties":283},"4fba2cd0-6465-42c9-b61f-53121f198f3d",5,[],[277],{"id":278,"sortIndex":25,"affiliation":279,"properties":24},"f2abafc5-1b00-4586-a76a-e0499064c435",{"id":154,"createTime":155,"updateTime":156,"relativeEntities":280,"slug":158,"properties":281,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":282},{"VI":161},{"openalex":284,"title":286},{"VOID":285},"A5090795661",{"EN":287},"Lyndon Wright","ARTICLE",{"url":24,"publisher":290,"properties":315},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":291,"slug":10,"properties":292,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":298,"manageAffiliations":299,"indexDatabases":300,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":293,"issn":294,"introduce":295,"eissn":296,"title":297},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[301,308],{"id":77,"indexDatabase":302,"url":92,"indexYears":24,"academicFieldIds":307,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":303,"label":304,"description":305,"key":88,"publicationTags":306,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":309,"url":109,"indexYears":110,"academicFieldIds":314,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":310,"label":311,"description":312,"key":106,"publicationTags":313,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":316,"pages":318,"issue":320},{"VOID":317},"38",{"VOID":319},"30-38",{"VOID":321},"1",22,{"total":322,"publishYear":24,"statisticByYear":324},{"2015":73,"2016":238,"2017":238,"2018":206,"2019":73,"2020":206,"2021":206,"2023":238,"2024":238},"2015-01-01",2015,[328,332,336,340,344,348,352,356,360,364,367,371,375,379,383,387,391,395,399,403,407,411,415,419,423,427,431,434,438,441,445,448,452,456,460,464,468,471,475,479,483,487,491,494,498,502,505,508,512,515,519,523,527,531,535],{"id":24,"text":329,"url":24,"identifiers":330},"Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.",{"doi":331},"10.1016\u002FS0140-6736(05)70151-3",{"id":24,"text":333,"url":24,"identifiers":334},"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM . Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51: 1403–1419.",{"doi":335},"10.1161\u002FHYPERTENSIONAHA.108.189141",{"id":24,"text":337,"url":24,"identifiers":338},"Malpas SC . Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 2010; 90: 513–557.",{"doi":339},"10.1152\u002Fphysrev.00007.2009",{"id":24,"text":341,"url":24,"identifiers":342},"Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F Task Force Members. 2013 ESH\u002FESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357.",{"doi":343},"10.1097\u002F01.hjh.0000431740.32696.cc",{"id":24,"text":345,"url":24,"identifiers":346},"Grassi G . Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23: 1052–1060.",{"doi":347},"10.1038\u002Fajh.2010.154",{"id":24,"text":349,"url":24,"identifiers":350},"Grassi G, Seravalle G, Quarti-Trevano F . The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 2010; 95: 581–586.",{"doi":351},"10.1113\u002Fexpphysiol.2009.047381",{"id":24,"text":353,"url":24,"identifiers":354},"Esler M, Kaye D . Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 2000; 35 (Suppl 4): S1–S7.",{"doi":355},"10.1097\u002F00005344-200000004-00001",{"id":24,"text":357,"url":24,"identifiers":358},"Parati G, Esler M . The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 2012; 33: 1058–1066.",{"doi":359},"10.1093\u002Feurheartj\u002Fehs041",{"id":24,"text":361,"url":24,"identifiers":362},"Grassi G, Bolla G, Quarti-Trevano F, Arenare F, Brambilla G, Mancia G . Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers. Eur J Heart Fail 2008; 10: 1186–1191.",{"doi":363},"10.1016\u002Fj.ejheart.2008.09.013",{"id":24,"text":365,"url":24,"identifiers":366},"Lee CS, Tkacs NC . Current concepts of neurohormonal activation in heart failure: mediators and mechanisms. AACN Adv Crit Care 2008; 19: 364–385.",{},{"id":24,"text":368,"url":24,"identifiers":369},"Mancia G, Grassi G, Giannattasio C, Seravalle G . Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34 (Pt 2): 724–728.",{"doi":370},"10.1161\u002F01.HYP.34.4.724",{"id":24,"text":372,"url":24,"identifiers":373},"Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M . Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275–1281.",{"doi":374},"10.1016\u002FS0140-6736(09)60566-3",{"id":24,"text":376,"url":24,"identifiers":377},"Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903–1909.",{"doi":378},"10.1016\u002FS0140-6736(10)62039-9",{"id":24,"text":380,"url":24,"identifiers":381},"Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V . Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 2013; 34: 2132–2140.",{"doi":382},"10.1093\u002Feurheartj\u002Feht197",{"id":24,"text":384,"url":24,"identifiers":385},"Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M . Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 2013; 128: 132–140.",{"doi":386},"10.1161\u002FCIRCULATIONAHA.112.000949",{"id":24,"text":388,"url":24,"identifiers":389},"Krum H, Schlaich MP, Sobotka PA, Bohm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD . Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2013; 383: 622–629.",{"doi":390},"10.1016\u002FS0140-6736(13)62192-3",{"id":24,"text":392,"url":24,"identifiers":393},"Mahfoud F, Luscher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C, Doevendans P, Fagard R, Fajadet J, Komajda M, Lefèvre T, Lotan C, Sievert H, Volpe M, Widimsky P, Wijns W, Williams B, Windecker S, Witkowski A, Zeller T, Böhm M European Society of Cardiology. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J 2013; 34: 2149–2157.",{"doi":394},"10.1093\u002Feurheartj\u002Feht154",{"id":24,"text":396,"url":24,"identifiers":397},"Hayek SS, Abdou MH, Demoss BD, Legaspi JM, Veledar E, Deka A, Krishnan SK, Wilmot KA, Patel AD, Kumar VR, Devireddy CM . Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. Am J Hypertens 2013, 1452–1458.",{"doi":398},"10.1093\u002Fajh\u002Fhpt132",{"id":24,"text":400,"url":24,"identifiers":401},"Stanley WC, Li B, Bonhaus DW, Johnson LG, Lee K, Porter S, Walker K, Martinez G, Eglen RM, Whiting RL, Hegde SS . Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol 1997; 121: 1803–1809.",{"doi":402},"10.1038\u002Fsj.bjp.0701315",{"id":24,"text":404,"url":24,"identifiers":405},"Bertera FM, Del Mauro JS, Lovera V, Chiappetta D, Polizio AH, Taira CA, Höcht C . Acute effects of third generation beta-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats. Hypertens Res 2013; 36: 349–355.",{"doi":406},"10.1038\u002Fhr.2012.209",{"id":24,"text":408,"url":24,"identifiers":409},"Hegde SS, Friday KF . Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure. Curr Pharm Des 1998; 4: 469–479.",{"doi":410},"10.2174\u002F138161280406221011113124",{"id":24,"text":412,"url":24,"identifiers":413},"Soares-da-Silva P . Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol 1986; 333: 219–223.",{"doi":414},"10.1007\u002FBF00512932",{"id":24,"text":416,"url":24,"identifiers":417},"Soares-da-Silva P . A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery. Br J Pharmacol 1987; 90: 91–98.",{"doi":418},"10.1111\u002Fj.1476-5381.1987.tb16828.x",{"id":24,"text":420,"url":24,"identifiers":421},"Gomes P, Soares-da-Silva P . Dopamine. In Michael Bader (ed.). Cardiovascular Hormone Systems: From Molecular Mechanisms to Novel Therapeutics. Wiley-Blackwell: Weinheim, Germany. 2008, pp 251–293.",{"doi":422},"10.1002\u002F9783527626236.ch11",{"id":24,"text":424,"url":24,"identifiers":425},"Jose PA, Eisner GM, Felder RA . Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 2002; 11: 87–92.",{"doi":426},"10.1097\u002F00041552-200201000-00013",{"id":24,"text":428,"url":24,"identifiers":429},"Jose PA, Soares-da-Silva P, Eisner GM, Felder RA . Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 2010; 1802: 1259–1267.",{"doi":430},"10.1016\u002Fj.bbadis.2010.02.004",{"id":24,"text":432,"url":24,"identifiers":433},"Ishii Y, Fujii Y, Mimura C, Umezawa H . Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs. Arzneimittelforschung 1975; 25: 55–59.",{},{"id":24,"text":435,"url":24,"identifiers":436},"Kruse LI, Kaiser C, DeWolf WE Jr, Frazee JS, Ross ST, Wawro J, Wise M, Flaim KE, Sawyer JL, Erickson RW . Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site. J Med Chem 1987; 30: 486–494.",{"doi":437},"10.1021\u002Fjm00386a008",{"id":24,"text":439,"url":24,"identifiers":440},"Ohlstein EH, Kruse LI, Ezekiel M, Sherman SS, Erickson R, DeWolf WE Jr, Berkowitz BA . Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats. J Pharmacol Exp Ther 1987; 241 (2): 554–559.",{},{"id":24,"text":442,"url":24,"identifiers":443},"Kruse LI, Kaiser C, DeWolf WE Jr, Frazee JS, Erickson RW, Ezekiel M, Ohlstein EH, Ruffolo RR Jr, Berkowitz BA . Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine beta-hydroxylase. J Med Chem 1986; 29: 887–889.",{"doi":444},"10.1021\u002Fjm00156a002",{"id":24,"text":446,"url":24,"identifiers":447},"Falcao A, Nunes T, Rocha JF, Almeida L, Soares-da-Silva P . Comparative bioavailability study of etamicastat (BIA 5-453) under fasted and fed conditions. J Clin Pharmacol 2009; 49: 1095 (abstract).",{},{"id":24,"text":449,"url":24,"identifiers":450},"Nunes T, Rocha JF, Vaz-da-Silva M, Falcao A, Almeida L, Soares-da-Silva P . Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study. Clin Ther 2011; 33: 776–791.",{"doi":451},"10.1016\u002Fj.clinthera.2011.05.048",{"id":24,"text":453,"url":24,"identifiers":454},"Nunes T, Rocha JF, Vaz-da-Silva M, Igreja B, Wright LC, Falcão A, Almeida L, Soares-da-Silva P . Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-beta-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects. Drugs R D 2010; 10: 225–242.",{"doi":455},"10.2165\u002F11586310-000000000-00000",{"id":24,"text":457,"url":24,"identifiers":458},"Rocha JF, Vaz-da-Silva M, Nunes T, Igreja B, Loureiro AI, Bonifácio MJ, Wright LC, Falcão A, Almeida L, Soares-da-Silva P . Single-dose tolerability, pharmacokinetics, and pharmacodynamics of etamicastat (BIA 5-453), a new dopamine {beta}-hydroxylase inhibitor, in healthy subjects. J Clin Pharmacol 2012; 52: 156–170.",{"doi":459},"10.1177\u002F0091270010390805",{"id":24,"text":461,"url":24,"identifiers":462},"Vaz-da-Silva M, Nunes T, Rocha JF, Falcao A, Almeida L, Soares-da-Silva P . Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453). Drugs R D 2011; 11: 127–136.",{"doi":463},"10.2165\u002F11587080-000000000-00000",{"id":24,"text":465,"url":24,"identifiers":466},"Beliaev A, Learmonth DA, Soares-da-Silva P . Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase. J Med Chem 2006; 49: 1191–1197.",{"doi":467},"10.1021\u002Fjm051051f",{"id":24,"text":469,"url":24,"identifiers":470},"Bonifácio MJ, Igreja B, Wright L, Soares-da-Silva P . Kinetic studies on the inhibition of dopamine-ß-hydroxylase by BIA 5-453. pA2 Online 2009; 7: 050P (abstract).",{},{"id":24,"text":472,"url":24,"identifiers":473},"Almeida L, Nunes T, Costa R, Rocha JF, Vaz-da-Silva M, Soares-da-Silva P . Etamicastat, a novel dopamine beta-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension. Clin Ther 2013; 35: 1983–1996.",{"doi":474},"10.1016\u002Fj.clinthera.2013.10.012",{"id":24,"text":476,"url":24,"identifiers":477},"Loureiro AI, Fernandes-Lopes C, Bonifacio MJ, Wright LC, Soares-da-Silva P . N-acetylation of etamicastat, a reversible dopamine-beta-hydroxylase inhibitor. Drug Metab Dispos 2013; 41: 2081–2086.",{"doi":478},"10.1124\u002Fdmd.113.053736",{"id":24,"text":480,"url":24,"identifiers":481},"Soares-da-Silva P, Pestana M, Vieira-Coelho MA, Fernandes MH, Albino-Teixeira A . Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model. Br J Pharmacol 1995; 114: 1403–1413.",{"doi":482},"10.1111\u002Fj.1476-5381.1995.tb13362.x",{"id":24,"text":484,"url":24,"identifiers":485},"Huetteman DA, Bogie H . Direct blood pressure monitoring in laboratory rodents via implantable radio telemetry. Methods Mol Biol 2009; 573: 57–73.",{"doi":486},"10.1007\u002F978-1-60761-247-6_4",{"id":24,"text":488,"url":24,"identifiers":489},"Clough DP, Hatton R, Keddie JR, Collis MG . Hypotensive action of captopril in spontaneously hypertensive and normotensive rats. Interference with neurogenic vasoconstriction. Hypertension 1982; 4: 764–772.",{"doi":490},"10.1161\u002F01.HYP.4.6.764",{"id":24,"text":492,"url":24,"identifiers":493},"Narita H, Nagao T, Yabana H, Yamaguchi I . Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats. J Pharmacol Exp Ther 1983; 227: 472–477.",{},{"id":24,"text":495,"url":24,"identifiers":496},"Wada T, Sanada T, Ojima M, Kanagawa R, Nishikawa K, Inada Y . Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats. Hypertens Res 1996; 19: 247–254.",{"doi":497},"10.1291\u002Fhypres.19.247",{"id":24,"text":499,"url":24,"identifiers":500},"DePasquale MJ, Fossa AA, Holt WF, Mangiapane ML . Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats. Hypertension 1992; 19 (Part 2): 668–671.",{"doi":501},"10.1161\u002F01.HYP.19.6.668",{"id":24,"text":503,"url":24,"identifiers":504},"Antonaccio MJ, High J, DeForrest JM, Sybertz E . Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. J Pharmacol Exp Ther 1986; 238: 378–387.",{},{"id":24,"text":506,"url":24,"identifiers":507},"Ryan MJ, Bjork FA, Cohen DM, Coughenour LL, Major TC, Mathias NP, Mertz TE, Olszewski BJ, Singer RM, Evans DB CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology. J Pharmacol Exp Ther 1986; 238: 473–479.",{},{"id":24,"text":509,"url":24,"identifiers":510},"Jose PA, Eisner GM, Felder RA . Dopamine and the kidney: a role in hypertension? Curr Opin Nephrol Hypertens 2003; 12: 189–194.",{"doi":511},"10.1097\u002F00041552-200303000-00010",{"id":24,"text":513,"url":24,"identifiers":514},"Igreja B, Wright L, Soares-da-Silva P . Sustained antihypertensive effects of a selective peripheral dopamine-ß-hydroxylase inhibitor. Hypertension 2007; 50: E133 (abstract).",{},{"id":24,"text":516,"url":24,"identifiers":517},"Foss JD, Fink GD, Osborn JW . Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension 2013; 61: 806–811.",{"doi":518},"10.1161\u002FHYPERTENSIONAHA.111.00474",{"id":24,"text":520,"url":24,"identifiers":521},"Pfeffer MA, Stevenson LW . Beta-adrenergic blockers and survival in heart failure. New Engl J Med 1996; 334: 1396–1397.",{"doi":522},"10.1056\u002FNEJM199605233342109",{"id":24,"text":524,"url":24,"identifiers":525},"Goldsmith SR . Interactions between the sympathetic nervous system and the RAAS in heart failure. Curr Heart Fail Rep 2004; 1: 45–50.",{"doi":526},"10.1007\u002Fs11897-004-0024-5",{"id":24,"text":528,"url":24,"identifiers":529},"Kalra S, Kalra B, Agrawal N . Combination therapy in hypertension: an update. Diabetol Metab Syndr 2010; 2: 44.",{"doi":530},"10.1186\u002F1758-5996-2-44",{"id":24,"text":532,"url":24,"identifiers":533},"Law MR, Morris JK, Wald NJ . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.",{"doi":534},"10.1136\u002Fbmj.b1665",{"id":24,"text":536,"url":24,"identifiers":537},"Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA . Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51: 55–61.",{"doi":538},"10.1161\u002FHYPERTENSIONAHA.107.100727",false,{"id":541,"createTime":542,"updateTime":542,"relativeEntities":543,"slug":544,"properties":545,"entityType":139,"verifyStatus":140,"verifyTime":542,"verifyNote":141,"syncStatus":23,"languages":560,"translateLanguages":24,"viewCount":25,"primaryUrl":561,"fullTextUrl":24,"authors":562,"publicationType":288,"publisherRelationship":603,"citationCount":635,"citationInfo":636,"publishDate":646,"publishYear":647,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":648,"isForceReanalyzing":539},"3c37d726-e5e3-4be4-a2e3-24a8dc004d35","2024-10-07T18:43:14.317+00:00",[],"Sympathetic-nervous-system-in-obesity-related-hypertension-mechanisms-and-clinical-implications",{"mag":546,"keywords":548,"pmc":549,"openalex":551,"abstract":553,"title":554,"pm":556,"doi":558},{"VOID":547},"2056092079",{},{"VOID":550},"3902842",{"VOID":552},"W2056092079",{},{"EN":555},"Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications",{"VOID":557},"22048570",{"VOID":559},"10.1038\u002Fhr.2011.173",[143],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fhr2011173",[563,582],{"id":564,"sortIndex":25,"researcher":24,"roles":565,"affiliations":566,"properties":577},"3c9329d4-56f8-468f-9ee1-d4d5ca0857ca",[],[567],{"id":568,"sortIndex":25,"affiliation":569,"properties":24},"74c1ca53-96d7-48c9-bb2f-17caa1b8c90c",{"id":570,"createTime":571,"updateTime":571,"relativeEntities":572,"slug":573,"properties":574,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"2e9e2b48-7ef0-494a-9970-5d3c29bb0392","2024-10-07T18:43:14.330+00:00",[],"Division-of-Endocrinology-Department-of-Internal-Medicine-Carver-College-of-Medicine-University-of-Iowa-Iowa-City-IA-52242-USA-",{"title":575},{"EN":576},"Division of Endocrinology, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.",{"openalex":578,"title":580},{"VOID":579},"A5004015869",{"EN":581},"Graziela Z Kalil",{"id":583,"sortIndex":238,"researcher":24,"roles":584,"affiliations":585,"properties":596},"57f12b8c-ff83-4d43-99c3-ca199a742847",[],[586],{"id":587,"sortIndex":25,"affiliation":588,"properties":24},"16d2c116-b121-4ea0-b149-87882a0507ef",{"id":589,"createTime":590,"updateTime":590,"relativeEntities":591,"slug":592,"properties":593,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"796d7623-9415-4eba-8152-a5c20a42cad9","2024-10-07T18:43:14.338+00:00",[],"Divisions-of-Endocrinology-and-Cardiovascular-Medicine-Department-of-Internal-Medicine-Carver-College-of-Medicine-University-of-Iowa-Iowa-City-USA",{"title":594},{"EN":595},"Divisions of Endocrinology and Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, USA",{"openalex":597,"orcid":599,"title":601},{"VOID":598},"A5078793399",{"VOID":600},"https:\u002F\u002Forcid.org\u002F0000-0003-1004-6136",{"EN":602},"William G. Haynes",{"url":24,"publisher":604,"properties":629},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":605,"slug":10,"properties":606,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":612,"manageAffiliations":613,"indexDatabases":614,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":607,"issn":608,"introduce":609,"eissn":610,"title":611},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[615,622],{"id":77,"indexDatabase":616,"url":92,"indexYears":24,"academicFieldIds":621,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":617,"label":618,"description":619,"key":88,"publicationTags":620,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":623,"url":109,"indexYears":110,"academicFieldIds":628,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":624,"label":625,"description":626,"key":106,"publicationTags":627,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":630,"pages":632,"issue":634},{"VOID":631},"35",{"VOID":633},"4-16",{"VOID":321},185,{"total":635,"publishYear":24,"statisticByYear":637},{"2012":638,"2013":639,"2014":640,"2015":641,"2016":640,"2017":642,"2018":641,"2019":638,"2020":642,"2021":643,"2022":644,"2023":645,"2024":642},9,16,12,15,14,18,7,30,"2012-01-01",2012,[649,652,656,660,664,668,672,676,680,684,688,692,696,700,704,708,711,714,717,721,725,729,733,737,741,745,749,753,757,761,765,769,773,777,781,785,789,793,797,801,805,809,813,817,821,825,829,833,837,841,844,847,851,855,859,863,867,871,875,879,883,887,891,895,899,903,907,911,915,919,923,927,931,935,939,942,946,950,954,958,962,966,970,974,978,982,986,990,994,998,1002,1006,1010,1014,1018,1022,1026,1030,1034,1038,1042,1046,1050,1054,1058,1062,1066,1070,1074,1078,1082,1086,1090,1094,1098,1102,1106,1110,1114,1118,1122,1126,1130,1134,1138,1142,1146,1150,1154,1158,1162,1166,1170,1174,1178,1182,1185,1189,1193,1196,1200,1204,1208,1212,1216,1220,1223,1227,1231,1235,1239,1243,1247,1251,1254,1258,1262,1266,1270,1274,1278,1281,1285,1289,1293],{"id":24,"text":650,"url":24,"identifiers":651},"CDC. State-specific prevalence of obesity among adults—United States, 2009. MMWR 2009; 59: 1–5.",{},{"id":24,"text":653,"url":24,"identifiers":654},"Matshushita Y, Takahashi Y, Mizoue T, Inoue M, Noda M, Tsugane S . Overweight and obesity trends among Japanese adults: a 10-year follow-up of the JPHC Study. Int J Obes 2008; 32: 1861–1867.",{"doi":655},"10.1038\u002Fijo.2008.188",{"id":24,"text":657,"url":24,"identifiers":658},"Lapidus L, Bengtsson C, Bjorntorp P . The quantitative relationship between ‘the metabolic syndrome’ and abdominal obesity in women. Obes Res 1994; 4: 372–377.",{"doi":659},"10.1002\u002Fj.1550-8528.1994.tb00077.x",{"id":24,"text":661,"url":24,"identifiers":662},"Emerging Risk Factors Collaboration Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, Sarwar N, Kizer JR, Lawlor DA, Nordestgaard BG, Ridker P, Salomaa V, Stevens J, Woodward M, Sattar N, Collins R, Thompson SG, Whitlock G, Danesh J . Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085–1095.",{"doi":663},"10.1016\u002FS0140-6736(11)60105-0",{"id":24,"text":665,"url":24,"identifiers":666},"Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M . Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8: 605–619.",{"doi":667},"10.1038\u002Foby.2000.79",{"id":24,"text":669,"url":24,"identifiers":670},"Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP . Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893–897.",{"doi":671},"10.1161\u002F01.HYP.25.4.893",{"id":24,"text":673,"url":24,"identifiers":674},"Samuelson A, Morris A, Igosheva N, Kirk SL, Pombo JMC, Coen CW, Poston L, Taylor PD . Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats. Hypertension 2010; 55: 76–82.",{"doi":675},"10.1161\u002FHYPERTENSIONAHA.109.139402",{"id":24,"text":677,"url":24,"identifiers":678},"Tuck ML . Obesity, the sympathetic nervous system and essential hypertension. Hypertension 1992; 19: I67–I77.",{"doi":679},"10.1161\u002F01.HYP.19.1_Suppl.I67",{"id":24,"text":681,"url":24,"identifiers":682},"Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I . Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 2007; 49: 27–33.",{"doi":683},"10.1161\u002F01.HYP.0000251679.87348.05",{"id":24,"text":685,"url":24,"identifiers":686},"Wofford MR, Anderson Jr DC, Brown CA, Jones DW, Miller ME, Hall JE . Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens 2001; 14: 694–698.",{"doi":687},"10.1016\u002FS0895-7061(01)01293-6",{"id":24,"text":689,"url":24,"identifiers":690},"Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G . Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25: 560–563.",{"doi":691},"10.1161\u002F01.HYP.25.4.560",{"id":24,"text":693,"url":24,"identifiers":694},"Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M . Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423–3429.",{"doi":695},"10.1161\u002F01.CIR.96.10.3423",{"id":24,"text":697,"url":24,"identifiers":698},"Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, Lambert G . Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007; 50: 862–868.",{"doi":699},"10.1161\u002FHYPERTENSIONAHA.107.094649",{"id":24,"text":701,"url":24,"identifiers":702},"Agapitov AV, Correia MLG, Sinkey CA, Haynes WG . Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 2008; 52: 687–695.",{"doi":703},"10.1161\u002FHYPERTENSIONAHA.107.109603",{"id":24,"text":705,"url":24,"identifiers":706},"Correia MLG, Agapitov AV, Siney CA, Mark AL, Haynes WG . Obesity does not increase sympathetic vascular tone in hypertensives. Am J Hypertens 2005; 2: 195A.",{"doi":707},"10.1016\u002Fj.amjhyper.2005.03.535",{"id":24,"text":709,"url":24,"identifiers":710},"Correia M, Agapitov A, Siney C, Mark A, Haynes W . Weight loss does not reduce sympathetic vascular tone I obese hypertensives. Obes Res 2005; 3 (Suppl): A47.",{},{"id":24,"text":712,"url":24,"identifiers":713},"Correia, Marcelo Lima De Gusmao. ‘Sympathetic Vascular Tone in Human Obesity’ PhD diss., University of Iowa, 2007. http:\u002F\u002Fir.uiowa.edu\u002Fetd\u002F134 .",{},{"id":24,"text":715,"url":24,"identifiers":716},"Tappy L, Girardet K, Schwaller N, Vollenweider L, Jequier E, Nodod P, Scherrer U . Metabolic effects of an increase of sympathetic activity in healthy humans. Int J Obesity Metab Dis 1995; 19: 419–422.",{},{"id":24,"text":718,"url":24,"identifiers":719},"Young JB, Weiss J, Boufath N . Effects of dietary monosaccharides on sympathetic nervous system activity in adipose tissues of male rats. Diabetes 2004; 53: 1271–1278.",{"doi":720},"10.2337\u002Fdiabetes.53.5.1271",{"id":24,"text":722,"url":24,"identifiers":723},"Serazin V, Dos Santos E, Morot M, Giudicelli Y . Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity. Endocrine 2004; 25: 97–104.",{"doi":724},"10.1385\u002FENDO:25:2:097",{"id":24,"text":726,"url":24,"identifiers":727},"Licata G, Volpe M, Scaglione R, Rubattu S . Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension 1994; 23: 1020–1024.",{"doi":728},"10.1161\u002F01.HYP.23.1_Suppl.I20",{"id":24,"text":730,"url":24,"identifiers":731},"Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M . The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930–933.",{"doi":732},"10.1056\u002FNEJM198104163041602",{"id":24,"text":734,"url":24,"identifiers":735},"Cooper R, Forrester T, Ogunbiyi O, Muffinda J . Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 1998; 16: 571–575.",{"doi":736},"10.1097\u002F00004872-199816050-00003",{"id":24,"text":738,"url":24,"identifiers":739},"Engeli S, Sharma AM . The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 2001; 79: 21–29.",{"doi":740},"10.1007\u002Fs001090000144",{"id":24,"text":742,"url":24,"identifiers":743},"Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM . Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356–362.",{"doi":744},"10.1161\u002F01.HYP.0000154361.47683.d3",{"id":24,"text":746,"url":24,"identifiers":747},"Giacchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C, Garrapa GG, Guerrieri M, Mantero F . Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord 2000; 24 (Suppl 2): S142–S143.",{"doi":748},"10.1038\u002Fsj.ijo.0801305",{"id":24,"text":750,"url":24,"identifiers":751},"Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P . Increased adipose angiotensinogen gene expression in human obesity. Obes Res 2000; 8: 337–341.",{"doi":752},"10.1038\u002Foby.2000.40",{"id":24,"text":754,"url":24,"identifiers":755},"Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL . Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. J Clin Invest 1991; 87: 2246–2252.",{"doi":756},"10.1172\u002FJCI115260",{"id":24,"text":758,"url":24,"identifiers":759},"Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL . Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992; 19: 621–627.",{"doi":760},"10.1161\u002F01.HYP.19.6.621",{"id":24,"text":762,"url":24,"identifiers":763},"Hausberg M, Hoffman RP, Somers VK, Sinkey CA, Mark AL, Anderson EA . Contrasting autonomic and hemodynamic effects of insulin in healthy elderly versus young subjects. Hypertension 1997; 29: 700–705.",{"doi":764},"10.1161\u002F01.HYP.29.3.700",{"id":24,"text":766,"url":24,"identifiers":767},"Rahmouni K, Morgan DA, Morgan GM, Liu X, Sigmund CD, Mark AL, Haynes WG . Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest 2004; 114: 625–628.",{"doi":768},"10.1172\u002FJCI21737",{"id":24,"text":770,"url":24,"identifiers":771},"Dallman MF, Strack AM, Akana SF, Bradburry MJ, Hanson ES, Scribner KA, Smith M . Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 1993; 14: 303–347.",{"doi":772},"10.1006\u002Ffrne.1993.1010",{"id":24,"text":774,"url":24,"identifiers":775},"Goodwin JE, Zhang J, Geller DS . A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension. J Am Soc Nephrol 2008; 19: 1291–1299.",{"doi":776},"10.1681\u002FASN.2007080911",{"id":24,"text":778,"url":24,"identifiers":779},"Sato A, Funder JW, Okubo M, Kubota E, Saruta T . Glucocorticoid-induced hypertension in the elderly relation to serum calcium and family history of essential hypertension. Am J Hypertens 1995; 8: 823–828.",{"doi":780},"10.1016\u002F0895-7061(95)00149-J",{"id":24,"text":782,"url":24,"identifiers":783},"Grassi G, Seravalle G, Dell Oro R, Turri C, Pasqualinotto L, Colombo M, Mancia G . Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 2001; 38: 1316–1320.",{"doi":784},"10.1161\u002Fhy1201.096117",{"id":24,"text":786,"url":24,"identifiers":787},"Matias I, Di Marzo V . Endocannabinoids and the control of energy balance. Trends Endocrinol Metabol 2007; 18: 27–37.",{"doi":788},"10.1016\u002Fj.tem.2006.11.006",{"id":24,"text":790,"url":24,"identifiers":791},"Jamshidi N, Taylor DA . Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 2001; 134: 1151–1154.",{"doi":792},"10.1038\u002Fsj.bjp.0704379",{"id":24,"text":794,"url":24,"identifiers":795},"Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, Batkai S, Pacher P, Harvery-White J, Luft FC, Sharma AM, Jordan J . Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005; 54: 2838–2843.",{"doi":796},"10.2337\u002Fdiabetes.54.10.2838",{"id":24,"text":798,"url":24,"identifiers":799},"Pacher P, Batkai S, Kunos G . Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology 2005; 48: 1130–1138.",{"doi":800},"10.1016\u002Fj.neuropharm.2004.12.005",{"id":24,"text":802,"url":24,"identifiers":803},"Brozoski DT, Dean C, Hopp FA, Hillard CJ, Seagard JL . Differential endocannabinoid regulation of baroreflex-evoked sympathoactivation in normotensive versus hypertensive rats. Auton Neurosci 2009; 150: 82–93.",{"doi":804},"10.1016\u002Fj.autneu.2009.05.243",{"id":24,"text":806,"url":24,"identifiers":807},"Ruilope LM, Despres JP, Scheen A, Pi-Sunyer X, Mancia G, Zanchetti A, Van Gaal L . Effect of rimonabant on blood pressure in overweight\u002Fobese patients with\u002Fwithout co-morbidities: analysis of pooled RIO study results. J Hypertens 2008; 26: 357–367.",{"doi":808},"10.1097\u002FHJH.0b013e3282f2d625",{"id":24,"text":810,"url":24,"identifiers":811},"Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G . Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 822–825.",{"doi":812},"10.1038\u002F35071088",{"id":24,"text":814,"url":24,"identifiers":815},"Tschop M, Smiley DL, Heiman ML . Ghrelin induces adiposity in rodents. Nature 2000; 407: 908–913.",{"doi":816},"10.1038\u002F35038090",{"id":24,"text":818,"url":24,"identifiers":819},"Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML . Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707–709.",{"doi":820},"10.2337\u002Fdiabetes.50.4.707",{"id":24,"text":822,"url":24,"identifiers":823},"Langenberg C, Bergstrom J, Laughlin GA, Barrett-Connor E . Ghrelin and the metabolic syndrome in older adults. J Clin Endocrinol Metab 2005; 90: 6448–6453.",{"doi":824},"10.1210\u002Fjc.2005-1358",{"id":24,"text":826,"url":24,"identifiers":827},"Lambert E, Lambert G, Ika-Sari C, Dawood T, Lee K, Chopra R, Straznicky N, Eikelis N, Drew S, Tilbrook A, Dixon J, Esler M, Schlaich MP . Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension 2011; 58: 43–50.",{"doi":828},"10.1161\u002FHYPERTENSIONAHA.111.171025",{"id":24,"text":830,"url":24,"identifiers":831},"Li ZF, Guo ZF, Yang SG, Zheng X, Cao J, Qin YW . Circulating ghrelin and ghrelin to obestatin ration are low in patients with untreated mild-to-moderate hypertension. Regul Pept 2010; 165: 206–209.",{"doi":832},"10.1016\u002Fj.regpep.2010.07.168",{"id":24,"text":834,"url":24,"identifiers":835},"Berthold HK, Giannakidou E, Krone W, Tregouet DA, Gouni-Berthold I . Influence of ghrelin gene polymorphisms on hypertension and atherosclerotic disease. Hypertens Res 2010; 33: 155–160.",{"doi":836},"10.1038\u002Fhr.2009.194",{"id":24,"text":838,"url":24,"identifiers":839},"Haqq AM, Stadler DD, Rosenfeld RG, Pratt KL, Weigle DS, Frayo RS, LaFranchi SH, Cummings DE, Purnell JQ . Circulating ghrelin levels are suppressed by meals and octreotide therapy in Prader-Willi Syndrome. J Clin Endocrinol Metab 2003; 88: 3573–3576.",{"doi":840},"10.1210\u002Fjc.2003-030205",{"id":24,"text":842,"url":24,"identifiers":843},"Vogels A, Fryns JP . Age at diagnosis, body mass index and physical morbidity in children and adults with the Prader-Willi syndrome. Genet Couns 2004; 15: 397–404.",{},{"id":24,"text":845,"url":24,"identifiers":846},"Tanida M, Shen J, Horii Y, Matsuda M, Kihara S, Funahashi T, Shimomura I, Sawai H, Fukuda Y, Matsuzawa Y, Nagai K . Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med 2007; 232: 390–397.",{},{"id":24,"text":848,"url":24,"identifiers":849},"Vasunta RL, Kesaniemi YA, Ukkola O . Plasma adiponectin concentration is associated with ambulatory daytime systolic blood pressure but not with the dipping status. J Hum Hypertens 2010; 24: 545–551.",{"doi":850},"10.1038\u002Fjhh.2009.98",{"id":24,"text":852,"url":24,"identifiers":853},"Celoria BMJ, Genelhu VA, Duarte SFP, Delfraro PAS, Francischetti EA . Hypoadiponectinemia is associated with prehypertension in obese individuals of multiethnic origin. Clin Cardiol 2010; 33: E61–E65.",{"doi":854},"10.1002\u002Fclc.20657",{"id":24,"text":856,"url":24,"identifiers":857},"Lim SY, Davidson SM, Paramanathan AJ, Smith CC, Yellon DM, Hausenloy DJ . The novel adipocytokine visfatin exerts direct cardioprotective effects. J Cell Mol Med 2008; 12: 1395–1403.",{"doi":858},"10.1111\u002Fj.1582-4934.2008.00332.x",{"id":24,"text":860,"url":24,"identifiers":861},"Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh A, Ostsuka N . Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis 2011; 10: 79.",{"doi":862},"10.1186\u002F1476-511X-10-79",{"id":24,"text":864,"url":24,"identifiers":865},"Kawamoto R, Tabara Y, Kohara K, Abe M, Kusunoki T, Miki T . Association of serum high molecular weight adiponectin and blood pressure among non-diabetic community dwelling men. Clin Exp Hypertens 2011; 33: 336–344.",{"doi":866},"10.3109\u002F10641963.2010.531847",{"id":24,"text":868,"url":24,"identifiers":869},"Takahashi N, Anan F, Nakagawa M, Yufu K, Shinohara T, Tsubone T, Goto K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Hara M, Saikawa T, Yoshimatsu H . Hypoadiponectinemia in type 2 diabetes mellitus in men is associated with sympathetic overactivity as evaluated by cardiac 123I-metaiodobenzylguanidine scintigraphy. Metabolism 2007; 56: 919–924.",{"doi":870},"10.1016\u002Fj.metabol.2007.02.005",{"id":24,"text":872,"url":24,"identifiers":873},"Leu H-B, Chung C-M, Lin S-J, Jong Y-S, Pan W-H, Chen JW . Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS One 2011; 6: e19999.",{"doi":874},"10.1371\u002Fjournal.pone.0019999",{"id":24,"text":876,"url":24,"identifiers":877},"Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K, Lamon-Fava S, Wilson PW, Matsuzawa Y, Shaefer EJ . Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis 2011; 217: 543–548.",{"doi":878},"10.1016\u002Fj.atherosclerosis.2011.05.035",{"id":24,"text":880,"url":24,"identifiers":881},"Thomopoulos C, Daskalaki M, Papazachou O, Rodolakis N, Bratsas A, Papadopoulos DP, Papavasileiou MV, Perrea D, Makris T . Association of resistin and adiponectin with different clinical blood pressure phenotypes. J Hum Hypertens 2011; 25: 38–46.",{"doi":882},"10.1038\u002Fjhh.2010.22",{"id":24,"text":884,"url":24,"identifiers":885},"Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM . Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543–546.",{"doi":886},"10.1126\u002Fscience.7624777",{"id":24,"text":888,"url":24,"identifiers":889},"Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI . Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270–278.",{"doi":890},"10.1172\u002FJCI119532",{"id":24,"text":892,"url":24,"identifiers":893},"Correia ML, Morgan DA, Sivitz WI, Mark AL, Haynes WG . Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001; 37: 936–942.",{"doi":894},"10.1161\u002F01.HYP.37.3.936",{"id":24,"text":896,"url":24,"identifiers":897},"Shek EW, Brands MW, Hall JE . Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409–414.",{"doi":898},"10.1161\u002F01.HYP.31.1.409",{"id":24,"text":900,"url":24,"identifiers":901},"Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K . Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243–1252.",{"doi":902},"10.1172\u002FJCI8341",{"id":24,"text":904,"url":24,"identifiers":905},"Carlyle M, Jones OK, Kuo JJ, Hall JE . Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002; 39: 496–501.",{"doi":906},"10.1161\u002Fhy0202.104398",{"id":24,"text":908,"url":24,"identifiers":909},"Farooqi SI, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O’Rahilly S . Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879–884.",{"doi":910},"10.1056\u002FNEJM199909163411204",{"id":24,"text":912,"url":24,"identifiers":913},"Ozata M, Ozdemir IC, Licino J . Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84: 3686–3695.",{"doi":914},"10.1210\u002Fjcem.84.10.5999",{"id":24,"text":916,"url":24,"identifiers":917},"Shintani M, Ikegami H, Fujisawa T, Kamaguchi Y, Ohishi M, Katsuya T, Higaki J, Shimmoto K, Ogihara T . Leptin gene polymorphism is associated with hypertension independent of obesity. J Clin Endocrinol Metab 2002; 87: 2909–2912.",{"doi":918},"10.1210\u002Fjcem.87.6.8595",{"id":24,"text":920,"url":24,"identifiers":921},"do Carmo JM, da Silva AA, Cai Z, Lin S, Dubinion JH, Hall JE . Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension 2011; 57: 918–926.",{"doi":922},"10.1161\u002FHYPERTENSIONAHA.110.161349",{"id":24,"text":924,"url":24,"identifiers":925},"Shankar A, Xiao J . Positive relationship between plasma leptin level and hypertension. Hypertension 2010; 56: 623–628.",{"doi":926},"10.1161\u002FHYPERTENSIONAHA.109.148213",{"id":24,"text":928,"url":24,"identifiers":929},"Grøntved A, Steene-Johannessen J, Kynde I, Franks PW, Helge JW, Froberg K, Anderssen SA, Andersen LB . Association between plasma leptin and blood pressure in two population-based samples of children and adolescents. J Hypertens 2011; 29: 1093–1100.",{"doi":930},"10.1097\u002FHJH.0b013e328346d787",{"id":24,"text":932,"url":24,"identifiers":933},"Abramson JL, Lewis C, Murrah NV . Body mass index, leptin, and ambulatory blood pressure variability in healthy adults. Atherosclerosis 2011; 214: 456–461.",{"doi":934},"10.1016\u002Fj.atherosclerosis.2010.11.003",{"id":24,"text":936,"url":24,"identifiers":937},"Rahmouni K, Haynes WG, Morgan DA, Mark AL . Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 2003; 41: 763–767.",{"doi":938},"10.1161\u002F01.HYP.0000048342.54392.40",{"id":24,"text":940,"url":24,"identifiers":941},"Rahmouni K, Sigmund CD, Haynes WG, Mark AL . Mitogen activated protein kinase: a newly discovered mediator of selective leptin actions. Hypertension 2005; 46: 867.",{},{"id":24,"text":943,"url":24,"identifiers":944},"Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers Jr MG . STAT3 signaling is required for leptin regulation of energy balance but not reproduction. Nature 2003; 421: 856–859.",{"doi":945},"10.1038\u002Fnature01388",{"id":24,"text":947,"url":24,"identifiers":948},"Flier JS . Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004; 116: 337–350.",{"doi":949},"10.1016\u002FS0092-8674(03)01081-X",{"id":24,"text":951,"url":24,"identifiers":952},"Fruhbeck G . Intracellular signaling pathways activated by leptin. Biochem J 2006; 393: 7–20.",{"doi":953},"10.1042\u002FBJ20051578",{"id":24,"text":955,"url":24,"identifiers":956},"Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL . The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002; 51: 439–442.",{"doi":957},"10.2337\u002Fdiabetes.51.2.439",{"id":24,"text":959,"url":24,"identifiers":960},"Rahmouni K, Haynes WG, Morgan DA, Mark AL . Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002; 39: 486–490.",{"doi":961},"10.1161\u002Fhy0202.102836",{"id":24,"text":963,"url":24,"identifiers":964},"Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG . Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 2005; 54: 2012–2018.",{"doi":965},"10.2337\u002Fdiabetes.54.7.2012",{"id":24,"text":967,"url":24,"identifiers":968},"Haynes WG, Morgan DA, Djalali A, Sivitz W, Mark AL . Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999; 33: 542–547.",{"doi":969},"10.1161\u002F01.HYP.33.1.542",{"id":24,"text":971,"url":24,"identifiers":972},"Hausberg M, Morgan DA, Chapleau MA, Sivitz WI, Mark AL, Haynes WG . Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 2002; 20: 1633–1641.",{"doi":973},"10.1097\u002F00004872-200208000-00027",{"id":24,"text":975,"url":24,"identifiers":976},"Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW, Dampney RA . Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 2003; 42: 488–493.",{"doi":977},"10.1161\u002F01.HYP.0000090097.22678.0A",{"id":24,"text":979,"url":24,"identifiers":980},"Munzberg H, Myers Jr MG . Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005; 8: 566–570.",{"doi":981},"10.1038\u002Fnn1454",{"id":24,"text":983,"url":24,"identifiers":984},"Munzberg H, Flier JS, Bjorbaek C . Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004; 145: 4880–4889.",{"doi":985},"10.1210\u002Fen.2004-0726",{"id":24,"text":987,"url":24,"identifiers":988},"Rhamouni K, Sigmund CD, Haynes WG, Mark AL . Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 2009; 58: 536–542.",{"doi":989},"10.2337\u002Fdb08-0822",{"id":24,"text":991,"url":24,"identifiers":992},"Lund IK, Hansen JA, Andersen HS, Moller NP, Billestrup N . Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signaling. J Mol Endocrinol 2005; 34: 339–351.",{"doi":993},"10.1677\u002Fjme.1.01694",{"id":24,"text":995,"url":24,"identifiers":996},"Kaszubska W, Falls HD, Schaefer VG, Haasch D, Frost L, Hessler P, Kroeger PE, White DW, Jirousek MR, Trevillyan JM . Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line. Mol Cell Endocrinol 2002; 195: 109–118.",{"doi":997},"10.1016\u002FS0303-7207(02)00178-8",{"id":24,"text":999,"url":24,"identifiers":1000},"Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML . Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2002; 4: 497–503.",{"doi":1001},"10.1016\u002FS1534-5807(02)00149-1",{"id":24,"text":1003,"url":24,"identifiers":1004},"Morrison CD, White CL, Wang Z, Lee SY, Lawrence DS, Cefaly WT, Zhang ZY, Gettys TW . Increased hypothalamic protein tyrosine phosphatase 1 contributes to leptin resistance with age. Endocrinology 2007; 148: 433–440.",{"doi":1005},"10.1210\u002Fen.2006-0672",{"id":24,"text":1007,"url":24,"identifiers":1008},"Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, Meyers Jr MG, Ozan U . Endoplasmic reticulum plays a central role in development of leptin resistance. Cell Metabolism 2009; 9: 31–51.",{"doi":1009},"10.1016\u002Fj.cmet.2008.12.004",{"id":24,"text":1011,"url":24,"identifiers":1012},"Park SW, Zhou Y, Lee J, Lu A, Sun C, Chung J, Ueki K, Ozcan U . The regulatory subunits of PI3K, p85 alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat Med 2010; 4: 429–437.",{"doi":1013},"10.1038\u002Fnm.2099",{"id":24,"text":1015,"url":24,"identifiers":1016},"Agata J, Masuda A, Takada M, Hiashura K, Murakami H, Miyazaki Y, Shimamoto K . High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171–1174.",{"doi":1017},"10.1016\u002FS0895-7061(97)00310-5",{"id":24,"text":1019,"url":24,"identifiers":1020},"Matsubara M, Chiba H, Maruoka S, Katayose S . Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. J Atheroscler Thromb 2000; 7: 231–237.",{"doi":1021},"10.5551\u002Fjat1994.7.231",{"id":24,"text":1023,"url":24,"identifiers":1024},"Barba G, Russo O, Siani A, Iacone R, Farinaro E, Gerardi MC, Russo P, Della Valle E, Strazzullo P . Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11: 160–166.",{"doi":1025},"10.1038\u002Foby.2003.25",{"id":24,"text":1027,"url":24,"identifiers":1028},"Alvarez-Aguilar C, Mondragon-Jimenez LI, Ramirez-Enriquez J, Gomez-Garcia A, Paniagua-Sierra R, Amato D . Hyperleptinemia as a risk factor in obesity-related hypertension. Med Clin 2004; 123: 766–769.",{"doi":1029},"10.1157\u002F13069809",{"id":24,"text":1031,"url":24,"identifiers":1032},"Nakamura Y, Ueshima H, Okuda N, Murakami Y, Miura K, Kita Y, Okamura T, Turin TC, Rodriguez B, Curb JD, Stamler J . Relation of serum leptin to blood pressure of Japanese in Japan and Japanese-Americans in Hawaii. Hypertension 2009; 54: 1416–1422.",{"doi":1033},"10.1161\u002FHYPERTENSIONAHA.109.133074",{"id":24,"text":1035,"url":24,"identifiers":1036},"Kramer CK, von Muhlen D, Barrett-Connor E . Does leptin predict incident hypertension in older adults? Clin Endocrinol 2010; 73: 201–205.",{"doi":1037},"10.1111\u002Fj.1365-2265.2010.03781.x",{"id":24,"text":1039,"url":24,"identifiers":1040},"Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M . Interactions between leptin and the human sympathetic nervous system. Hypertension 2003; 41: 1072–1079.",{"doi":1041},"10.1161\u002F01.HYP.0000066289.17754.49",{"id":24,"text":1043,"url":24,"identifiers":1044},"Mackintosh RM, Hirsch J . The effects of leptin administration in non-obese human subjects. Obes Res 2001; 9: 462–469.",{"doi":1045},"10.1038\u002Foby.2001.60",{"id":24,"text":1047,"url":24,"identifiers":1048},"Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL . Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115: 3579–3586.",{"doi":1049},"10.1172\u002FJCI25977",{"id":24,"text":1051,"url":24,"identifiers":1052},"Banglore S, Parkar S, Grossman E, Messerli F . A meta-analysis of 94 492 patients with hypertension treated with beta-blockers to determine the risk of new-onset diabetes mellitus. J Am Coll Cardiol 2007; 100: 1254–1262.",{"doi":1053},"10.1016\u002Fj.amjcard.2007.05.057",{"id":24,"text":1055,"url":24,"identifiers":1056},"Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Ledeballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H . Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995–1003.",{"doi":1057},"10.1016\u002FS0140-6736(02)08089-3",{"id":24,"text":1059,"url":24,"identifiers":1060},"Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Östergren J, for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required, in the Anglo-Scandinavian Cardiac Outcomes Trial Blood-Pressure Lowering Arm (ASCOT-BPLA): a multicenter randomized controlled trial. Lancet 2005; 366: 895–906.",{"doi":1061},"10.1016\u002FS0140-6736(05)67185-1",{"id":24,"text":1063,"url":24,"identifiers":1064},"Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dhlof B, Faire U, Fyhrquist F, Ibsen H, Julius S, Kjeldsen SE, Laderballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB . Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention for Endpoint reduction in hypertension) Study. Circulation 2005; 111: 1924–1931.",{"doi":1065},"10.1161\u002F01.CIR.0000161799.91577.0A",{"id":24,"text":1067,"url":24,"identifiers":1068},"UKPDS. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications of type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713–720.",{"doi":1069},"10.1136\u002Fbmj.317.7160.713",{"id":24,"text":1071,"url":24,"identifiers":1072},"Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH . Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension a randomized controlled trial. JAMA 2004; 292: 2227–2236.",{"doi":1073},"10.1001\u002Fjama.292.18.2227",{"id":24,"text":1075,"url":24,"identifiers":1076},"Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G . Efficacy and tolerability profile of nebivolol vs atenolol in mid-to-moderate essential hypertension: results of a double-blind randomized multicentre trial. Blood Press Suppl 2003; 2: 35–40.",{"doi":1077},"10.1080\u002F08038020310023271",{"id":24,"text":1079,"url":24,"identifiers":1080},"Correia ML, Haynes WG . Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs 2005; 10: 643–660.",{"doi":1081},"10.1517\u002F14728214.10.3.643",{"id":24,"text":1083,"url":24,"identifiers":1084},"Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretics versus beta-blocker as first-step antihypertensive therapy: the final results from the antihypertensive therapy. The final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42: 239–246.",{"doi":1085},"10.1161\u002F01.HYP.0000086521.95630.5A",{"id":24,"text":1087,"url":24,"identifiers":1088},"Cushman WC, Ford CE, Einhorn PT, Wright JT, Preston RA, Davis BR, Basile JN, Whelton PK, Weiss RJ, Bastien A, Courtney DL, Hamilton BP, Kirchner K, Louis GT, Retta TM, Vidt DG, for the ALLHAT Collaborative Research Group. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2008; 10: 751–760.",{"doi":1089},"10.1111\u002Fj.1751-7176.2008.00015.x",{"id":24,"text":1091,"url":24,"identifiers":1092},"Wright JT, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood J, Jafri SZA, Lois GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR . Clinical outcomes by race in patients with or without the metabolic syndrome ALLHAT. Arch Intern Med 2008; 168: 207–217.",{"doi":1093},"10.1001\u002Farchinternmed.2007.66",{"id":24,"text":1095,"url":24,"identifiers":1096},"Barzilay JI, Davis BR, Bettencourt J, Margolis KL, Goff DC, Black H, Habib G, Ellsworth A, Force RW, Wiegman T, Ciocon JO, Basile JN . Cardiovascular outcomes using doxazosin vs chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT Study. J Clin Hypertens 2004; 6: 116–125.",{"doi":1097},"10.1111\u002Fj.1524-6175.2004.03216.x",{"id":24,"text":1099,"url":24,"identifiers":1100},"Topal E, Cikim AS, Cikim K, Temel I, Ozdemir R . The effect of moxonidine on endothelial dysfunction in metabolic syndrome. Am J Cardiovasc Drugs 2006; 6: 343–348.",{"doi":1101},"10.2165\u002F00129784-200606050-00007",{"id":24,"text":1103,"url":24,"identifiers":1104},"Reisin E, Weir MR, Falkner B . Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. Hypertension 1997; 30 (1 Part 1): 140–145.",{"doi":1105},"10.1161\u002F01.HYP.30.1.140",{"id":24,"text":1107,"url":24,"identifiers":1108},"Jordan J, Engeli S, Boye SW, Le Breton S, Keefe DL . Direct renin inhibition with aliskiren in obese patients with arterial hypertension. Hypertension 2007; 49: 1047–1055.",{"doi":1109},"10.1161\u002FHYPERTENSIONAHA.106.084301",{"id":24,"text":1111,"url":24,"identifiers":1112},"Sowers JR, Raij L, Jiall I, Egan BM, Ofili EO, Zappe DH, Purkayastha D, Deedwanis PC . Angiotensin receptor blocker\u002Fdiuretic combination preserves insulin responses in obese hypertensives. J Hypertens 2010; 28: 1761–1799.",{"doi":1113},"10.1097\u002FHJH.0b013e32833af380",{"id":24,"text":1115,"url":24,"identifiers":1116},"Jordan J, Engeli S, Boschmann M, Weidinger G, Luft FC, Sharma AM, Kreuzberg U . Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients. J Hypertens 2005; 23: 2313–2318.",{"doi":1117},"10.1097\u002F01.hjh.0000188734.98463.82",{"id":24,"text":1119,"url":24,"identifiers":1120},"Elliott WJ, Meyer PM . Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369: 201–207.",{"doi":1121},"10.1016\u002FS0140-6736(07)60108-1",{"id":24,"text":1123,"url":24,"identifiers":1124},"Jansen PM, Danser JAH, Spiering W, Meiracket AH . Drug mechanisms to help in managing resistant hypertension in obesity. Curr Hypertens Rep 2010; 12: 220–225.",{"doi":1125},"10.1007\u002Fs11906-010-0123-5",{"id":24,"text":1127,"url":24,"identifiers":1128},"de Souza F, Muxfeldt E, Fiszman R, Salles G . Efficacy of spironolactone therapy in patients with true resistant hypertension. Hypertension 2010; 55: 147–152.",{"doi":1129},"10.1161\u002FHYPERTENSIONAHA.109.140988",{"id":24,"text":1131,"url":24,"identifiers":1132},"Ernst ME, Carter BL, Goerdt C, Steffensmeir JJG, Philips BB, Zimmerman MB, Bergus GR . Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006; 47: 352–358.",{"doi":1133},"10.1161\u002F01.HYP.0000203309.07140.d3",{"id":24,"text":1135,"url":24,"identifiers":1136},"Cooper-Dehoff RM, Wen S, Beitelshees AL, Zineh I, Gums JG, Turner ST, Gong Y, Hall K, Parekh V, Chapman AB, Boerwinkle E, Johnson JA . Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications. Hypertension 2010; 55: 61–68.",{"doi":1137},"10.1161\u002FHYPERTENSIONAHA.109.139592",{"id":24,"text":1139,"url":24,"identifiers":1140},"Gentille CL, Orr JS, Davy BM, Davy KP . Modest weight gain is associated with sympathetic neural activation in non-obese humans. Am J Physiology Regal Integra Comp Physiology 2007; 292: R1834–R1838.",{"doi":1141},"10.1152\u002Fajpregu.00876.2006",{"id":24,"text":1143,"url":24,"identifiers":1144},"Andersson B, Elam M, Wallin BG, Bjorntorp P, Andersson OK . Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women. Hypertension 1991; 18: 783–789.",{"doi":1145},"10.1161\u002F01.HYP.18.6.783",{"id":24,"text":1147,"url":24,"identifiers":1148},"Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, Mancia G . Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97: 2037–2042.",{"doi":1149},"10.1161\u002F01.CIR.97.20.2037",{"id":24,"text":1151,"url":24,"identifiers":1152},"Trombetta IC, Batalha LT, Rondon MUPB, Laterza MC, Kuniyoshi FHS, Gowdak MMG, Barretto ACP, Halpern A, Villares SMF, Negrao CE . Weight loss improves neurovascular muscle metaboreflex control in obesity. Am J Physiol Heart Circ Physiol 2003; 285: H974–H982.",{"doi":1153},"10.1152\u002Fajpheart.01090.2002",{"id":24,"text":1155,"url":24,"identifiers":1156},"Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ . Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 5998–6005.",{"doi":1157},"10.1210\u002Fjc.2005-0961",{"id":24,"text":1159,"url":24,"identifiers":1160},"Neter JE, Stam BE, Kok FJ, Robbee DE, Geleijnse JM . Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42: 878–884.",{"doi":1161},"10.1161\u002F01.HYP.0000094221.86888.AE",{"id":24,"text":1163,"url":24,"identifiers":1164},"Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, Bays H, Shanahan WR, and the Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363: 245–256.",{"doi":1165},"10.1056\u002FNEJMoa0909809",{"id":24,"text":1167,"url":24,"identifiers":1168},"Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett S, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J . Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care 1998; 21: 1288–1294.",{"doi":1169},"10.2337\u002Fdiacare.21.8.1288",{"id":24,"text":1171,"url":24,"identifiers":1172},"Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M . A randomized double-blind placebo-controlled study of the long term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Metab Disord 2004; 28: 1399–1410.",{"doi":1173},"10.1038\u002Fsj.ijo.0802783",{"id":24,"text":1175,"url":24,"identifiers":1176},"Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW . Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese (CONQUER): a randomized, placebo-controlled, phase 3 trial. Lancet 2011; 377: 1341–1352.",{"doi":1177},"10.1016\u002FS0140-6736(11)60205-5",{"id":24,"text":1179,"url":24,"identifiers":1180},"Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E . Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomized, double-blind, placebo-controlled, phase 5 trial. Lancet 2010; 376: 595–605.",{"doi":1181},"10.1016\u002FS0140-6736(10)60888-4",{"id":24,"text":1183,"url":24,"identifiers":1184},"The Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus. Arch Intern Med 2010; 170: 1566–1575.",{},{"id":24,"text":1186,"url":24,"identifiers":1187},"Sjostrom L, Narbro K, Sjostrom D, Karason K, Larrsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgreen S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Senlof K, Torgerson J, Agren G . Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741–752.",{"doi":1188},"10.1056\u002FNEJMoa066254",{"id":24,"text":1190,"url":24,"identifiers":1191},"James WPT, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP, Torp-Pedrsen C, Sharma AM, Shepherd GM, Rode RA, Renz CL, SCOUT Investigator Group. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905–917.",{"doi":1192},"10.1056\u002FNEJMoa1003114",{"id":24,"text":1194,"url":24,"identifiers":1195},"Agapitov AV, Correia ML, Sinkey CA, Phillips BG, Haynes WG . Weight loss does not alter sympathetically-mediated vascular tone in normotensive obese humans. Pharmacotherapy 2002; 22: 1329–1330.",{},{"id":24,"text":1197,"url":24,"identifiers":1198},"Correia ML, Agapitov A, Sinkey CA, Haynes WG . Vasodilatation induced by beta2 adrenergic receptor activation is impaired in obese hypertensives before and after weight loss. J Hypertens 2010; 28: e437.",{"doi":1199},"10.1097\u002F01.hjh.0000379521.28713.72",{"id":24,"text":1201,"url":24,"identifiers":1202},"Nogueiras R, Perez D, Christelle VD, Varela L, Haynes WG, Patterson JT, Disse E, Pfluger PT, Lopez M, Woods SC, DiMarchi R, Diegues C, Rahmouni K, Rohner-Jeanrenaud F, Tschop MH . Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet induced obesity. J Neurosci 2009; 29: 5916–5925.",{"doi":1203},"10.1523\u002FJNEUROSCI.5977-08.2009",{"id":24,"text":1205,"url":24,"identifiers":1206},"Astrup A, Bosser S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME . Efffects of liraglutide in the treatment of obesity: a randomized, double-blind, placebo-controlled stud. Lancet 2009; 374: 1606–1616.",{"doi":1207},"10.1016\u002FS0140-6736(09)61375-1",{"id":24,"text":1209,"url":24,"identifiers":1210},"Toplak H, Haman A, Moore A, Masson E, Gorska M, Vercryusse F, Sun X, Fitchet M . Efficacy and safety of topiramate in combination with metformin in the treatment of the obese subject with type 2 diabetes: a randomized, double-blind, placebo controlled study. Int J Obes 2007; 31: 138–146.",{"doi":1211},"10.1038\u002Fsj.ijo.0803382",{"id":24,"text":1213,"url":24,"identifiers":1214},"Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM . Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 2006; 147: 5855–5864.",{"doi":1215},"10.1210\u002Fen.2006-0393",{"id":24,"text":1217,"url":24,"identifiers":1218},"Roth JD, Roland BL, Cole R, Trevaskis JL, Weyer C, Koda JE, Anderson CM, Parkes DG, Baron AD . Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 2008; 105: 7257–7262.",{"doi":1219},"10.1073\u002Fpnas.0706473105",{"id":24,"text":1221,"url":24,"identifiers":1222},"Amylin Pharmaceuticals USA. Pramlintide Acetate Prescribing Information. Revised July 2008. Amylin Pharmaceuticals USA: San Diego, CA, 2008.",{},{"id":24,"text":1224,"url":24,"identifiers":1225},"Aronne LJ, Halseth AE, Burns CM, Miller S, Shen LZ . Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial. Obesity 2010; 18: 1739–1746.",{"doi":1226},"10.1038\u002Foby.2009.478",{"id":24,"text":1228,"url":24,"identifiers":1229},"Wulffelé MG, Kooy A, Zeeuw D, Stehouwer CDA, Gansevoort RT . The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med 2004; 256: 1–14.",{"doi":1230},"10.1111\u002Fj.1365-2796.2004.01328.x",{"id":24,"text":1232,"url":24,"identifiers":1233},"Holman RR, Paul SK, Bethel A, Matthews DR, Neil HAW . 10-year follow-up of intensive glucose control in Type 2 diabetes. N Engl J Med 2008; 359: 1–13.",{"doi":1234},"10.1056\u002FNEJMp0804448",{"id":24,"text":1236,"url":24,"identifiers":1237},"Diabetes Prevention Program Research Group. Intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005; 28: 888–894.",{"doi":1238},"10.2337\u002Fdiacare.28.4.888",{"id":24,"text":1240,"url":24,"identifiers":1241},"O’brien PE, Dixon JB, Laurie C, Skinner S, Rioretto J, Mcneil JM . Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding. Ann Intern Med 2006; 144: 625–633.",{"doi":1242},"10.7326\u002F0003-4819-144-9-200605020-00005",{"id":24,"text":1244,"url":24,"identifiers":1245},"Hofso D, Nordtrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollersev J, Godang K, Sandbu R, Roilsien J, Hjelmeseth J . Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010; 163: 735–745.",{"doi":1246},"10.1530\u002FEJE-10-0514",{"id":24,"text":1248,"url":24,"identifiers":1249},"Erondu N, Addy C, Kaifeng L, Mallick M, Musser B, Gantz I, Prioretto J, Astrup A, Toubro S, Rissannen A, Tonstad S, Haynes WG, Gottesdiener K, Kaufan KD, Amatruda JM, Heymsfield SB . NPY5R Antagonism does not augment the weight loss efficacy of orlistat vs sibutramine. Obesity 2007; 15: 2027–2042.",{"doi":1250},"10.1038\u002Foby.2007.242",{"id":24,"text":1252,"url":24,"identifiers":1253},"United States Food and Drug Administration (FDA) NDA 22580 Briefing Documents. Endocrinologic and Metabolic Drugs Advisory Committee Meeting. Gaithersburg, MD 2010.",{},{"id":24,"text":1255,"url":24,"identifiers":1256},"Kang JG, Park CY, Kang JH, Park YW, Park SW . Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. Diabetes Obes Metab 2010; 12: 876–882.",{"doi":1257},"10.1111\u002Fj.1463-1326.2010.01242.x",{"id":24,"text":1259,"url":24,"identifiers":1260},"Cercato C, Roizenblatt VA, Leanca CC, Segal A, Lopes Filho AP, Mancini MC, Halpern A . A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects. Int J Obes 2009; 33: 857–865.",{"doi":1261},"10.1038\u002Fijo.2009.124",{"id":24,"text":1263,"url":24,"identifiers":1264},"Anderson JW, Greenway FL, Fujioka K, Gadde KM, McKenney J, O’Neil PM . Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial. Obes Res 2002; 10: 633–641.",{"doi":1265},"10.1038\u002Foby.2002.86",{"id":24,"text":1267,"url":24,"identifiers":1268},"Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Kempf M . Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998; 352: 167–172.",{"doi":1269},"10.1016\u002FS0140-6736(97)11509-4",{"id":24,"text":1271,"url":24,"identifiers":1272},"Torgerson JS, Boldrin MN, Hauptman J, Sjostrom L . Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: a randomize study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155–161.",{"doi":1273},"10.2337\u002Fdiacare.27.1.155",{"id":24,"text":1275,"url":24,"identifiers":1276},"Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Forey T, Aronne L, Klein S . Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care 2002; 25: 11123–11128.",{"doi":1277},"10.2337\u002Fdiacare.25.7.1123",{"id":24,"text":1279,"url":24,"identifiers":1280},"Buse JB, Rosenstock J, Sesti G, Schimidt WE, Montanya E, Brett JH, Zychma M, Blonde L, LaEAD-6 Study Group. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomized, parallel-group, multinational, open-label trial (LEAD-6). Lancet 2009; 10: 633–641.",{},{"id":24,"text":1282,"url":24,"identifiers":1283},"Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH . A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003; 11: 722–733.",{"doi":1284},"10.1038\u002Foby.2003.102",{"id":24,"text":1286,"url":24,"identifiers":1287},"Tonstad S, Tykarski A, Weissgarten J, Ivleva A, Levy B, Fitchet M . Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. Am J Cardiol 2005; 96: 243–251.",{"doi":1288},"10.1016\u002Fj.amjcard.2005.03.053",{"id":24,"text":1290,"url":24,"identifiers":1291},"Stenlof K, Rossner S, Verruysse F, Kumar A, Fitchet M, Sjostrom L . Topiramate in the treatment of obese subjects with drug-naïve type 2 diabetes. Diabetes Obes Metab 2007; 9: 360–368.",{"doi":1292},"10.1111\u002Fj.1463-1326.2006.00618.x",{"id":24,"text":1294,"url":24,"identifiers":1295},"Gadde KM, Franciscy DM, Wagner II HR, Krishnan KR . Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA 2003; 289: 1820–1825.",{"doi":1296},"10.1001\u002Fjama.289.14.1820",{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1300,"slug":1301,"properties":1302,"entityType":139,"verifyStatus":140,"verifyTime":1299,"verifyNote":141,"syncStatus":23,"languages":1315,"translateLanguages":24,"viewCount":25,"primaryUrl":1316,"fullTextUrl":24,"authors":1317,"publicationType":288,"publisherRelationship":1487,"citationCount":643,"citationInfo":1518,"publishDate":325,"publishYear":326,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":1520,"isForceReanalyzing":539},"1a8a510e-1154-47d6-a55a-a51cff50804f","2024-09-17T18:34:55.115+00:00",[],"Slight-increase-in-urinary-albumin-excretion-within-the-normal-range-predicts-incident-hypertension-in-a-community-based-Japanese-population-the-Takahata-study",{"mag":1303,"keywords":1305,"openalex":1306,"abstract":1308,"title":1309,"pm":1311,"doi":1313},{"VOID":1304},"2067173979",{},{"VOID":1307},"W2067173979",{},{"EN":1310},"Slight increase in urinary albumin excretion within the normal range predicts incident hypertension in a community-based Japanese population: the Takahata study",{"VOID":1312},"25007767",{"VOID":1314},"10.1038\u002Fhr.2014.117",[143],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fhr2014117",[1318,1340,1357,1374,1394,1410,1431,1448,1470],{"id":1319,"sortIndex":238,"researcher":24,"roles":1320,"affiliations":1321,"properties":1333},"f66e2594-f2ac-4fda-8bc4-71a19e767033",[],[1322],{"id":1323,"sortIndex":25,"affiliation":1324,"properties":24},"b86d8f1a-1f00-4660-87f7-309fc7f62f7b",{"id":1325,"createTime":1326,"updateTime":1327,"relativeEntities":1328,"slug":1329,"properties":1330,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"06d6ca45-1ce2-4a61-ab73-1a1a111851b9","2024-01-19T17:28:45.463+00:00","2025-06-11T19:53:51.142+00:00",[],"Department-of-Cardiology-Pulmonology-and-Nephrology-Yamagata-University-School-of-Medicine-Yamagata-Japan",{"title":1331},{"VI":1332},"Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan",{"openalex":1334,"orcid":1336,"title":1338},{"VOID":1335},"A5031762822",{"VOID":1337},"https:\u002F\u002Forcid.org\u002F0000-0001-7681-6469",{"EN":1339},"Tsuneo Konta",{"id":1341,"sortIndex":274,"researcher":24,"roles":1342,"affiliations":1343,"properties":1350},"68228e62-3a4b-4f8b-a81a-bdd51d4bcd04",[],[1344],{"id":1345,"sortIndex":25,"affiliation":1346,"properties":24},"05e5b468-0c46-4eb5-ba3d-9c5c3cee87a6",{"id":1325,"createTime":1326,"updateTime":1327,"relativeEntities":1347,"slug":1329,"properties":1348,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1349},{"VI":1332},{"openalex":1351,"orcid":1353,"title":1355},{"VOID":1352},"A5022557754",{"VOID":1354},"https:\u002F\u002Forcid.org\u002F0000-0003-1794-0026",{"EN":1356},"Yoko Shibata",{"id":1358,"sortIndex":171,"researcher":24,"roles":1359,"affiliations":1360,"properties":1367},"d1ff8cd0-77ec-4771-8792-56eff4d9e9a6",[],[1361],{"id":1362,"sortIndex":25,"affiliation":1363,"properties":24},"db47e430-1b1c-41f9-8c85-77801d81a373",{"id":1325,"createTime":1326,"updateTime":1327,"relativeEntities":1364,"slug":1329,"properties":1365,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1366},{"VI":1332},{"openalex":1368,"orcid":1370,"title":1372},{"VOID":1369},"A5100705669",{"VOID":1371},"https:\u002F\u002Forcid.org\u002F0000-0002-4565-3799",{"EN":1373},"Tetsu Watanabe",{"id":1375,"sortIndex":73,"researcher":24,"roles":1376,"affiliations":1377,"properties":1389},"e6cd177c-a548-4653-9091-8b3e2a6ce4b5",[],[1378],{"id":1379,"sortIndex":25,"affiliation":1380,"properties":24},"d0e4cbf1-c503-4d8f-ab45-e03345e3b27f",{"id":1381,"createTime":1382,"updateTime":1383,"relativeEntities":1384,"slug":1385,"properties":1386,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"083e8dea-7377-4d00-8f8f-879ded73c208","2024-02-11T15:39:56.929+00:00","2025-06-11T21:14:51.178+00:00",[],"Global-COE-Yamagata-University-School-of-Medicine-Yamagata-Japan",{"title":1387},{"VI":1388},"Global COE, Yamagata University School of Medicine, Yamagata, Japan",{"openalex":1390,"title":1392},{"VOID":1391},"A5057687484",{"EN":1393},"Takamasa Kayama",{"id":1395,"sortIndex":1396,"researcher":24,"roles":1397,"affiliations":1398,"properties":1405},"aae0403c-36b4-4cbf-96d6-b134f4dc25a2",8,[],[1399],{"id":1400,"sortIndex":25,"affiliation":1401,"properties":24},"c4880e87-7bf7-4a11-8eb3-c457f7ffa448",{"id":1381,"createTime":1382,"updateTime":1383,"relativeEntities":1402,"slug":1385,"properties":1403,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1404},{"VI":1388},{"openalex":1406,"title":1408},{"VOID":1407},"A5018539336",{"EN":1409},"Isao Kubota",{"id":1411,"sortIndex":206,"researcher":24,"roles":1412,"affiliations":1413,"properties":1424},"0a3b482b-5484-4833-8171-e2eda3bdf7c9",[],[1414],{"id":1415,"sortIndex":25,"affiliation":1416,"properties":24},"3912e942-2137-43bf-977b-38e6d745a432",{"id":1417,"createTime":1418,"updateTime":1418,"relativeEntities":1419,"slug":1420,"properties":1421,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"7a9af284-72d1-4148-90c9-5e4c867d6ba3","2024-09-17T18:34:55.280+00:00",[],"Department-of-Preventive-Medicine-and-Epidemiology-Tohoku-Medical-Megabank-Organization-Yamagata-Japan",{"title":1422},{"EN":1423},"Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Yamagata, Japan",{"openalex":1425,"orcid":1427,"title":1429},{"VOID":1426},"A5013972052",{"VOID":1428},"https:\u002F\u002Forcid.org\u002F0000-0002-8031-8523",{"EN":1430},"Atsushi Hozawa",{"id":1432,"sortIndex":25,"researcher":24,"roles":1433,"affiliations":1434,"properties":1441},"9d406ca0-d97f-4320-b34a-9d7743b109ca",[],[1435],{"id":1436,"sortIndex":25,"affiliation":1437,"properties":24},"ea86b7fd-9499-40e0-93fa-53b13c5f7a78",{"id":1325,"createTime":1326,"updateTime":1327,"relativeEntities":1438,"slug":1329,"properties":1439,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1440},{"VI":1332},{"openalex":1442,"orcid":1444,"title":1446},{"VOID":1443},"A5035142077",{"VOID":1445},"https:\u002F\u002Forcid.org\u002F0000-0002-6712-6930",{"EN":1447},"Atsushi Hirayama",{"id":1449,"sortIndex":644,"researcher":24,"roles":1450,"affiliations":1451,"properties":1463},"52cf8147-a461-4c86-b5b9-ace149f3ce37",[],[1452],{"id":1453,"sortIndex":25,"affiliation":1454,"properties":24},"c92849b1-84b6-4728-9ed1-7434f21ff89d",{"id":1455,"createTime":1456,"updateTime":1457,"relativeEntities":1458,"slug":1459,"properties":1460,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"7f26bbcf-bfad-450a-af01-5ec4c0c0ad5a","2024-02-12T05:10:23.753+00:00","2024-09-17T18:34:55.331+00:00",[],"Department-of-Public-Health-Yamagata-University-School-of-Medicine-Yamagata-Japan",{"title":1461},{"VI":1462},"Department of Public Health, Yamagata University School of Medicine, Yamagata, Japan",{"openalex":1464,"orcid":1466,"title":1468},{"VOID":1465},"A5103087372",{"VOID":1467},"https:\u002F\u002Forcid.org\u002F0000-0003-4575-0369",{"EN":1469},"Akira Fukao",{"id":1471,"sortIndex":148,"researcher":24,"roles":1472,"affiliations":1473,"properties":1480},"66ab0b1e-5670-46df-bdce-e33f59470900",[],[1474],{"id":1475,"sortIndex":25,"affiliation":1476,"properties":24},"1ed6693e-e181-4b59-97cc-725a879535d8",{"id":1455,"createTime":1456,"updateTime":1457,"relativeEntities":1477,"slug":1459,"properties":1478,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1479},{"VI":1462},{"openalex":1481,"orcid":1483,"title":1485},{"VOID":1482},"A5025647523",{"VOID":1484},"https:\u002F\u002Forcid.org\u002F0000-0002-7492-6303",{"EN":1486},"Ryo Kawasaki",{"url":24,"publisher":1488,"properties":1513},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1489,"slug":10,"properties":1490,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1496,"manageAffiliations":1497,"indexDatabases":1498,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1491,"issn":1492,"introduce":1493,"eissn":1494,"title":1495},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[1499,1506],{"id":77,"indexDatabase":1500,"url":92,"indexYears":24,"academicFieldIds":1505,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":1501,"label":1502,"description":1503,"key":88,"publicationTags":1504,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":1507,"url":109,"indexYears":110,"academicFieldIds":1512,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":1508,"label":1509,"description":1510,"key":106,"publicationTags":1511,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":1514,"pages":1515,"issue":1517},{"VOID":317},{"VOID":1516},"56-60",{"VOID":321},{"total":643,"publishYear":24,"statisticByYear":1519},{"2014":238,"2016":206,"2017":148,"2018":148,"2019":206,"2020":206,"2021":238,"2022":206,"2023":206},[1521,1525,1529,1533,1537,1541,1545,1549,1553,1557,1561,1565,1569,1573,1576,1580,1584,1588,1592,1596,1600,1604,1608,1612,1616,1620,1624,1628],{"id":24,"text":1522,"url":24,"identifiers":1523},"Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL . Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747–1757.",{"doi":1524},"10.1016\u002FS0140-6736(06)68770-9",{"id":24,"text":1526,"url":24,"identifiers":1527},"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.",{"doi":1528},"10.1001\u002Fjama.289.19.2560",{"id":24,"text":1530,"url":24,"identifiers":1531},"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073–2081.",{"doi":1532},"10.1016\u002FS0140-6736(10)60674-5",{"id":24,"text":1534,"url":24,"identifiers":1535},"Konta T, Kudo K, Sato H, Ichikawa K, Ikeda A, Suzuki K, Hirayama A, Shibata Y, Watanabe T, Daimon M, Kato T, Ueno Y, Kayama T, Kubota I . Albuminuria is an independent predictor of all-cause and cardiovascular mortality in the Japanese population: the Takahata study. Clin Exp Nephrol 2013; 17: 805–810.",{"doi":1536},"10.1007\u002Fs10157-013-0770-3",{"id":24,"text":1538,"url":24,"identifiers":1539},"Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT . Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2006; 17: 331–335.",{"doi":1540},"10.1681\u002FASN.2005111153",{"id":24,"text":1542,"url":24,"identifiers":1543},"Forman JP, Fisher ND, Schopick EL, Curhan GC . Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol 2008; 19: 1983–1988.",{"doi":1544},"10.1681\u002FASN.2008010038",{"id":24,"text":1546,"url":24,"identifiers":1547},"Gerber LM, Schwartz JE, Pickering TG . Albumin-to-creatinine ratio predicts change in ambulatory blood pressure in normotensive persons: a 7.5-year prospective study. Am J Hypertens 2006; 19: 220–226.",{"doi":1548},"10.1016\u002Fj.amjhyper.2005.07.025",{"id":24,"text":1550,"url":24,"identifiers":1551},"Jessani S, Levey AS, Chaturvedi N, Jafar TH . High normal levels of albuminuria and risk of hypertension in Indo-Asian population. Nephrol Dial Transplant 2012; 27 (Suppl 3): iii58–iii64.",{"doi":1552},"10.1093\u002Fndt\u002Fgfr200",{"id":24,"text":1554,"url":24,"identifiers":1555},"Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D’Agostino RB, Levy D, Vasan RS . Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370–1376.",{"doi":1556},"10.1161\u002F01.CIR.0000158434.69180.2D",{"id":24,"text":1558,"url":24,"identifiers":1559},"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–992.",{"doi":1560},"10.1053\u002Fj.ajkd.2008.12.034",{"id":24,"text":1562,"url":24,"identifiers":1563},"Kawasaki T, Itoh K, Uezono K, Sasaki H . A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 1993; 20: 7–14.",{"doi":1564},"10.1111\u002Fj.1440-1681.1993.tb01496.x",{"id":24,"text":1566,"url":24,"identifiers":1567},"Ito S, Nagasawa T, Abe M, Mori T . Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 2009; 32: 115–121.",{"doi":1568},"10.1038\u002Fhr.2008.27",{"id":24,"text":1570,"url":24,"identifiers":1571},"Satoh M . Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol 2012; 16: 518–521.",{"doi":1572},"10.1007\u002Fs10157-012-0646-y",{"id":24,"text":1574,"url":24,"identifiers":1575},"Neves MF, Kasal DA, Cunha AR, Medeiros F . Vascular dysfunction as target organ damage in animal models of hypertension. Int J Hypertens 2012; 2012: 187526.",{},{"id":24,"text":1577,"url":24,"identifiers":1578},"Figueiredo VN, Yugar-Toledo JC, Martins LC, Martins LB, de Faria AP, de Haro Moraes C, Sierra C, Coca A, Moreno H . Vascular stiffness and endothelial dysfunction: correlations at different levels of blood pressure. Blood Press 2012; 21: 31–38.",{"doi":1579},"10.3109\u002F08037051.2011.617045",{"id":24,"text":1581,"url":24,"identifiers":1582},"Higashi Y, Kihara Y, Noma K . Endothelial dysfunction and hypertension in aging. Hypertens Res 2012; 35: 1039–1047.",{"doi":1583},"10.1038\u002Fhr.2012.138",{"id":24,"text":1585,"url":24,"identifiers":1586},"Schulz E, Gori T, Munzel T . Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 2011; 34: 665–673.",{"doi":1587},"10.1038\u002Fhr.2011.39",{"id":24,"text":1589,"url":24,"identifiers":1590},"Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zedeh K . Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol 2013; 61: 1626–1633.",{"doi":1591},"10.1016\u002Fj.jacc.2012.11.071",{"id":24,"text":1593,"url":24,"identifiers":1594},"Xu J, Knowler WC, Devereux RB, Yeh J, Umans JG, Begum M, Febsitz RR, Lee ET . Albuminuria within the ‘normal’ range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis 2007; 49: 208–216.",{"doi":1595},"10.1053\u002Fj.ajkd.2006.10.017",{"id":24,"text":1597,"url":24,"identifiers":1598},"Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D’Agostino RB, Vasan RS . Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969–975.",{"doi":1599},"10.1161\u002FCIRCULATIONAHA.105.538132",{"id":24,"text":1601,"url":24,"identifiers":1602},"Blecker S, Matsushita K, Kottgen A, Loehr LR, Bertoni AG, Boulware LE, Coresh J . High-normal albuminuria and risk of heart failure in the community. Am J Kidney Dis 2011; 58: 47–55.",{"doi":1603},"10.1053\u002Fj.ajkd.2011.02.391",{"id":24,"text":1605,"url":24,"identifiers":1606},"Kim BJ, Lee HA, Kim NH, Kim MW, Kim BS, Kang JH . The association of albuminuria, arterial stiffness, and blood pressure status in nondiabetic, nonhypertensive individuals. J Hypertens 2011; 29: 2091–2098.",{"doi":1607},"10.1097\u002FHJH.0b013e32834b5627",{"id":24,"text":1609,"url":24,"identifiers":1610},"Lieb W, Mayer B, Stritzke J, Doering A, Hense HW, Loewel H, Erdmann J, Schunkert H . Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA\u002FKORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant 2006; 21: 2780–2787.",{"doi":1611},"10.1093\u002Fndt\u002Fgfl364",{"id":24,"text":1613,"url":24,"identifiers":1614},"Ma H, Lin H, Hofman A, Hu Y, Li X, He W, Jeekel J, Jin X, Gao J, Zhao N, Gao X . Low-grade albuminuria is associated with carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults: The Shanghai Changfeng Study. Atherosclerosis 2013; 228: 237–242.",{"doi":1615},"10.1016\u002Fj.atherosclerosis.2013.02.007",{"id":24,"text":1617,"url":24,"identifiers":1618},"Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y . Cigarette smoking and chronic kidney diseases. Hypertens Res 2012; 35: 261–265.",{"doi":1619},"10.1038\u002Fhr.2011.205",{"id":24,"text":1621,"url":24,"identifiers":1622},"Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, Ichikawa K, Takasaki S, Kubota I . Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 2006; 70: 751–756.",{"doi":1623},"10.1038\u002Fsj.ki.5001504",{"id":24,"text":1625,"url":24,"identifiers":1626},"White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ . Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant 2009; 24: 2464–2472.",{"doi":1627},"10.1093\u002Fndt\u002Fgfp114",{"id":24,"text":1629,"url":24,"identifiers":1630},"Nathan DM, Rosenbaum C, Protasowicki VD . Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 1987; 10: 414–418.",{"doi":1631},"10.2337\u002Fdiacare.10.4.414",{"id":1633,"createTime":1634,"updateTime":1634,"relativeEntities":1635,"slug":1636,"properties":1637,"entityType":139,"verifyStatus":140,"verifyTime":1634,"verifyNote":141,"syncStatus":23,"languages":1650,"translateLanguages":24,"viewCount":25,"primaryUrl":1651,"fullTextUrl":24,"authors":1652,"publicationType":288,"publisherRelationship":1760,"citationCount":640,"citationInfo":1792,"publishDate":1794,"publishYear":326,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":1795,"isForceReanalyzing":539},"4f630005-31b1-4c35-8d4e-4ab8fba861db","2024-09-17T18:34:54.545+00:00",[],"Carotid-intima-media-thickness-and-elastic-properties-of-aortas-in-normotensive-children-of-hypertensive-parents",{"mag":1638,"keywords":1640,"openalex":1641,"abstract":1643,"title":1644,"pm":1646,"doi":1648},{"VOID":1639},"856408453",{},{"VOID":1642},"W856408453",{},{"EN":1645},"Carotid intima-media thickness and elastic properties of aortas in normotensive children of hypertensive parents",{"VOID":1647},"25971629",{"VOID":1649},"10.1038\u002Fhr.2015.49",[143],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fhr201549",[1653,1672,1689,1706,1723,1738],{"id":1654,"sortIndex":206,"researcher":24,"roles":1655,"affiliations":1656,"properties":1667},"f649c0ce-ecfc-4b1b-90ed-fad23e2ccf44",[],[1657],{"id":1658,"sortIndex":25,"affiliation":1659,"properties":24},"c42b2370-cdc4-4b95-a178-b93d75bbcef8",{"id":1660,"createTime":1661,"updateTime":1661,"relativeEntities":1662,"slug":1663,"properties":1664,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"f4a1cddb-89b5-4787-b704-bc8e6584d5ce","2024-09-17T18:34:54.617+00:00",[],"Department-of-Pediatric-Cardiology-Medical-Faculty-Eskisehir-Osmangazi-University-Eskisehir-Turkey",{"title":1665},{"EN":1666},"Department of Pediatric Cardiology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey",{"openalex":1668,"title":1670},{"VOID":1669},"A5100819291",{"EN":1671},"Gökmen Özdemir",{"id":1673,"sortIndex":238,"researcher":24,"roles":1674,"affiliations":1675,"properties":1682},"b6dd62d6-ce2c-45db-85fd-d571f547061b",[],[1676],{"id":1677,"sortIndex":25,"affiliation":1678,"properties":24},"371d29da-5ffe-43f6-8285-4035fe0252a1",{"id":1660,"createTime":1661,"updateTime":1661,"relativeEntities":1679,"slug":1663,"properties":1680,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1681},{"EN":1666},{"openalex":1683,"orcid":1685,"title":1687},{"VOID":1684},"A5061197633",{"VOID":1686},"https:\u002F\u002Forcid.org\u002F0000-0002-3926-9002",{"EN":1688},"Pelin Köşger",{"id":1690,"sortIndex":171,"researcher":24,"roles":1691,"affiliations":1692,"properties":1699},"12233e0d-e094-4916-aa24-f99cae696b01",[],[1693],{"id":1694,"sortIndex":25,"affiliation":1695,"properties":24},"4708f675-8c8d-4e34-a535-1800fe728412",{"id":1660,"createTime":1661,"updateTime":1661,"relativeEntities":1696,"slug":1663,"properties":1697,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1698},{"EN":1666},{"openalex":1700,"orcid":1702,"title":1704},{"VOID":1701},"A5011767149",{"VOID":1703},"https:\u002F\u002Forcid.org\u002F0000-0002-7746-6058",{"EN":1705},"Birsen Uçar",{"id":1707,"sortIndex":25,"researcher":24,"roles":1708,"affiliations":1709,"properties":1716},"cb4596aa-b0a7-4014-b605-16675909ad1d",[],[1710],{"id":1711,"sortIndex":25,"affiliation":1712,"properties":24},"71ad4f02-70fb-4117-ba7a-09e59b03c325",{"id":1660,"createTime":1661,"updateTime":1661,"relativeEntities":1713,"slug":1663,"properties":1714,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1715},{"EN":1666},{"openalex":1717,"orcid":1719,"title":1721},{"VOID":1718},"A5054787066",{"VOID":1720},"https:\u002F\u002Forcid.org\u002F0000-0001-7587-3904",{"EN":1722},"Atilla Yıldırım",{"id":1724,"sortIndex":274,"researcher":24,"roles":1725,"affiliations":1726,"properties":1733},"ea1538f7-54f1-4740-8fa5-1d761a71b455",[],[1727],{"id":1728,"sortIndex":25,"affiliation":1729,"properties":24},"65619aad-ba1a-41d0-807e-b90e88008b23",{"id":1660,"createTime":1661,"updateTime":1661,"relativeEntities":1730,"slug":1663,"properties":1731,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1732},{"EN":1666},{"openalex":1734,"title":1736},{"VOID":1735},"A5027054199",{"EN":1737},"Zübeyir Kılıç",{"id":1739,"sortIndex":148,"researcher":24,"roles":1740,"affiliations":1741,"properties":1753},"b1779f98-fd7d-4877-9b1a-556fe1c2f4b7",[],[1742],{"id":1743,"sortIndex":25,"affiliation":1744,"properties":24},"7571558a-d985-4cb2-9bcc-e8c1803cfc39",{"id":1745,"createTime":1746,"updateTime":1747,"relativeEntities":1748,"slug":1749,"properties":1750,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"92e55156-6c13-4ef0-99f2-43df916c2b22","2024-02-11T08:18:36.354+00:00","2024-09-17T18:34:55.028+00:00",[],"Department-of-Biostatistics-Faculty-of-Medicine-Eskisehir-Osmangazi-University-Eskisehir-Turkey",{"title":1751},{"VI":1752},"Department of Biostatistics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey",{"openalex":1754,"orcid":1756,"title":1758},{"VOID":1755},"A5064350163",{"VOID":1757},"https:\u002F\u002Forcid.org\u002F0000-0002-9339-4031",{"EN":1759},"Fezan Mutlu",{"url":24,"publisher":1761,"properties":1786},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1762,"slug":10,"properties":1763,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1769,"manageAffiliations":1770,"indexDatabases":1771,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1764,"issn":1765,"introduce":1766,"eissn":1767,"title":1768},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[1772,1779],{"id":77,"indexDatabase":1773,"url":92,"indexYears":24,"academicFieldIds":1778,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":1774,"label":1775,"description":1776,"key":88,"publicationTags":1777,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":1780,"url":109,"indexYears":110,"academicFieldIds":1785,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":1781,"label":1782,"description":1783,"key":106,"publicationTags":1784,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":1787,"pages":1788,"issue":1790},{"VOID":317},{"VOID":1789},"621-626",{"VOID":1791},"9",{"total":640,"publishYear":24,"statisticByYear":1793},{"2015":238,"2016":238,"2017":274,"2018":206,"2021":238,"2023":206},"2015-09-01",[1796,1800,1804,1807,1811,1815,1819,1823,1827,1831,1835,1839,1843,1847,1851,1855,1859,1863,1867,1870,1873,1876,1880,1884,1888,1892,1896,1900,1904,1908,1912,1916,1920,1923,1926,1930,1934,1937,1941,1945,1949,1953,1957,1961],{"id":24,"text":1797,"url":24,"identifiers":1798},"Staessen JA, Wang J, Bianchi G . Essential Hypertension. Lancet 2003; 261: 1629–1641.",{"doi":1799},"10.1016\u002FS0140-6736(03)13302-8",{"id":24,"text":1801,"url":24,"identifiers":1802},"Karpettas N, Nasothimiou E, Kollias A, Vazeou A, Stergiou GS . Ambulatory and home blood pressure monitoring in children and adolescents: diagnosis of hypertension and assessment of target-organ damage. Hypertens Res 2013; 36: 285–292.",{"doi":1803},"10.1038\u002Fhr.2012.220",{"id":24,"text":1805,"url":24,"identifiers":1806},"Waeber B, Brunner HR, Burnier M . Hypertension. In Willerson JT, Cohn JN (eds). Cardiovascular Medicine 2th edn.Springer, Philadelphia. 2000, 1496–1511.",{},{"id":24,"text":1808,"url":24,"identifiers":1809},"Robinson RF, Batisky DL, Hayes JR . Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol 2004; 19: 1379–1384.",{"doi":1810},"10.1007\u002Fs00467-004-1588-8",{"id":24,"text":1812,"url":24,"identifiers":1813},"Davis PH, Dawson JD, Mahoney LT, Lauer RM . Increased carotid intimal- medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation 1999; 100: 838–842.",{"doi":1814},"10.1161\u002F01.CIR.100.8.838",{"id":24,"text":1816,"url":24,"identifiers":1817},"Smilde TJ, van Wissen S, Wollersheim H, Kastelein JJ, Stalenhoef AF . Genetic and metabolic factors predicting risk of cardiovascular disease in familial hypercholesterolemia. Neth J Med 2001; 59: 184–195.",{"doi":1818},"10.1016\u002FS0300-2977(01)00155-3",{"id":24,"text":1820,"url":24,"identifiers":1821},"Salonen JT, Salonen R . Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245–1249.",{"doi":1822},"10.1161\u002F01.ATV.11.5.1245",{"id":24,"text":1824,"url":24,"identifiers":1825},"Bruckert E, Giral P, Salloum J, Kahn JF, Dairou F, Truffert J, Reverdy V, Thomas D, Evans J, Grosgogeat Y . Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population. Atherosclerosis 1992; 92: 105–114.",{"doi":1826},"10.1016\u002F0021-9150(92)90269-M",{"id":24,"text":1828,"url":24,"identifiers":1829},"Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE . Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432–1437.",{"doi":1830},"10.1161\u002F01.CIR.96.5.1432",{"id":24,"text":1832,"url":24,"identifiers":1833},"Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP . The role of carotid artery intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262–269.",{"doi":1834},"10.7326\u002F0003-4819-128-4-199802150-00002",{"id":24,"text":1836,"url":24,"identifiers":1837},"McGill HC Jr, McMahan CA, Herderick EE, Tracy RE, Malcom GT, Zieske AW, Strong JP . Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery: PDAY research group, Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 2000; 20: 836–845.",{"doi":1838},"10.1161\u002F01.ATV.20.3.836",{"id":24,"text":1840,"url":24,"identifiers":1841},"Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD, Evans G . Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151: 478–487.",{"doi":1842},"10.1093\u002Foxfordjournals.aje.a010233",{"id":24,"text":1844,"url":24,"identifiers":1845},"Kitamura A, Iso H, Imano H, Ohira T, Okada T, Sato S, Kiyama M, Tanigawa T, Yamagishi K, Shimamoto T . Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004; 35: 2788–2794.",{"doi":1846},"10.1161\u002F01.STR.0000147723.52033.9e",{"id":24,"text":1848,"url":24,"identifiers":1849},"Rosvall M, Janzon L, Berglund G, Engstrom G, Hedblad B . Incident coronary events and case fatality in relation to common carotid intima media thickness. J Intern Med 2005; 257: 430–437.",{"doi":1850},"10.1111\u002Fj.1365-2796.2005.01485.x",{"id":24,"text":1852,"url":24,"identifiers":1853},"van der Meer I, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC . Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam study. Circulation 2004; 109: 1089–1094.",{"doi":1854},"10.1161\u002F01.CIR.0000120708.59903.1B",{"id":24,"text":1856,"url":24,"identifiers":1857},"Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M . Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87–92.",{"doi":1858},"10.1161\u002F01.STR.0000196964.24024.ea",{"id":24,"text":1860,"url":24,"identifiers":1861},"O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr . Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14–22.",{"doi":1862},"10.1056\u002FNEJM199901073400103",{"id":24,"text":1864,"url":24,"identifiers":1865},"Laurent S, Cockcroft J, Van Bortel L . Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–2605.",{"doi":1866},"10.1093\u002Feurheartj\u002Fehl254",{"id":24,"text":1868,"url":24,"identifiers":1869},"Garg R, Malhotra V, Dhar U, Tripathi Y . The isometric handgrip exercise as a test for unmasking hypertension in the offsprings of hypertensive parents. J Clin Diagn Res 2013; 7: 996–999.",{},{"id":24,"text":1871,"url":24,"identifiers":1872},"Kolo P, Sanya E, Ogunmodede J, Omotoso A, Soladoye A . Normotensive offspring of hypertensive Nigerians have increased left ventricular mass and abnormal geometric patterns. Pan Afr Med J 2012; 11: 6.",{},{"id":24,"text":1874,"url":24,"identifiers":1875},"El Samahy MH, Matter RM, Youssef OI, Shams El Din El Telbany MA, Kamal NA . Relation between carotid intima media thickness and oxidative stress markers in type 1 diabetic childrenand adolescents. J Diabetes Metab Disord 2013; 19: 12–50.",{},{"id":24,"text":1877,"url":24,"identifiers":1878},"Kusters DM, Wiegman A, Kastelein JJ, Hutten BA . Carotid intima-media thickness in children with familial hypercholesterolemia. Circ Res 2014; 114: 307–310.",{"doi":1879},"10.1161\u002FCIRCRESAHA.114.301430",{"id":24,"text":1881,"url":24,"identifiers":1882},"Lamotte C, Iliescu C, Libersa C, Gottrand F . Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies. Eur J Pediatr 2011; 170: 719–729.",{"doi":1883},"10.1007\u002Fs00431-010-1328-y",{"id":24,"text":1885,"url":24,"identifiers":1886},"Cuomo S, Gaeta G, Guarini P, Tudisca G, De Michele M, Gene Bond M, Trevisan M . Increased carotid intima-media thickness in healthy young subjects with a parental history of hypertension (parental hypertension and vascular health). Heart 2007; 93: 368–369.",{"doi":1887},"10.1136\u002Fhrt.2006.091769",{"id":24,"text":1889,"url":24,"identifiers":1890},"Zanardo V, Visentin S, Trevisanuto D, Bertin M, Cavallin F, Cosmi E . Fetal aortic wall thickness: a marker of hypertension in IUGR children? Hypertens Res 2013; 36: 440–443.",{"doi":1891},"10.1038\u002Fhr.2012.219",{"id":24,"text":1893,"url":24,"identifiers":1894},"Xiang AH, Azen SP, Buchanan TA, Raffel LJ, Tan S, Cheng LS, Diaz J, Toscano E, Quinonnes M, Liu CR, Liu CH, Castellani LW, Hsueh WA, Rotter JI, Hodis HN . Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler Thromb Vasc Biol 2002; 22: 843–848.",{"doi":1895},"10.1161\u002F01.ATV.0000015329.15481.E8",{"id":24,"text":1897,"url":24,"identifiers":1898},"Evelein AM, Geerts CC, Bots ML, van der Ent CK, Grobbee DE, Uiterwaal CS . Parental blood pressure is related to vascular properties of their 5-year-old offspring. Am J Hypertens 2012; 25: 907–913.",{"doi":1899},"10.1038\u002Fajh.2012.66",{"id":24,"text":1901,"url":24,"identifiers":1902},"Kyvelou SM, Vyssoulis GP, Karpanou EA, Adamopoulos DN, Gialernios TP, Spanos PG, Cokkinos DV, Stefanadis CI . Arterial hypertension parental burden affects arterial stiffness and wave reflection to the aorta in young offsprings. Int J Cardiol 2010; 144: 156–160.",{"doi":1903},"10.1016\u002Fj.ijcard.2008.12.154",{"id":24,"text":1905,"url":24,"identifiers":1906},"Meaney E, Samaniego V, Alva F, Valdovinos RA, Marrufo R, Vela A, Allen T, Misra A, Madsen R . Increased arterial stiffness in children with a parental history of hypertension. Pediatr Cardiol 1999; 20: 203–205.",{"doi":1907},"10.1007\u002Fs002469900441",{"id":24,"text":1909,"url":24,"identifiers":1910},"Kucerová J, Filipovský J, Staessen JA, Cwynar M, Wojciechowska W, Stolarz K, Kuznetsova T, Gasowski J, Dolejsová M, Grodzicki T, Kawecka-Jaszcz K, Fagard R . Arterial characteristics in normotensive offspring of parents with or without a history of hypertension. Am J Hypertens 2006; 19: 264–269.",{"doi":1911},"10.1016\u002Fj.amjhyper.2005.09.015",{"id":24,"text":1913,"url":24,"identifiers":1914},"Dernellis J, Panaretou M . Aortic stiffness in children of parents with hypertension. J Hum Hypertens 2006; 20: 225–226.",{"doi":1915},"10.1038\u002Fsj.jhh.1001966",{"id":24,"text":1917,"url":24,"identifiers":1918},"Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Morales-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, Wühl E, Zanchetti A . Management of high blood pressure in children and adolescents: recommendations of the European society of hypertension. J Hypertens 2009; 27: 1719–1742.",{"doi":1919},"10.1097\u002FHJH.0b013e32832f4f6b",{"id":24,"text":1921,"url":24,"identifiers":1922},"Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H . Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal 2006; 27: 2588–2605.",{"doi":1866},{"id":24,"text":1924,"url":24,"identifiers":1925},"van den Elzen AP, de Ridder MA, Grobbee DE, Hofman A, Witteman JC, Uiterwaal CS . Families and the natural history of blood pressure. A 27-year follow-up study. Am J Hypertens 2004; 17: 936–940.",{},{"id":24,"text":1927,"url":24,"identifiers":1928},"Myers RH, Kiely DK, Cupples LA, Kannel WB . Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J 1990; 120: 963–969.",{"doi":1929},"10.1016\u002F0002-8703(90)90216-K",{"id":24,"text":1931,"url":24,"identifiers":1932},"Grandi AM, Gaudio G, Fachinetti A, Bianchi L, Nardo B, Zanzi P, Ceriani L, Guasti L, Venco A . Hyperinsulinemia, family history of hypertension, and essential hypertension. Am J Hypertens 1996; 9: 732–738.",{"doi":1933},"10.1016\u002F0895-7061(96)00095-7",{"id":24,"text":1935,"url":24,"identifiers":1936},"von Eiff AW, Gogolin E, Jacobs U, Neus H . Ambulatory blood pressure in children followed for 3 years. Influence of sex and family history of hypertension. Clin Exp Hypertens A 1986; 8: 577–581.",{},{"id":24,"text":1938,"url":24,"identifiers":1939},"Munger RG, Prineas RJ, Gomez-Marin O . Persistent elevation of blood pressure among children with a family history of hypertension: the Minneapolis Children’s Blood Pressure Study. J Hypertens 1988; 6: 647–653.",{"doi":1940},"10.1097\u002F00004872-198808000-00008",{"id":24,"text":1942,"url":24,"identifiers":1943},"Evrengul H, Tanriverdi H, Kilic ID, Dursunoglu D, Ozcan EE, Kaftan A, Kilic M . Aortic stiffness and flow-mediated dilatation in normotensive offspring of parents with hypertension. Cardiol Young 2012; 22: 451–456.",{"doi":1944},"10.1017\u002FS104795111200008X",{"id":24,"text":1946,"url":24,"identifiers":1947},"Demirpençe S, Güven B, Meşe T, Serdaroğlu E, Yılmazer MM, Firuzan E, Tavlı V . Evaluation of left atrial functions in children with chronic renal failure. Anadolu Kardiyol Derg 2014; 14: 280–285.",{"doi":1948},"10.5152\u002Fakd.2014.4675",{"id":24,"text":1950,"url":24,"identifiers":1951},"Barra S, Gaeta G, Cuomo S, Guarini P, Foglia MC, Capozzi G, Materazzi C, Trevisan M . Early increase of carotid intima-media thickness in children with parental history of premature myocardial infarction. Heart 2009; 95: 642–645.",{"doi":1952},"10.1136\u002Fhrt.2008.142836",{"id":24,"text":1954,"url":24,"identifiers":1955},"Zhou L, Chen Y, Sun N, Liu X . Family history of hypertension and arteriel elasticity characterics in healty people. Hypertens Res 2008; 31: 833–839.",{"doi":1956},"10.1291\u002Fhypres.31.833",{"id":24,"text":1958,"url":24,"identifiers":1959},"Rajzer MW, Klocek M, Kawecka-Jaszcz K, Czarnecka D, Baran W, Dudek K, Petriczek T . Aortic pulse wave velocity in young normotensives with a family history of hypertension. J Hypertens 1999; 17: 1821–1824.",{"doi":1960},"10.1097\u002F00004872-199917121-00006",{"id":24,"text":1962,"url":24,"identifiers":1963},"Rodríguez-Moran M, Aradillas-García C, Simental-Mendia LE, Monreal-Escalante E, de la Cruz Mendoza E, Dávila Esqueda ME, Guerrero-Romero F . Family history of hypertension and cardiovascular risk factors in prepubertal children. Am J Hypertens 2010; 23: 299–304.",{"doi":1964},"10.1038\u002Fajh.2009.257",{"id":1966,"createTime":1967,"updateTime":1967,"relativeEntities":1968,"slug":1969,"properties":1970,"entityType":139,"verifyStatus":140,"verifyTime":1967,"verifyNote":141,"syncStatus":23,"languages":1981,"translateLanguages":24,"viewCount":25,"primaryUrl":1982,"fullTextUrl":24,"authors":1983,"publicationType":288,"publisherRelationship":2144,"citationCount":2177,"citationInfo":2178,"publishDate":2180,"publishYear":2181,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":2182,"isForceReanalyzing":539},"1bf217f5-774e-468d-b3c6-276b02aca409","2024-09-17T18:34:43.268+00:00",[],"Skin-microvascular-function-as-assessed-with-laser-speckle-contrast-imaging-is-impaired-in-untreated-essential-and-masked-hypertension",{"keywords":1971,"openalex":1972,"abstract":1974,"title":1975,"pm":1977,"doi":1979},{},{"VOID":1973},"W4200565078",{},{"EN":1976},"Skin microvascular function, as assessed with laser speckle contrast imaging, is impaired in untreated essential and masked hypertension",{"VOID":1978},"34916663",{"VOID":1980},"10.1038\u002Fs41440-021-00816-w",[143],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fs41440-021-00816-w",[1984,2005,2027,2042,2059,2076,2093,2110,2127],{"id":1985,"sortIndex":206,"researcher":24,"roles":1986,"affiliations":1987,"properties":1998},"bd3782ef-0800-4d9e-9bf4-3042d08b29d8",[],[1988],{"id":1989,"sortIndex":25,"affiliation":1990,"properties":24},"069bef8e-15d0-40a1-a8eb-6106d92bf74e",{"id":1991,"createTime":1992,"updateTime":1992,"relativeEntities":1993,"slug":1994,"properties":1995,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"a65e766c-7952-4dd0-9d42-32c7cd97f860","2024-09-17T18:34:43.312+00:00",[],"Exercise-Physiology-and-%CE%92iochemistry-Laboratory-Aristotle-University-of-Thessaloniki-Serres-Greece",{"title":1996},{"EN":1997},"Exercise Physiology and Βiochemistry Laboratory, Aristotle University of Thessaloniki, Serres, Greece",{"openalex":1999,"orcid":2001,"title":2003},{"VOID":2000},"A5012724974",{"VOID":2002},"https:\u002F\u002Forcid.org\u002F0000-0001-5902-3467",{"EN":2004},"Κωνσταντίνα Δίπλα",{"id":2006,"sortIndex":25,"researcher":24,"roles":2007,"affiliations":2008,"properties":2020},"0cbc323e-f658-4f58-a5ee-a4643da64666",[],[2009],{"id":2010,"sortIndex":25,"affiliation":2011,"properties":24},"4425c4f4-526b-43b8-9fb0-63fc4867b00f",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2015,"slug":2016,"properties":2017,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"67438898-f85e-4da9-bc62-70daf4d557bf","2023-12-03T07:06:11.422+00:00","2024-09-17T18:34:55.181+00:00",[],"3rd-Department-of-Internal-Medicine-Papageorgiou-Hospital-Aristotle-University-of-Thessaloniki-Thessaloniki-Greece",{"title":2018},{"VI":2019},"3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece",{"openalex":2021,"orcid":2023,"title":2025},{"VOID":2022},"A5069060833",{"VOID":2024},"https:\u002F\u002Forcid.org\u002F0000-0002-7205-4644",{"EN":2026},"Αntonios Lazaridis",{"id":2028,"sortIndex":73,"researcher":24,"roles":2029,"affiliations":2030,"properties":2037},"b7f6cd43-30b0-4243-b9d6-cd9d408af76c",[],[2031],{"id":2032,"sortIndex":25,"affiliation":2033,"properties":24},"a643c19b-d1df-4def-8e36-55502fd6e7a1",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2034,"slug":2016,"properties":2035,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2036},{"VI":2019},{"openalex":2038,"title":2040},{"VOID":2039},"A5028405912",{"EN":2041},"Spyros Aslanidis",{"id":2043,"sortIndex":644,"researcher":24,"roles":2044,"affiliations":2045,"properties":2052},"1a675cec-d8d6-4d00-8e27-117aa7f4a0c0",[],[2046],{"id":2047,"sortIndex":25,"affiliation":2048,"properties":24},"ad86078e-ac73-49cf-9cfe-67c637e8e696",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2049,"slug":2016,"properties":2050,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2051},{"VI":2019},{"openalex":2053,"orcid":2055,"title":2057},{"VOID":2054},"A5004094835",{"VOID":2056},"https:\u002F\u002Forcid.org\u002F0000-0001-6263-3688",{"EN":2058},"Στέλλα Δούμα",{"id":2060,"sortIndex":1396,"researcher":24,"roles":2061,"affiliations":2062,"properties":2069},"a23415b1-55eb-4029-b383-986cb338f127",[],[2063],{"id":2064,"sortIndex":25,"affiliation":2065,"properties":24},"7c6e9f35-4daf-45a6-a707-b60308490a4c",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2066,"slug":2016,"properties":2067,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2068},{"VI":2019},{"openalex":2070,"orcid":2072,"title":2074},{"VOID":2071},"A5050688361",{"VOID":2073},"https:\u002F\u002Forcid.org\u002F0000-0002-6324-2475",{"EN":2075},"Εugenia Gkaliagkousi",{"id":2077,"sortIndex":171,"researcher":24,"roles":2078,"affiliations":2079,"properties":2086},"385158d2-5d9a-40b8-9edd-8418e2a8e714",[],[2080],{"id":2081,"sortIndex":25,"affiliation":2082,"properties":24},"8291c5ca-dd75-4c22-85a5-2ee5c8cc6852",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2083,"slug":2016,"properties":2084,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2085},{"VI":2019},{"openalex":2087,"orcid":2089,"title":2091},{"VOID":2088},"A5082575758",{"VOID":2090},"https:\u002F\u002Forcid.org\u002F0000-0001-6976-2802",{"EN":2092},"Nikolaos Koletsos",{"id":2094,"sortIndex":238,"researcher":24,"roles":2095,"affiliations":2096,"properties":2103},"21416a17-0553-45b2-a0c7-41c9851d1902",[],[2097],{"id":2098,"sortIndex":25,"affiliation":2099,"properties":24},"ede6e38f-67bf-4112-881d-d3c14ddddb51",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2100,"slug":2016,"properties":2101,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2102},{"VI":2019},{"openalex":2104,"orcid":2106,"title":2108},{"VOID":2105},"A5025672213",{"VOID":2107},"https:\u002F\u002Forcid.org\u002F0000-0001-7644-0684",{"EN":2109},"Αreti Triantafyllou",{"id":2111,"sortIndex":274,"researcher":24,"roles":2112,"affiliations":2113,"properties":2120},"d4965799-15bd-40e4-99a1-daf404d5f7a5",[],[2114],{"id":2115,"sortIndex":25,"affiliation":2116,"properties":24},"6d993323-c4d3-49b5-b058-c0caa3f02647",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2117,"slug":2016,"properties":2118,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2119},{"VI":2019},{"openalex":2121,"orcid":2123,"title":2125},{"VOID":2122},"A5069152790",{"VOID":2124},"https:\u002F\u002Forcid.org\u002F0000-0002-5658-4629",{"EN":2126},"Panagiota Anyfanti",{"id":2128,"sortIndex":148,"researcher":24,"roles":2129,"affiliations":2130,"properties":2137},"f9e6febe-4ee2-4162-ab59-42bc400f174b",[],[2131],{"id":2132,"sortIndex":25,"affiliation":2133,"properties":24},"465bb687-37cd-4f00-b1a3-f47b1c3910cc",{"id":2012,"createTime":2013,"updateTime":2014,"relativeEntities":2134,"slug":2016,"properties":2135,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2136},{"VI":2019},{"openalex":2138,"orcid":2140,"title":2142},{"VOID":2139},"A5078007667",{"VOID":2141},"https:\u002F\u002Forcid.org\u002F0000-0002-5623-3335",{"EN":2143},"Panagiotis Dolgyras",{"url":24,"publisher":2145,"properties":2170},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2146,"slug":10,"properties":2147,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2153,"manageAffiliations":2154,"indexDatabases":2155,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2148,"issn":2149,"introduce":2150,"eissn":2151,"title":2152},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[2156,2163],{"id":77,"indexDatabase":2157,"url":92,"indexYears":24,"academicFieldIds":2162,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":2158,"label":2159,"description":2160,"key":88,"publicationTags":2161,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":2164,"url":109,"indexYears":110,"academicFieldIds":2169,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":2165,"label":2166,"description":2167,"key":106,"publicationTags":2168,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":2171,"pages":2173,"issue":2175},{"VOID":2172},"45",{"VOID":2174},"445-454",{"VOID":2176},"3",17,{"total":2177,"publishYear":24,"statisticByYear":2179},{"2022":206,"2023":640,"2024":148},"2022-03-01",2022,[2183,2187,2191,2195,2199,2203,2207,2211,2215,2219,2223,2227,2231,2235,2239,2243,2247,2250,2254,2258,2262,2266,2270,2274,2278,2282,2286,2290,2294,2298,2302,2306,2310,2314,2318,2322,2326,2330,2334,2338,2342,2346,2350,2354,2358,2362,2366,2370,2374],{"id":24,"text":2184,"url":24,"identifiers":2185},"Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation? Hypertension 2006;48:1012–7.",{"doi":2186},"10.1161\u002F01.HYP.0000249510.20326.72",{"id":24,"text":2188,"url":24,"identifiers":2189},"Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safaret M, et al. Impaired tissue perfusion a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 2008;118:968–76.",{"doi":2190},"10.1161\u002FCIRCULATIONAHA.107.763730",{"id":24,"text":2192,"url":24,"identifiers":2193},"Seliger SL, Salimi S, Pierre V, Giffuni J, Katzel L, Parsa A. Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults. BMC Nephrol. 2016;17:82.",{"doi":2194},"10.1186\u002Fs12882-016-0303-x",{"id":24,"text":2196,"url":24,"identifiers":2197},"Yamamoto-Suganuma R, Aso Y. Relationship between post-occlusive forearm skin reactive hyperaemia and vascular disease in patients with Type 2 diabetes—a novel index for detecting micro- and macrovascular dysfunction using laser Doppler flowmetry. Diabet Med. 2009;26:83–8.",{"doi":2198},"10.1111\u002Fj.1464-5491.2008.02609.x",{"id":24,"text":2200,"url":24,"identifiers":2201},"Triantafyllou A, Anyfanti P, Zabulis X, Gavriilaki E, Karamaounas P, Gkaliagkousi E, et al. Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients. J Am Soc Hypertens. 2014;8:542–9.",{"doi":2202},"10.1016\u002Fj.jash.2014.04.008",{"id":24,"text":2204,"url":24,"identifiers":2205},"Vuilleumier P, Decosterd D, Maillard M, Burnier M, Hayoz D. Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J Hypertens. 2002;20:1753–7.",{"doi":2206},"10.1097\u002F00004872-200209000-00018",{"id":24,"text":2208,"url":24,"identifiers":2209},"Hellmann M, Roustit M, Cracowski JL. Skin microvascular endothelial function as a biomarker in cardiovascular diseases? Pharmacol Rep. Published online 2015.",{"doi":2210},"10.1016\u002Fj.pharep.2015.05.008",{"id":24,"text":2212,"url":24,"identifiers":2213},"Holowatz LA, Thompson-torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol. 2008;105:370–2.",{"doi":2214},"10.1152\u002Fjapplphysiol.00858.2007",{"id":24,"text":2216,"url":24,"identifiers":2217},"Heeman W, Boerma EC, Heeman W, Steenbergen W, Van Dam GM, Boerma EC. Clinical applications of laser speckle contrast imaging: a review. J Biomed Opt. 2019;24:080901.",{"doi":2218},"10.1117\u002F1.JBO.24.8.080901",{"id":24,"text":2220,"url":24,"identifiers":2221},"Mahé G, Humeau-Heurtier A, Durand S, Leftheriotis G, Abraham P. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging. Circ Cardiovasc Imaging. 2012;5:155–63.",{"doi":2222},"10.1161\u002FCIRCIMAGING.111.970418",{"id":24,"text":2224,"url":24,"identifiers":2225},"Boas DA, Dunn AK. Laser speckle contrast imaging in biomedical optics. J Biomed Opt. 2010;15:011109.",{"doi":2226},"10.1117\u002F1.3285504",{"id":24,"text":2228,"url":24,"identifiers":2229},"Humeau-Heurtier A, Abraham P, Durand S, Mahé G. Excellent inter-and intra-observer reproducibility of microvascular tests using laser speckle contrast imaging. Clin Hemorheol Microcirc. 2014;58:439–46.",{"doi":2230},"10.3233\u002FCH-131804",{"id":24,"text":2232,"url":24,"identifiers":2233},"De Jongh RT, Serné EH, Ijzerman RG, Stehouwer CDA. Microvascular function: a potential link between salt sensitivity, insulin resistance and hypertension. J Hypertens. 2007;25:1887–93.",{"doi":2234},"10.1097\u002FHJH.0b013e32825e1db7",{"id":24,"text":2236,"url":24,"identifiers":2237},"Kaiser SE, Sanjuliani AF, Estato V, Gomes MB, Tibiriçá E. Antihypertensive treatment improves microvascular rarefaction and reactivity in low-risk hypertensive individuals. Microcirculation 2013;20:703–16.",{"doi":2238},"10.1111\u002Fmicc.12067",{"id":24,"text":2240,"url":24,"identifiers":2241},"Serné EH, Gans ROB, Ter Maaten JC, Ter Wee PM, Donker AJM, Stehouwer CDA. Capillary recruitment is impaired in essential hypertension and relates to insulin’s metabolic and vascular actions. Cardiovasc Res. 2001;49:161–8.",{"doi":2242},"10.1016\u002FS0008-6363(00)00198-X",{"id":24,"text":2244,"url":24,"identifiers":2245},"Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibiriçà E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens. 2006;19:477–83.",{"doi":2246},"10.1016\u002Fj.amjhyper.2005.10.021",{"id":24,"text":2248,"url":24,"identifiers":2249},"Gryglewska B, Necki M, Cwynar M, Baron T, Grodzicki T. Neurogenic and myogenic resting skin blood flowmotion in subjects with masked hypertension. J Physiol Pharm. 2010;61:551–8.",{},{"id":24,"text":2251,"url":24,"identifiers":2252},"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\u002FESH Guidelines for the management of arterial hypertension. J Hypertens. 2018;36:1953–2041.",{"doi":2253},"10.1097\u002FHJH.0000000000001940",{"id":24,"text":2255,"url":24,"identifiers":2256},"Anyfanti P, Triantafyllidou E, Papadopoulos S, Triantafyllou A, Nikolaidis M, Kyparos A, et al. Smoking before isometric exercise amplifies myocardial stress and dysregulates baroreceptor sensitivity and cerebral oxygenation. J Am Soc Hypertens. 2017;11:376–84.",{"doi":2257},"10.1016\u002Fj.jash.2017.04.004",{"id":24,"text":2259,"url":24,"identifiers":2260},"Roustit M, Cracowski JL. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharm Sci. 2013;34:373–84.",{"doi":2261},"10.1016\u002Fj.tips.2013.05.007",{"id":24,"text":2263,"url":24,"identifiers":2264},"Draijer M, Hondebrink E, Van Leeuwen T, Steenbergen W. Review of laser speckle contrast techniques for visualizing tissue perfusion. Lasers Med Sci. 2009;24:639–51.",{"doi":2265},"10.1007\u002Fs10103-008-0626-3",{"id":24,"text":2267,"url":24,"identifiers":2268},"Briers JD. Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. Physiol Meas. 2001;22:35–66.",{"doi":2269},"10.1088\u002F0967-3334\u002F22\u002F4\u002F201",{"id":24,"text":2271,"url":24,"identifiers":2272},"Senarathna J, Member S, Rege A, Li N, Thakor NV. Laser speckle contrast imaging: theory, instrumentation and applications. IEEE Rev Biomed Eng. 2013;6:99–110.",{"doi":2273},"10.1109\u002FRBME.2013.2243140",{"id":24,"text":2275,"url":24,"identifiers":2276},"Bee G, Tee Y, Hanum A, Rahman A, Halim AS. Dependence of human forearm skin postocclusive reactive hyperemia on occlusion time. J Pharm Toxicol Methods. 2004;50:73–78.",{"doi":2277},"10.1016\u002Fj.vascn.2004.02.002",{"id":24,"text":2279,"url":24,"identifiers":2280},"Dipla K, Triantafyllou A, Koletsos N, Papadopoulos S, Sachpekidis V, Vrabas I, et al. Impaired muscle oxygenation and elevated exercise blood pressure in hypertensive patients: links with vascular stiffness. Hypertension 2017;70:444–51.",{"doi":2281},"10.1161\u002FHYPERTENSIONAHA.117.09558",{"id":24,"text":2283,"url":24,"identifiers":2284},"Rosenberry R, Nelson MD. Reactive hyperemia: a review of methods, mechanisms, and considerations. Am J Physiol - Regul Integr Comp Physiol. 2020;318:R605–R618.",{"doi":2285},"10.1152\u002Fajpregu.00339.2019",{"id":24,"text":2287,"url":24,"identifiers":2288},"IJzerman RG, de Jongh RT, Beijk MAM, van Weissenbruch MM, Delemarre-van de Waal HA, Serné EH, Stehouwer. CDA. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest. 2003;31:536–42.",{"doi":2289},"10.1046\u002Fj.1365-2362.2003.01179.x",{"id":24,"text":2291,"url":24,"identifiers":2292},"Aine Q, Uzzaman S, Pfenninger D, Chakrabarti A, Kacirotti N, Rubenfire M, et al. Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses. Clin Sci. 2002;103:267–73.",{"doi":2293},"10.1042\u002Fcs1030267",{"id":24,"text":2295,"url":24,"identifiers":2296},"Rossi M, Matteucci E, Pesce M, Consani C, Franzoni F, Santoro G, et al. Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: a preliminary study. Clin Hemorheol Microcirc. 2013;54:381–91.",{"doi":2297},"10.3233\u002FCH-2012-1628",{"id":24,"text":2299,"url":24,"identifiers":2300},"Cordovil I, Huguenin G, Rosa G, Bello A, Köhler O, Moraeset de R, et al. Evaluation of systemic microvascular endothelial function using laser speckle contrast imaging. Microvasc Res. 2012;83:376–9.",{"doi":2301},"10.1016\u002Fj.mvr.2012.01.004",{"id":24,"text":2303,"url":24,"identifiers":2304},"Triantafyllou A, Doumas M, Anyfanti P, Gkaliagkousi E, Zabulis X, Petidis K, et al. Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension. Am J Hypertens. 2013;26:318–25.",{"doi":2305},"10.1093\u002Fajh\u002Fhps040",{"id":24,"text":2307,"url":24,"identifiers":2308},"Ramoshaba NE, Huisman HW, Lammertyn L, Kotliar KE, Schutte AE, Smith W. Retinal microvasculature and masked hypertension in young adults: the African-PREDICT study. Hypertens Res. 2020;43:1231–8.",{"doi":2309},"10.1038\u002Fs41440-020-0487-0",{"id":24,"text":2311,"url":24,"identifiers":2312},"Anyfanti P, Gkaliagkousi E, Triantafyllou A, Dipla K, Zarifis H, Arseniou P, et al. Noninvasive assessment of myocardial perfusion in different blood pressure phenotypes and its association with arterial stiffness indices. Am J Hypertens. 2019;32:557–63.",{"doi":2313},"10.1093\u002Fajh\u002Fhpz039",{"id":24,"text":2315,"url":24,"identifiers":2316},"Serné EH, Gans ROB, Ter Maaten JC, Tangelder GJ, Donker AJM, Stehouwer CDA. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001;38:238–42.",{"doi":2317},"10.1161\u002F01.HYP.38.2.238",{"id":24,"text":2319,"url":24,"identifiers":2320},"Prasad A, Dunnill GS, Mortimer PS, Macgregor GA. Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens. 1995;13:265–8.",{"doi":2321},"10.1097\u002F00004872-199502000-00015",{"id":24,"text":2323,"url":24,"identifiers":2324},"Caliskan M, Caliskan Z, Gullu H, Keles N, Bulur S, Turan Y, et al. Increased morning blood pressure surge and coronary microvascular dysfunction in patient with early stage hypertension. J Am Soc Hypertens. 2014;8:652–9.",{"doi":2325},"10.1016\u002Fj.jash.2014.05.010",{"id":24,"text":2327,"url":24,"identifiers":2328},"Henskens LHG, Van Oostenbrugge RJ, Kroon AA, De Leeuw PW, Lodder J. Brain microbleeds are associated with ambulatory blood pressure levels in a hypertensive population. Hypertension 2008;51:62–68.",{"doi":2329},"10.1161\u002FHYPERTENSIONAHA.107.100610",{"id":24,"text":2331,"url":24,"identifiers":2332},"Wei FF, Zhang ZY, Thijs L, Yang WY, Jacobs L, Cauwenberghs N, et al. Conventional and ambulatory blood pressure as predictors of retinal arteriolar narrowing. Hypertension 2016;68:511–20.",{"doi":2333},"10.1161\u002FHYPERTENSIONAHA.116.07523",{"id":24,"text":2335,"url":24,"identifiers":2336},"Hashimoto J. Central hemodynamics and target organ damage in hypertension. Tohoku J Exp Med. 2014;233:1–8.",{"doi":2337},"10.1620\u002Ftjem.233.1",{"id":24,"text":2339,"url":24,"identifiers":2340},"Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension 2011;58:839–46.",{"doi":2341},"10.1161\u002FHYPERTENSIONAHA.111.177469",{"id":24,"text":2343,"url":24,"identifiers":2344},"Ott C, Raff U, Harazny JM, Michelson G, Schmieder RE. Central pulse pressure is an independent determinant of vascular remodeling in the retinal circulation. Hypertension 2013;61:1340–5.",{"doi":2345},"10.1161\u002FHYPERTENSIONAHA.111.00617",{"id":24,"text":2347,"url":24,"identifiers":2348},"Pellaton C, Kubli S, Feihl F, Waeber B. Blunted vasodilatory responses in the cutaneous microcirculation of cigarette smokers. Am Heart J. 2002;144:269–74.",{"doi":2349},"10.1067\u002Fmjh.2002.123842",{"id":24,"text":2351,"url":24,"identifiers":2352},"Binggeli C, Spieker LE, Corti R, Sudano I, Stojanovic V, Hayoz D, et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol. 2003;42:71–77.",{"doi":2353},"10.1016\u002FS0735-1097(03)00505-9",{"id":24,"text":2355,"url":24,"identifiers":2356},"Štulc T, Kasalová Z, Prázný M, Vrablík M, Škrha J, Češka R. Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment. Physiol Res. 2003;52:439–45.",{"doi":2357},"10.33549\u002Fphysiolres.930356",{"id":24,"text":2359,"url":24,"identifiers":2360},"Roustit M, Cracowski J. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation 2011;19:47–64.",{"doi":2361},"10.1111\u002Fj.1549-8719.2011.00129.x",{"id":24,"text":2363,"url":24,"identifiers":2364},"Cracowski JL, Roustit M. Human skin microcirculation. Compr Physiol. 2020;10:1105–54.",{"doi":2365},"10.1002\u002Fcphy.c190008",{"id":24,"text":2367,"url":24,"identifiers":2368},"Thompson OB, Andrews MK. Tissue perfusion measurements: multiple-exposure laser speckle analysis generates laser Doppler–like spectra. J Biomed Opt. 2010;15:027015.",{"doi":2369},"10.1117\u002F1.3400721",{"id":24,"text":2371,"url":24,"identifiers":2372},"Tew GA, Klonizakis M, Crank H, Briers JD, Hodges GJ. Comparison of laser speckle contrast imaging with laser Doppler for assessing microvascular function. Microvasc Res. 2011;82:326–32.",{"doi":2373},"10.1016\u002Fj.mvr.2011.07.007",{"id":24,"text":2375,"url":24,"identifiers":2376},"Millet C, Roustit M, Blaise S, Cracowski JL. Comparison between laser speckle contrast imaging and laser Doppler imaging to assess skin blood flow in humans. Microvasc Res. 2011;82:147–51.",{"doi":2377},"10.1016\u002Fj.mvr.2011.06.006",{"id":2379,"createTime":2380,"updateTime":2380,"relativeEntities":2381,"slug":2382,"properties":2383,"entityType":139,"verifyStatus":140,"verifyTime":2380,"verifyNote":141,"syncStatus":23,"languages":2398,"translateLanguages":24,"viewCount":25,"primaryUrl":2399,"fullTextUrl":24,"authors":2400,"publicationType":288,"publisherRelationship":2453,"citationCount":148,"citationInfo":2486,"publishDate":2488,"publishYear":2489,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":2490,"isForceReanalyzing":539},"bc4572f8-fe5f-4ec1-a67c-596d117e818a","2024-09-17T18:34:34.938+00:00",[],"Relationship-between-subtle-urinary-albumin-excretion-and-risk-of-incident-hypertension-modification-by-glomerular-filtration-rate",{"mag":2384,"keywords":2386,"pmc":2387,"openalex":2389,"abstract":2391,"title":2392,"pm":2394,"doi":2396},{"VOID":2385},"2757641927",{},{"VOID":2388},"5746590",{"VOID":2390},"W2757641927",{},{"EN":2393},"Relationship between subtle urinary albumin excretion and risk of incident hypertension: modification by glomerular filtration rate",{"VOID":2395},"28933781",{"VOID":2397},"10.1038\u002Fhr.2017.77",[143],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fhr201777",[2401,2423,2438],{"id":2402,"sortIndex":206,"researcher":24,"roles":2403,"affiliations":2404,"properties":2416},"7bdb2558-4ae5-40b6-837b-1626b503c118",[],[2405],{"id":2406,"sortIndex":25,"affiliation":2407,"properties":24},"df867ea7-9900-448c-b178-79b8ed65a702",{"id":2408,"createTime":2409,"updateTime":2410,"relativeEntities":2411,"slug":2412,"properties":2413,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"db13e7e9-cc92-4fd5-bab0-d5a4e6cc9af0","2023-12-28T09:56:12.588+00:00","2024-09-17T18:34:34.954+00:00",[],"Research-Center-for-Lifestyle-related-Disease-Tohoku-Rosai-Hospital-Sendai-Japan",{"title":2414},{"VI":2415},"Research Center for Lifestyle-related Disease, Tohoku Rosai Hospital, Sendai, Japan",{"openalex":2417,"orcid":2419,"title":2421},{"VOID":2418},"A5025695892",{"VOID":2420},"https:\u002F\u002Forcid.org\u002F0000-0001-6439-2443",{"EN":2422},"Satoshi Konno",{"id":2424,"sortIndex":25,"researcher":24,"roles":2425,"affiliations":2426,"properties":2433},"aa86d6f5-6d45-4d23-a30c-bfd3af297b16",[],[2427],{"id":2428,"sortIndex":25,"affiliation":2429,"properties":24},"d018e514-f7d4-434b-918c-2445cba8601f",{"id":2408,"createTime":2409,"updateTime":2410,"relativeEntities":2430,"slug":2412,"properties":2431,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2432},{"VI":2415},{"openalex":2434,"title":2436},{"VOID":2435},"A5024164389",{"EN":2437},"Masanori Munakata",{"id":2439,"sortIndex":238,"researcher":24,"roles":2440,"affiliations":2441,"properties":2448},"e2286df5-0ff0-41d7-b422-cdfbd896eb75",[],[2442],{"id":2443,"sortIndex":25,"affiliation":2444,"properties":24},"fc3c7f97-34f3-405f-a726-0531fe38f1fb",{"id":2408,"createTime":2409,"updateTime":2410,"relativeEntities":2445,"slug":2412,"properties":2446,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2447},{"VI":2415},{"openalex":2449,"title":2451},{"VOID":2450},"A5078849824",{"EN":2452},"Tomomi Hattori",{"url":24,"publisher":2454,"properties":2479},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2455,"slug":10,"properties":2456,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2462,"manageAffiliations":2463,"indexDatabases":2464,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2457,"issn":2458,"introduce":2459,"eissn":2460,"title":2461},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[2465,2472],{"id":77,"indexDatabase":2466,"url":92,"indexYears":24,"academicFieldIds":2471,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":2467,"label":2468,"description":2469,"key":88,"publicationTags":2470,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":2473,"url":109,"indexYears":110,"academicFieldIds":2478,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":2474,"label":2475,"description":2476,"key":106,"publicationTags":2477,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":2480,"pages":2482,"issue":2484},{"VOID":2481},"40",{"VOID":2483},"994-998",{"VOID":2485},"12",{"total":148,"publishYear":24,"statisticByYear":2487},{"2020":238,"2021":238,"2023":238},"2017-12-01",2017,[2491,2495,2499,2502,2505,2507,2509,2513,2516,2520,2524,2528,2532,2536,2540,2544,2548,2552,2556,2560,2564,2567,2571,2574,2576,2580,2584,2588],{"id":24,"text":2492,"url":24,"identifiers":2493},"Lawes CM, Vander Hoorn S, Rodgers A, International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513–1518.",{"doi":2494},"10.1016\u002FS0140-6736(08)60655-8",{"id":24,"text":2496,"url":24,"identifiers":2497},"Cowley AW Jr., Roman RJ . The role of the kidney in hypertension. JAMA 1996; 275: 1581–1589.",{"doi":2498},"10.1001\u002Fjama.1996.03530440061038",{"id":24,"text":2500,"url":24,"identifiers":2501},"Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, Levy D, Vasan RS . Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370–1376.",{"doi":1556},{"id":24,"text":2503,"url":24,"identifiers":2504},"Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT . Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2016; 17: 331–335.",{"doi":1540},{"id":24,"text":1542,"url":24,"identifiers":2506},{"doi":1544},{"id":24,"text":1550,"url":24,"identifiers":2508},{"doi":1552},{"id":24,"text":2510,"url":24,"identifiers":2511},"Park SK, Moon SY, Oh CM, Ryoo JH, Park MS . High normal urine albumin-to-creatinine ratio predicts development of hypertension in Korean men. Circ J 2014; 78: 656–661.",{"doi":2512},"10.1253\u002Fcircj.CJ-13-0745",{"id":24,"text":2514,"url":24,"identifiers":2515},"Hirayama A, Konta T, Hozawa A, Kawasaki R, Watanabe T, Shibata Y, Kayama T, Fukao A, Kubota I . Slight increase in urinary albumin excretion within the normal range predicts incident hypertension in a community-based Japanese population: the Takahata study. Hypertens Res 2015; 38: 56–60.",{"doi":1314},{"id":24,"text":2517,"url":24,"identifiers":2518},"Kestenbaum B, Rudser KD, de Boer IH, Peralta CA, Fried LF, Shlipak MG, Palmas W, Stehman-Breen C, Siscovick DS . Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med 2008; 148: 501–508.",{"doi":2519},"10.7326\u002F0003-4819-148-7-200804010-00006",{"id":24,"text":2521,"url":24,"identifiers":2522},"Keller G, Zimmer G, Mall G, Ritz E, Amann K . Nephron number in patients with primary hypertension. N Engl J Med 2003; 9 348: 101–208.",{"doi":2523},"10.1056\u002FNEJMoa020549",{"id":24,"text":2525,"url":24,"identifiers":2526},"Kokubo Y . Prevention of hypertension and cardiovascular diseases: a comparison of lifestyle factors in Westerners and East Asians. Hypertension 2014; 63: 655–660.",{"doi":2527},"10.1161\u002FHYPERTENSIONAHA.113.00543",{"id":24,"text":2529,"url":24,"identifiers":2530},"Munakata M, Konno S, Ohshima M, Ikeda T, Miura Y, Ito S . High-normal blood pressure is associated with microalbuminuria in the general population: the Watari study. Hypertens Res 2011; 34: 1135–1140.",{"doi":2531},"10.1038\u002Fhr.2011.98",{"id":24,"text":2533,"url":24,"identifiers":2534},"Konno S, Hozawa A, Miura Y, Ito S, Munakata M . High-normal diastolic blood pressure is a risk for development of microalbuminuria in the general population: the Watari study. J Hypertens 2013; 31: 798–804.",{"doi":2535},"10.1097\u002FHJH.0b013e32835e2146",{"id":24,"text":2537,"url":24,"identifiers":2538},"Konno S, Munakata M . Moderately increased albuminuria is an independent risk factor of cardiovascular events in the general Japanese population under 75 years of age: the Watari study. PLoS ONE 2015; 10: e0123893.",{"doi":2539},"10.1371\u002Fjournal.pone.0123893",{"id":24,"text":2541,"url":24,"identifiers":2542},"Hattori T, Konno S, Munakata M . Gender differences in lifestyle factors associated with metabolic syndrome and preliminary metabolic syndrome in the general population: the Watari study. Intren Med 2017; 56: 2253–2259.",{"doi":2543},"10.2169\u002Finternalmedicine.8578-16",{"id":24,"text":2545,"url":24,"identifiers":2546},"Dworkin LD, Hostetter TH, Rennke HG, Brenner BM . Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 1984; 73: 1448–1461.",{"doi":2547},"10.1172\u002FJCI111349",{"id":24,"text":2549,"url":24,"identifiers":2550},"Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, Sattar N, Zukowska-Szczechowska E, Dominiczak AF . Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007; 71: 816–821.",{"doi":2551},"10.1038\u002Fsj.ki.5002160",{"id":24,"text":2553,"url":24,"identifiers":2554},"Naderpoor N, Lyons JG, Mousa A, Ranasinha S, Courten MP, Soldatos G, Courten B . Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort. Sci Rep 2017; 3 7 45522.",{"doi":2555},"10.1038\u002Fsrep45522",{"id":24,"text":2557,"url":24,"identifiers":2558},"Nørrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MJ, Korsgaard N . Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 1994; 24: 301–308.",{"doi":2559},"10.1161\u002F01.HYP.24.3.301",{"id":24,"text":2561,"url":24,"identifiers":2562},"Gu YM, Petit T, Wei FF, Thijs L, Jacobs L, Zhang ZY, Yang WY, Cauwenberghs N, Knez J, Struijker-Boudier HA, Kuznetsova T, Verhamme P, Staessen JA . Renal glomerular dysfunction in relation to retinal arteriolar narrowing and high pulse pressure in seniors. Hypertens Res 2016; 39: 138–143.",{"doi":2563},"10.1038\u002Fhr.2015.125",{"id":24,"text":2565,"url":24,"identifiers":2566},"Kimura G, Brenner B . In Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. Raven Press, 1005: 1569–1588.",{},{"id":24,"text":2568,"url":24,"identifiers":2569},"Brenner BM, Garcia DL, Anderson S . Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1: 335–347.",{"doi":2570},"10.1093\u002Fajh\u002F1.4.335",{"id":24,"text":2572,"url":24,"identifiers":2573},"Seedat YK . Race, environment and blood pressure: the South African experience. J Hypetens 1983; 1: 7–12.",{},{"id":24,"text":1629,"url":24,"identifiers":2575},{"doi":1631},{"id":24,"text":2577,"url":24,"identifiers":2578},"Bakker AJ . Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999; 22: 307–313.",{"doi":2579},"10.2337\u002Fdiacare.22.2.307",{"id":24,"text":2581,"url":24,"identifiers":2582},"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–147.",{"doi":2583},"10.7326\u002F0003-4819-139-2-200307150-00013",{"id":24,"text":2585,"url":24,"identifiers":2586},"Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A . Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29–34.",{"doi":2587},"10.1053\u002Fajkd.2000.8237",{"id":24,"text":2589,"url":24,"identifiers":2590},"Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP . Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312–318.",{"doi":2591},"10.1038\u002Fki.1995.40",{"id":2593,"createTime":2594,"updateTime":2594,"relativeEntities":2595,"slug":2596,"properties":2597,"entityType":139,"verifyStatus":23,"verifyTime":2608,"verifyNote":2609,"syncStatus":23,"languages":2610,"translateLanguages":24,"viewCount":25,"primaryUrl":2611,"fullTextUrl":24,"authors":2612,"publicationType":288,"publisherRelationship":2946,"citationCount":2978,"citationInfo":2979,"publishDate":2985,"publishYear":2986,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":2987,"isForceReanalyzing":539},"ee1430fa-6527-49a2-acff-88b810cc44b0","2024-11-29T17:06:58.910+00:00",[],"Erratum-The-Japanese-Society-of-Hypertension-Guidelines-for-the-Management-of-Hypertension-JSH-2009-Chapter-2",{"mag":2598,"keywords":2600,"openalex":2601,"abstract":2603,"title":2604,"doi":2606},{"VOID":2599},"1482820024",{},{"VOID":2602},"W1482820024",{},{"EN":2605},"Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2",{"VOID":2607},"10.1038\u002Fhr.2009.34","2024-11-29T17:06:58.909+00:00","Author affiliation is blank",[143],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fhr200934",[2613,2635,2645,2657,2667,2676,2688,2698,2707,2716,2725,2735,2744,2755,2767,2776,2787,2796,2808,2817,2828,2838,2849,2869,2881,2891,2902,2913,2924,2934],{"id":2614,"sortIndex":73,"researcher":24,"roles":2615,"affiliations":2616,"properties":2628},"c266e1e8-6487-4e2a-b72e-f4cc266f8e0e",[],[2617],{"id":2618,"sortIndex":25,"affiliation":2619,"properties":24},"0440a213-1975-45b0-bf3c-b851a86b85bd",{"id":2620,"createTime":2621,"updateTime":2622,"relativeEntities":2623,"slug":2624,"properties":2625,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"feed9369-8924-41be-9f42-9530841679c1","2024-09-20T20:10:24.839+00:00","2024-12-02T08:28:36.379+00:00",[],"Pharmaceutical-Sciences",{"title":2626},{"EN":2627},"Pharmaceutical Sciences",{"openalex":2629,"orcid":2631,"title":2633},{"VOID":2630},"A5008308259",{"VOID":2632},"https:\u002F\u002Forcid.org\u002F0000-0003-3925-8837",{"EN":2634},"Yutaka Imai",{"id":2636,"sortIndex":2637,"researcher":24,"roles":2638,"affiliations":2639,"properties":2640},"a0d8877d-0372-42a7-b25a-73abbc55711a",28,[],[],{"openalex":2641,"title":2643},{"VOID":2642},"A5112715259",{"EN":2644},"Toshihiko Ishimitsu",{"id":2646,"sortIndex":2647,"researcher":24,"roles":2648,"affiliations":2649,"properties":2650},"ab3a0f75-3206-40a8-b9c6-c7fa1c8914a7",25,[],[],{"openalex":2651,"orcid":2653,"title":2655},{"VOID":2652},"A5075058891",{"VOID":2654},"https:\u002F\u002Forcid.org\u002F0000-0003-0456-0841",{"EN":2656},"Shinichiro Ueda",{"id":2658,"sortIndex":2659,"researcher":24,"roles":2660,"affiliations":2661,"properties":2662},"39f9fe04-7111-4157-8285-edc32f08a0b7",21,[],[],{"openalex":2663,"title":2665},{"VOID":2664},"A5111432381",{"EN":2666},"Shuichi Takishita",{"id":2668,"sortIndex":238,"researcher":24,"roles":2669,"affiliations":2670,"properties":2671},"12c7c5ee-73a9-4603-b4d7-b7600e9b0930",[],[],{"openalex":2672,"title":2674},{"VOID":2673},"A5016330001",{"EN":2675},"Kenjiro Kikuchi",{"id":2677,"sortIndex":2678,"researcher":24,"roles":2679,"affiliations":2680,"properties":2681},"2705c602-8fa5-4256-8c49-e7ed77b4f10b",29,[],[],{"openalex":2682,"orcid":2684,"title":2686},{"VOID":2683},"A5021267745",{"VOID":2685},"https:\u002F\u002Forcid.org\u002F0000-0001-6508-4338",{"EN":2687},"Hiromi Rakugi",{"id":2689,"sortIndex":2690,"researcher":24,"roles":2691,"affiliations":2692,"properties":2693},"c9bb8fc3-29eb-446c-837b-c25e2165d225",24,[],[],{"openalex":2694,"title":2696},{"VOID":2695},"A5108123977",{"EN":2697},"Makoto Uchiyama",{"id":2699,"sortIndex":640,"researcher":24,"roles":2700,"affiliations":2701,"properties":2702},"b7a8bc3a-399a-427f-a11e-1e1cbef3de6c",[],[],{"openalex":2703,"title":2705},{"VOID":2704},"A5062992073",{"EN":2706},"Shokei Kim‐Mitsuyama",{"id":2708,"sortIndex":644,"researcher":24,"roles":2709,"affiliations":2710,"properties":2711},"6aab5dbf-6c9b-4463-ae35-4c252c144800",[],[],{"openalex":2712,"title":2714},{"VOID":2713},"A5108747648",{"EN":2715},"Tsutomu Imaizumi",{"id":2717,"sortIndex":206,"researcher":24,"roles":2718,"affiliations":2719,"properties":2720},"4ef58712-47a1-4e20-911b-3751aca8ccb3",[],[],{"openalex":2721,"title":2723},{"VOID":2722},"A5112718849",{"EN":2724},"Hiroaki Matsuoka",{"id":2726,"sortIndex":2727,"researcher":24,"roles":2728,"affiliations":2729,"properties":2730},"9d5f9152-d0a8-46a3-8fa6-66e89278adeb",27,[],[],{"openalex":2731,"title":2733},{"VOID":2732},"A5111708707",{"EN":2734},"Satoshi Umemura",{"id":2736,"sortIndex":171,"researcher":24,"roles":2737,"affiliations":2738,"properties":2739},"1ebedfc6-4bbc-4bab-8fc1-f831701dc9d2",[],[],{"openalex":2740,"title":2742},{"VOID":2741},"A5111653520",{"EN":2743},"Jitsuo Higaki",{"id":2745,"sortIndex":25,"researcher":24,"roles":2746,"affiliations":2747,"properties":2748},"c808ce3d-c4f9-4f39-8f9f-786ee560336b",[],[],{"openalex":2749,"orcid":2751,"title":2753},{"VOID":2750},"A5078822609",{"VOID":2752},"https:\u002F\u002Forcid.org\u002F0000-0002-7119-7192",{"EN":2754},"Toshio Ogihara",{"id":2756,"sortIndex":2757,"researcher":24,"roles":2758,"affiliations":2759,"properties":2760},"c6c89321-9929-40ab-add3-0336eaf81463",26,[],[],{"openalex":2761,"orcid":2763,"title":2765},{"VOID":2762},"A5006558823",{"VOID":2764},"https:\u002F\u002Forcid.org\u002F0000-0002-7742-4253",{"EN":2766},"Hirotsugu Ueshima",{"id":2768,"sortIndex":322,"researcher":24,"roles":2769,"affiliations":2770,"properties":2771},"5384cb05-b54d-47aa-9686-1ac457a045f1",[],[],{"openalex":2772,"title":2774},{"VOID":2773},"A5111606434",{"EN":2775},"Norio Tanahashi",{"id":2777,"sortIndex":2177,"researcher":24,"roles":2778,"affiliations":2779,"properties":2780},"9cd2c84d-b791-4bbc-a703-c8215d374579",[],[],{"openalex":2781,"orcid":2783,"title":2785},{"VOID":2782},"A5054114051",{"VOID":2784},"https:\u002F\u002Forcid.org\u002F0000-0002-2023-5769",{"EN":2786},"Ikuo Saito",{"id":2788,"sortIndex":638,"researcher":24,"roles":2789,"affiliations":2790,"properties":2791},"ac16cd45-72ee-4e9d-9db7-c14325982a5a",[],[],{"openalex":2792,"title":2794},{"VOID":2793},"A5100834250",{"EN":2795},"Hiroshi Iwao",{"id":2797,"sortIndex":2798,"researcher":24,"roles":2799,"affiliations":2800,"properties":2801},"d7976787-c2d2-461e-8723-8cae89cfcd26",20,[],[],{"openalex":2802,"orcid":2804,"title":2806},{"VOID":2803},"A5078175026",{"VOID":2805},"https:\u002F\u002Forcid.org\u002F0000-0003-1434-7104",{"EN":2807},"Hiromichi Suzuki",{"id":2809,"sortIndex":274,"researcher":24,"roles":2810,"affiliations":2811,"properties":2812},"ab015c06-e51c-4587-87ec-2f3755756190",[],[],{"openalex":2813,"title":2815},{"VOID":2814},"A5001563356",{"EN":2816},"Masatsugu Horiuchi",{"id":2818,"sortIndex":641,"researcher":24,"roles":2819,"affiliations":2820,"properties":2821},"b679ef87-f9cc-4ce0-ab1a-7622ff823096",[],[],{"openalex":2822,"orcid":2824,"title":2826},{"VOID":2823},"A5043663301",{"VOID":2825},"https:\u002F\u002Forcid.org\u002F0000-0002-0907-2153",{"EN":2827},"Hideo Matsuura",{"id":2829,"sortIndex":2830,"researcher":24,"roles":2831,"affiliations":2832,"properties":2833},"6f790374-0ba2-4155-99e1-9f6294f349b3",10,[],[],{"openalex":2834,"title":2836},{"VOID":2835},"A5052061737",{"EN":2837},"Kazuomi Kario",{"id":2839,"sortIndex":643,"researcher":24,"roles":2840,"affiliations":2841,"properties":2842},"51f21ee6-9c4b-47e1-8dde-254458dd1ffb",[],[],{"openalex":2843,"orcid":2845,"title":2847},{"VOID":2844},"A5068557516",{"VOID":2846},"https:\u002F\u002Forcid.org\u002F0000-0002-1075-9219",{"EN":2848},"Kazuyuki Shimada",{"id":2850,"sortIndex":1396,"researcher":24,"roles":2851,"affiliations":2852,"properties":2862},"ac84f11d-e37a-40ad-892d-b40cf541d2bd",[],[2853],{"id":2854,"sortIndex":25,"affiliation":2855,"properties":24},"06e05d13-b811-49df-ae19-f13407bc6e6c",{"id":2856,"createTime":2857,"updateTime":2857,"relativeEntities":2858,"slug":2859,"properties":2860,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"527c3d34-7322-4b99-8869-939604ddfe13","2024-11-29T17:06:59.294+00:00",[],"Leadership",{"title":2861},{"EN":2859},{"openalex":2863,"orcid":2865,"title":2867},{"VOID":2864},"A5066495888",{"VOID":2866},"https:\u002F\u002Forcid.org\u002F0000-0002-5092-3626",{"EN":2868},"Sadayoshi Ito",{"id":2870,"sortIndex":2871,"researcher":24,"roles":2872,"affiliations":2873,"properties":2874},"caad6c29-abfb-487b-9e3a-bada14c4e22a",11,[],[],{"openalex":2875,"orcid":2877,"title":2879},{"VOID":2876},"A5063030973",{"VOID":2878},"https:\u002F\u002Forcid.org\u002F0000-0002-0049-259X",{"EN":2880},"Yuhei Kawano",{"id":2882,"sortIndex":2883,"researcher":24,"roles":2884,"affiliations":2885,"properties":2886},"a6910db8-44a2-4f23-865c-b4d80e1db364",19,[],[],{"openalex":2887,"title":2889},{"VOID":2888},"A5055196139",{"EN":2890},"Kazuaki Shimamoto",{"id":2892,"sortIndex":639,"researcher":24,"roles":2893,"affiliations":2894,"properties":2895},"294f67de-a84a-4ac1-93c4-ee3dc0938399",[],[],{"openalex":2896,"orcid":2898,"title":2900},{"VOID":2897},"A5090348913",{"VOID":2899},"https:\u002F\u002Forcid.org\u002F0000-0002-8977-4090",{"EN":2901},"Mitsuhide Naruse",{"id":2903,"sortIndex":148,"researcher":24,"roles":2904,"affiliations":2905,"properties":2906},"e0ce16bc-db91-4c3b-a28f-869dbf5db21c",[],[],{"openalex":2907,"orcid":2909,"title":2911},{"VOID":2908},"A5080266991",{"VOID":2910},"https:\u002F\u002Forcid.org\u002F0000-0001-9141-7060",{"EN":2912},"Toshiro Fujita",{"id":2914,"sortIndex":642,"researcher":24,"roles":2915,"affiliations":2916,"properties":2917},"06cdce22-f4da-40ca-900d-d50472ae5077",[],[],{"openalex":2918,"orcid":2920,"title":2922},{"VOID":2919},"A5088800086",{"VOID":2921},"https:\u002F\u002Forcid.org\u002F0000-0002-8408-4234",{"EN":2923},"Hiroaki Matsubara",{"id":2925,"sortIndex":2926,"researcher":24,"roles":2927,"affiliations":2928,"properties":2929},"cca1f2c4-1ba7-4534-9a2f-261e7f359376",13,[],[],{"openalex":2930,"title":2932},{"VOID":2931},"A5020639447",{"EN":2933},"Genjiro Kimura",{"id":2935,"sortIndex":2936,"researcher":24,"roles":2937,"affiliations":2938,"properties":2939},"13ced196-edc3-459d-9a44-7be5bc09b642",23,[],[],{"openalex":2940,"orcid":2942,"title":2944},{"VOID":2941},"A5006292446",{"VOID":2943},"https:\u002F\u002Forcid.org\u002F0000-0003-2412-1117",{"EN":2945},"Takuya Tsuchihashi",{"url":24,"publisher":2947,"properties":2972},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2948,"slug":10,"properties":2949,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2955,"manageAffiliations":2956,"indexDatabases":2957,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2950,"issn":2951,"introduce":2952,"eissn":2953,"title":2954},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[2958,2965],{"id":77,"indexDatabase":2959,"url":92,"indexYears":24,"academicFieldIds":2964,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":2960,"label":2961,"description":2962,"key":88,"publicationTags":2963,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":2966,"url":109,"indexYears":110,"academicFieldIds":2971,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":2967,"label":2968,"description":2969,"key":106,"publicationTags":2970,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":2973,"pages":2974,"issue":2976},{"VOID":119},{"VOID":2975},"318-318",{"VOID":2977},"4",478,{"total":2978,"publishYear":24,"statisticByYear":2980},{"2012":2981,"2013":2982,"2014":2983,"2015":2984,"2016":645,"2017":645,"2018":322,"2019":640,"2020":644,"2021":171,"2022":644,"2023":73,"2024":148},80,74,66,34,"2009-04-01",2009,[],{"id":2989,"createTime":2990,"updateTime":2990,"relativeEntities":2991,"slug":2992,"properties":2993,"entityType":139,"verifyStatus":140,"verifyTime":3006,"verifyNote":141,"syncStatus":23,"languages":3007,"translateLanguages":24,"viewCount":25,"primaryUrl":3008,"fullTextUrl":24,"authors":3009,"publicationType":288,"publisherRelationship":3166,"citationCount":3198,"citationInfo":3199,"publishDate":3210,"publishYear":3211,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":3212,"isForceReanalyzing":539},"468ff642-618e-432d-b133-da5b205f4f4a","2024-11-29T17:06:57.682+00:00",[],"Validity-Reproducibility-and-Clinical-Significance-of-Noninvasive-Brachial-Ankle-Pulse-Wave-Velocity-Measurement-",{"mag":2994,"keywords":2996,"openalex":2997,"abstract":2999,"title":3000,"pm":3002,"doi":3004},{"VOID":2995},"2083982449",{},{"VOID":2998},"W2083982449",{},{"EN":3001},"Validity, Reproducibility, and Clinical Significance of Noninvasive Brachial-Ankle Pulse Wave Velocity Measurement.",{"VOID":3003},"12135313",{"VOID":3005},"10.1291\u002Fhypres.25.359","2024-11-29T17:06:57.681+00:00",[143],"http:\u002F\u002Fwww.jstage.jst.go.jp\u002Farticle\u002Fhypres\u002F25\u002F3\u002F25_3_359\u002F_article",[3010,3031,3053,3072,3087,3102,3117,3134,3149],{"id":3011,"sortIndex":1396,"researcher":24,"roles":3012,"affiliations":3013,"properties":3024},"8c445543-cb28-48c6-ab03-eabaa9aab484",[],[3014],{"id":3015,"sortIndex":25,"affiliation":3016,"properties":24},"37e119ed-9d85-4b31-bae5-bada7be953b1",{"id":3017,"createTime":3018,"updateTime":3018,"relativeEntities":3019,"slug":3020,"properties":3021,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"29c7f4a8-0562-488c-a864-72a398d79fec","2024-11-29T17:06:58.033+00:00",[],"the-Health-Care-Center-Kajima-Corp-",{"title":3022},{"EN":3023},"the Health Care Center, Kajima Corp.",{"openalex":3025,"orcid":3027,"title":3029},{"VOID":3026},"A5015802554",{"VOID":3028},"https:\u002F\u002Forcid.org\u002F0000-0002-8978-5865",{"EN":3030},"Yoshio Yamamoto",{"id":3032,"sortIndex":171,"researcher":24,"roles":3033,"affiliations":3034,"properties":3046},"e0055903-7564-4cea-a873-d058dce54746",[],[3035],{"id":3036,"sortIndex":25,"affiliation":3037,"properties":24},"c1160193-6a9d-4bf9-842c-3a4e84532023",{"id":3038,"createTime":3039,"updateTime":3040,"relativeEntities":3041,"slug":3042,"properties":3043,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"02a83e97-e8db-4667-a9df-e5bccd60bf59","2024-11-29T17:06:57.726+00:00","2025-06-11T16:03:07.091+00:00",[],"The-Second-Department-of-Internal-Medicine-Tokyo-Medical-University",{"title":3044},{"EN":3045},"The Second Department of Internal Medicine, Tokyo Medical University",{"openalex":3047,"orcid":3049,"title":3051},{"VOID":3048},"A5043840057",{"VOID":3050},"https:\u002F\u002Forcid.org\u002F0000-0003-4583-8301",{"EN":3052},"Tomio Arai",{"id":3054,"sortIndex":644,"researcher":24,"roles":3055,"affiliations":3056,"properties":3067},"28d0f7d5-a9ca-4230-b582-24d37c135e14",[],[3057],{"id":3058,"sortIndex":25,"affiliation":3059,"properties":24},"9ab6c78d-2edd-4a02-968e-4200d8c7ebcc",{"id":3060,"createTime":3061,"updateTime":3061,"relativeEntities":3062,"slug":3063,"properties":3064,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"2f9d835c-f49a-44e2-9cdb-0611bbdc0bc6","2024-11-29T17:06:57.980+00:00",[],"the-Preventive-Medical-Center-St-Luke-s-International-Hospital",{"title":3065},{"EN":3066},"the Preventive Medical Center, St. Luke’s International Hospital",{"openalex":3068,"title":3070},{"VOID":3069},"A5052098738",{"EN":3071},"Saburoh Hori",{"id":3073,"sortIndex":25,"researcher":24,"roles":3074,"affiliations":3075,"properties":3082},"a4ad1e6f-456c-4df9-b8bb-23b57319433c",[],[3076],{"id":3077,"sortIndex":25,"affiliation":3078,"properties":24},"d69de44b-9806-40e0-9cf0-1c7396d62628",{"id":3038,"createTime":3039,"updateTime":3040,"relativeEntities":3079,"slug":3042,"properties":3080,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3081},{"EN":3045},{"openalex":3083,"title":3085},{"VOID":3084},"A5012132556",{"EN":3086},"Akira Yamashina",{"id":3088,"sortIndex":73,"researcher":24,"roles":3089,"affiliations":3090,"properties":3097},"22420d6a-2de3-41df-9795-5825dce48687",[],[3091],{"id":3092,"sortIndex":25,"affiliation":3093,"properties":24},"087f93b9-94d1-4a36-9ce1-05eb4bd8ccdc",{"id":3038,"createTime":3039,"updateTime":3040,"relativeEntities":3094,"slug":3042,"properties":3095,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3096},{"EN":3045},{"openalex":3098,"title":3100},{"VOID":3099},"A5052402957",{"EN":3101},"Yutaka Koji",{"id":3103,"sortIndex":274,"researcher":24,"roles":3104,"affiliations":3105,"properties":3112},"e7df1cd8-797e-46e0-ba8b-801a72ab2811",[],[3106],{"id":3107,"sortIndex":25,"affiliation":3108,"properties":24},"9da4987a-d70a-4a9a-951c-9355f460efa8",{"id":3038,"createTime":3039,"updateTime":3040,"relativeEntities":3109,"slug":3042,"properties":3110,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3111},{"EN":3045},{"openalex":3113,"title":3115},{"VOID":3114},"A5101088401",{"EN":3116},"Kenichi Hirose",{"id":3118,"sortIndex":238,"researcher":24,"roles":3119,"affiliations":3120,"properties":3127},"54ef2312-da6b-4fc1-a487-b17308ec0583",[],[3121],{"id":3122,"sortIndex":25,"affiliation":3123,"properties":24},"a9622011-c690-4726-ab7d-d7623ee610c0",{"id":3038,"createTime":3039,"updateTime":3040,"relativeEntities":3124,"slug":3042,"properties":3125,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3126},{"EN":3045},{"openalex":3128,"orcid":3130,"title":3132},{"VOID":3129},"A5102888412",{"VOID":3131},"https:\u002F\u002Forcid.org\u002F0000-0002-8373-7862",{"EN":3133},"Hirofumi Tomiyama",{"id":3135,"sortIndex":148,"researcher":24,"roles":3136,"affiliations":3137,"properties":3144},"f7559e11-4685-46fe-964b-2e1b2bc0f30b",[],[3138],{"id":3139,"sortIndex":25,"affiliation":3140,"properties":24},"78824569-7aa8-4344-9c23-51ea41b3c8a3",{"id":3038,"createTime":3039,"updateTime":3040,"relativeEntities":3141,"slug":3042,"properties":3142,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3143},{"EN":3045},{"openalex":3145,"title":3147},{"VOID":3146},"A5074805324",{"EN":3148},"Hideichi Tsuda",{"id":3150,"sortIndex":206,"researcher":24,"roles":3151,"affiliations":3152,"properties":3159},"53faa849-f4bb-4a44-9b96-093d912fc311",[],[3153],{"id":3154,"sortIndex":25,"affiliation":3155,"properties":24},"dceaf41e-68ed-4da4-98f0-2b6ce098d3a1",{"id":3038,"createTime":3039,"updateTime":3040,"relativeEntities":3156,"slug":3042,"properties":3157,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3158},{"EN":3045},{"openalex":3160,"orcid":3162,"title":3164},{"VOID":3161},"A5002785342",{"VOID":3163},"https:\u002F\u002Forcid.org\u002F0000-0003-3992-6014",{"EN":3165},"Kazuhiro Takeda",{"url":24,"publisher":3167,"properties":3192},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":3168,"slug":10,"properties":3169,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":3175,"manageAffiliations":3176,"indexDatabases":3177,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":3170,"issn":3171,"introduce":3172,"eissn":3173,"title":3174},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[3178,3185],{"id":77,"indexDatabase":3179,"url":92,"indexYears":24,"academicFieldIds":3184,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":3180,"label":3181,"description":3182,"key":88,"publicationTags":3183,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":3186,"url":109,"indexYears":110,"academicFieldIds":3191,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":3187,"label":3188,"description":3189,"key":106,"publicationTags":3190,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":3193,"pages":3195,"issue":3197},{"VOID":3194},"25",{"VOID":3196},"359-364",{"VOID":2176},1527,{"total":3198,"publishYear":24,"statisticByYear":3200},{"2012":3201,"2013":3202,"2014":3203,"2015":3204,"2016":2982,"2017":3205,"2018":3201,"2019":2983,"2020":3206,"2021":2981,"2022":3207,"2023":3208,"2024":3209},82,70,102,117,76,87,55,45,32,"2002-01-01",2002,[3213,3216,3220,3223,3227,3231,3235,3238,3241,3245,3249,3252,3256,3259,3262,3266,3269,3273,3276,3280,3283,3287,3291],{"id":24,"text":3214,"url":24,"identifiers":3215},"10.1016\u002FS0140-6736(99)00179-8",{"doi":3214},{"id":24,"text":3217,"url":24,"identifiers":3218},"1995, Hypertension, 26, 485, 10.1161\u002F01.HYP.26.3.485",{"doi":3219},"10.1161\u002F01.HYP.26.3.485",{"id":24,"text":3221,"url":24,"identifiers":3222},"Cohn JN, 1999, J Hypertens, 17 (Suppl 5), S41",{},{"id":24,"text":3224,"url":24,"identifiers":3225},"van Popele NM, Grobbee DE, Bots ML, et al, 2001, Stroke, 32, 454, 10.1161\u002F01.STR.32.2.454",{"doi":3226},"10.1161\u002F01.STR.32.2.454",{"id":24,"text":3228,"url":24,"identifiers":3229},"Laurent S, Boutouyrie P, Asmar R, et al, 2001, Hypertension, 37, 1236, 10.1161\u002F01.HYP.37.5.1236",{"doi":3230},"10.1161\u002F01.HYP.37.5.1236",{"id":24,"text":3232,"url":24,"identifiers":3233},"Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM, 2001, Circulation, 103, 987, 10.1161\u002F01.CIR.103.7.987",{"doi":3234},"10.1161\u002F01.CIR.103.7.987",{"id":24,"text":3236,"url":24,"identifiers":3237},"10.1097\u002F00004872-200104000-00019",{"doi":3236},{"id":24,"text":3239,"url":24,"identifiers":3240},"O’Rourke MF, 1999, J Hypertens, 17 (Suppl 5), S45",{},{"id":24,"text":3242,"url":24,"identifiers":3243},"Suzuki E, Kashiwagi A, Nishio Y, et al, 2001, Diabetes Care, 24, 2107, 10.2337\u002Fdiacare.24.12.2107",{"doi":3244},"10.2337\u002Fdiacare.24.12.2107",{"id":24,"text":3246,"url":24,"identifiers":3247},"McDonald DA, 1968, J Appl Physiol, 24, 73, 10.1152\u002Fjappl.1968.24.1.73",{"doi":3248},"10.1152\u002Fjappl.1968.24.1.73",{"id":24,"text":3250,"url":24,"identifiers":3251},"10.1016\u002F0002-8703(91)90153-9",{"doi":3250},{"id":24,"text":3253,"url":24,"identifiers":3254},"Bland JM, Altman DG, 1986, Lancet, 1, 307, 10.1016\u002FS0140-6736(86)90837-8",{"doi":3255},"10.1016\u002FS0140-6736(86)90837-8",{"id":24,"text":3257,"url":24,"identifiers":3258},"10.1046\u002Fj.1365-2125.1998.00656.x",{"doi":3257},{"id":24,"text":3260,"url":24,"identifiers":3261},"O’Rouke MF, 1982, 185",{},{"id":24,"text":3263,"url":24,"identifiers":3264},"LEHMANN E D, 1998, Hypertension, 32, 565, 10.1161\u002F01.HYP.32.3.565",{"doi":3265},"10.1161\u002F01.HYP.32.3.565",{"id":24,"text":3267,"url":24,"identifiers":3268},"Asmar R, 1999, 57",{},{"id":24,"text":3270,"url":24,"identifiers":3271},"1998, Hypertension, 31, 1021, 10.1161\u002F01.HYP.31.4.1021",{"doi":3272},"10.1161\u002F01.HYP.31.4.1021",{"id":24,"text":3274,"url":24,"identifiers":3275},"10.1016\u002F0002-8703(71)90229-8",{"doi":3274},{"id":24,"text":3277,"url":24,"identifiers":3278},"Safar ME, Blacher J, Mourad JJ, London GM, 2000, Stroke, 31, 782, 10.1161\u002F01.STR.31.3.782",{"doi":3279},"10.1161\u002F01.STR.31.3.782",{"id":24,"text":3281,"url":24,"identifiers":3282},"Asmar R, 1999, 25",{},{"id":24,"text":3284,"url":24,"identifiers":3285},"Avolio AP, Deng FQ, Li WQ, et al, 1985, Circulation, 71, 202, 10.1161\u002F01.CIR.71.2.202",{"doi":3286},"10.1161\u002F01.CIR.71.2.202",{"id":24,"text":3288,"url":24,"identifiers":3289},"HASHIMOTO M, 2000, Hypertens Res, 23, 233, 10.1291\u002Fhypres.23.233",{"doi":3290},"10.1291\u002Fhypres.23.233",{"id":24,"text":3292,"url":24,"identifiers":3293},"de Gaudemaris R, Chau NP, Mallion JM, 1994, J Hypertens, 12, 831",{},{"id":3295,"createTime":3296,"updateTime":3296,"relativeEntities":3297,"slug":3298,"properties":3299,"entityType":139,"verifyStatus":140,"verifyTime":3312,"verifyNote":141,"syncStatus":23,"languages":3313,"translateLanguages":24,"viewCount":25,"primaryUrl":3314,"fullTextUrl":24,"authors":3315,"publicationType":288,"publisherRelationship":3378,"citationCount":3410,"citationInfo":3411,"publishDate":3413,"publishYear":3414,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":3415,"isForceReanalyzing":539},"6b84fd76-5287-44c7-8f7a-22ca24e5d87c","2024-11-29T17:06:49.399+00:00",[],"Associations-of-Brachial-Ankle-Pulse-Wave-Velocity-and-Carotid-Atherosclerotic-Lesions-with-Silent-Cerebral-Lesions",{"mag":3300,"keywords":3302,"openalex":3303,"abstract":3305,"title":3306,"pm":3308,"doi":3310},{"VOID":3301},"2084476657",{},{"VOID":3304},"W2084476657",{},{"EN":3307},"Associations of Brachial-Ankle Pulse Wave Velocity and Carotid Atherosclerotic Lesions with Silent Cerebral Lesions",{"VOID":3309},"18037768",{"VOID":3311},"10.1291\u002Fhypres.30.767","2024-11-29T17:06:49.398+00:00",[143],"http:\u002F\u002Fwww.nature.com\u002Fdoifinder\u002F10.1291\u002Fhypres.30.767",[3316,3338,3359],{"id":3317,"sortIndex":238,"researcher":24,"roles":3318,"affiliations":3319,"properties":3331},"89bb39d2-d172-4c5f-8aea-8a70fe87a651",[],[3320],{"id":3321,"sortIndex":25,"affiliation":3322,"properties":24},"f583b59f-5663-4da1-b18b-6aceb7fa18c5",{"id":3323,"createTime":3324,"updateTime":3325,"relativeEntities":3326,"slug":3327,"properties":3328,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"e467ffb9-ad03-43dc-a182-61ee9265d107","2024-02-12T01:54:51.961+00:00","2024-11-29T17:06:49.476+00:00",[],"Department-of-Public-Health-Graduate-School-of-Medicine-University-of-Tokyo-Tokyo-Japan",{"title":3329},{"VI":3330},"Department of Public Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan",{"openalex":3332,"orcid":3334,"title":3336},{"VOID":3333},"A5089071534",{"VOID":3335},"https:\u002F\u002Forcid.org\u002F0000-0001-7003-8635",{"EN":3337},"Kazuo Inoue",{"id":3339,"sortIndex":25,"researcher":24,"roles":3340,"affiliations":3341,"properties":3352},"0d41b008-c198-4c64-914a-8fb704b116df",[],[3342],{"id":3343,"sortIndex":25,"affiliation":3344,"properties":24},"8c941b4d-0502-4816-8131-9f55d1582880",{"id":3345,"createTime":3346,"updateTime":3346,"relativeEntities":3347,"slug":3348,"properties":3349,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"a3e13025-92c1-4ef7-893c-bb1269c67ad4","2024-11-29T17:06:49.445+00:00",[],"Division-of-Community-and-Family-Medicine-Centre-for-Community-Medicine-Jichi-Medical-University-School-of-Medicine-Shimotsuke-Japan-",{"title":3350},{"EN":3351},"Division of Community and Family Medicine, Centre for Community Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.",{"openalex":3353,"orcid":3355,"title":3357},{"VOID":3354},"A5064227794",{"VOID":3356},"https:\u002F\u002Forcid.org\u002F0000-0002-8341-9303",{"EN":3358},"Masatoshi Matsumoto",{"id":3360,"sortIndex":206,"researcher":24,"roles":3361,"affiliations":3362,"properties":3373},"6dfc43b6-8304-4045-af77-dab25950f6fd",[],[3363],{"id":3364,"sortIndex":25,"affiliation":3365,"properties":24},"abd941f3-7bfa-4fe8-a298-8f0395f666f1",{"id":3366,"createTime":3367,"updateTime":3367,"relativeEntities":3368,"slug":3369,"properties":3370,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"e0762669-5c29-499c-8067-23d539bb5fd7","2024-11-29T17:06:49.507+00:00",[],"Division-of-Neurosurgery-Mominoki-Hospital-Kochi-Japan",{"title":3371},{"EN":3372},"Division of Neurosurgery, Mominoki Hospital, Kochi, Japan",{"openalex":3374,"title":3376},{"VOID":3375},"A5113775558",{"EN":3377},"Akihito Moriki",{"url":24,"publisher":3379,"properties":3404},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":3380,"slug":10,"properties":3381,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":3387,"manageAffiliations":3388,"indexDatabases":3389,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":3382,"issn":3383,"introduce":3384,"eissn":3385,"title":3386},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[3390,3397],{"id":77,"indexDatabase":3391,"url":92,"indexYears":24,"academicFieldIds":3396,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":3392,"label":3393,"description":3394,"key":88,"publicationTags":3395,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":3398,"url":109,"indexYears":110,"academicFieldIds":3403,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":3399,"label":3400,"description":3401,"key":106,"publicationTags":3402,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":3405,"pages":3407,"issue":3409},{"VOID":3406},"30",{"VOID":3408},"767-773",{"VOID":1791},52,{"total":3410,"publishYear":24,"statisticByYear":3412},{"2012":73,"2013":206,"2014":274,"2015":148,"2016":171,"2017":148,"2018":148,"2019":206,"2020":238,"2021":238,"2022":171,"2023":274},"2007-01-01",2007,[3416,3419,3422,3426,3430,3433,3437,3441,3445,3448,3452,3455,3459,3463,3467,3471,3474,3477,3481,3483,3487,3490,3494,3497,3501,3505,3509,3513,3516,3520,3524,3527,3531,3535,3539,3543,3547,3550,3552,3555,3558,3561,3564,3567,3570,3574,3578,3582],{"id":24,"text":3417,"url":24,"identifiers":3418},"1. Nowaczenko M, Sarzynska-Dlugosz I, Czlonkowska A: Prevalence of carotid arteries atherosclerotic changes in ischemic stroke patients. \u003Ci>Neurol Neurochir Pol\u003C\u002Fi> 2003; \u003Cb>37\u003C\u002Fb>: 27-36.",{},{"id":24,"text":3420,"url":24,"identifiers":3421},"10.1161\u002F01.CIR.0000079160.07364.6A",{"doi":3420},{"id":24,"text":3423,"url":24,"identifiers":3424},"3. Handa N, Matsumoto M, Maeda H, \u003Ci>et al\u003C\u002Fi>: Ischemic stroke events and carotid atherosclerosis: results of the Osaka follow-up study for ultrasonographic assessment of carotid atherosclerosis (the OSACA study). \u003Ci>Stroke\u003C\u002Fi> 1995; \u003Cb>26\u003C\u002Fb>: 1781-1786.",{"doi":3425},"10.1161\u002F01.STR.26.10.1781",{"id":24,"text":3427,"url":24,"identifiers":3428},"4. Hunt KJ, Evans GW, Folsom AR, \u003Ci>et al\u003C\u002Fi>: Acoustic shadowing on b-mode ultrasound of the carotid artery predicts ischemic stroke: the atherosclerosis risk in communities (ARIC) study. \u003Ci>Stroke\u003C\u002Fi> 2001; \u003Cb>32\u003C\u002Fb>: 1120-1126.",{"doi":3429},"10.1161\u002F01.STR.32.5.1120",{"id":24,"text":3431,"url":24,"identifiers":3432},"5. Oliviero U, Orefice G, Coppola G, \u003Ci>et al\u003C\u002Fi>: Carotid atherosclerosis and ischemic stroke in young patients. \u003Ci>Int Angiol\u003C\u002Fi> 2002; \u003Cb>21\u003C\u002Fb>: 117-122.",{},{"id":24,"text":3434,"url":24,"identifiers":3435},"6. Blaser T, Hofmann K, Buerger T, \u003Ci>et al\u003C\u002Fi>: Risk of stroke, transient ischemic attack, and vessel occlusion before endarterectomy in patients with symptomatic severe carotid stenosis. \u003Ci>Stroke\u003C\u002Fi> 2002; \u003Cb>33\u003C\u002Fb>: 1057-1062.",{"doi":3436},"10.1161\u002F01.STR.0000013671.70986.39",{"id":24,"text":3438,"url":24,"identifiers":3439},"7. Iannuzzi A, Wilcosky T, Mercuri M, \u003Ci>et al\u003C\u002Fi>: Ultrasonographic correlates of carotid atherosclerosis in transient ischemic attack and stroke. \u003Ci>Stroke\u003C\u002Fi> 1995; \u003Cb>26\u003C\u002Fb>: 614-619.",{"doi":3440},"10.1161\u002F01.STR.26.4.614",{"id":24,"text":3442,"url":24,"identifiers":3443},"8. Jungquist G, Nilsson B, Ostberg H, \u003Ci>et al\u003C\u002Fi>: Carotid artery blood flow velocity related to transient ischemic attack and stroke in a population study of 69-year-old men. \u003Ci>Stroke\u003C\u002Fi> 1989; \u003Cb>20\u003C\u002Fb>: 1327-1330.",{"doi":3444},"10.1161\u002F01.STR.20.10.1327",{"id":24,"text":3446,"url":24,"identifiers":3447},"9. Saruta T: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). \u003Ci>Nippon Rinsho\u003C\u002Fi> 2005; \u003Cb>63\u003C\u002Fb>: 952-958 (in Japanese).",{},{"id":24,"text":3449,"url":24,"identifiers":3450},"10. Cifkova R, Erdine S, Fagard R, \u003Ci>et al\u003C\u002Fi>: Practice guidelines for primary care physicians: 2003 ESH\u002FESC hypertension guidelines. \u003Ci>J Hypertens\u003C\u002Fi> 2003; \u003Cb>21\u003C\u002Fb>: 1779-1786.",{"doi":3451},"10.1097\u002F00004872-200310000-00001",{"id":24,"text":3453,"url":24,"identifiers":3454},"10.1291\u002Fhypres.27.71",{"doi":3453},{"id":24,"text":3456,"url":24,"identifiers":3457},"12. Ogawa O, Onuma T, Kubo S, \u003Ci>et al\u003C\u002Fi>: Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study. \u003Ci>Cardiovasc Diabetol\u003C\u002Fi> 2003; \u003Cb>2\u003C\u002Fb>: 10.",{"doi":3458},"10.1186\u002F1475-2840-2-10",{"id":24,"text":3460,"url":24,"identifiers":3461},"13. Matsuoka O, Otsuka K, Murakami S, \u003Ci>et al\u003C\u002Fi>: Arterial stiffness independently predicts cardiovascular events in an elderly community—Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. \u003Ci>Biomed Pharmacother\u003C\u002Fi> 2005; \u003Cb>59\u003C\u002Fb>: S40-S44.",{"doi":3462},"10.1016\u002FS0753-3322(05)80008-3",{"id":24,"text":3464,"url":24,"identifiers":3465},"14. Bernick C, Kuller L, Dulberg C, \u003Ci>et al\u003C\u002Fi>: Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. \u003Ci>Neurology\u003C\u002Fi> 2001; \u003Cb>57\u003C\u002Fb>: 1222-1229.",{"doi":3466},"10.1212\u002FWNL.57.7.1222",{"id":24,"text":3468,"url":24,"identifiers":3469},"15. Shinkawa A, Ueda K, Kiyohara Y, \u003Ci>et al\u003C\u002Fi>: Silent cerebral infarction in a community-based autopsy series in Japan: the Hisayama study. \u003Ci>Stroke\u003C\u002Fi> 1995; \u003Cb>26\u003C\u002Fb>: 380-385.",{"doi":3470},"10.1161\u002F01.STR.26.3.380",{"id":24,"text":3472,"url":24,"identifiers":3473},"10.1161\u002F01.STR.0000068408.82115.D2",{"doi":3472},{"id":24,"text":3475,"url":24,"identifiers":3476},"10.1001\u002Farchneur.55.9.1217",{"doi":3475},{"id":24,"text":3478,"url":24,"identifiers":3479},"18. Kobayashi S, Okada K, Koide H, \u003Ci>et al\u003C\u002Fi>: Subcortical silent brain infarction as a risk factor for clinical stroke. \u003Ci>Stroke\u003C\u002Fi> 1997; \u003Cb>28\u003C\u002Fb>: 1932-1939.",{"doi":3480},"10.1161\u002F01.STR.28.10.1932",{"id":24,"text":3005,"url":24,"identifiers":3482},{"doi":3005},{"id":24,"text":3484,"url":24,"identifiers":3485},"20. Paivansalo M, Rantala A, Kauma H, \u003Ci>et al\u003C\u002Fi>: Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects: a cross-sectional systematic study with duplex ultrasound. \u003Ci>J Hypertens\u003C\u002Fi> 1996; \u003Cb>14\u003C\u002Fb>: 1433-1439.",{"doi":3486},"10.1097\u002F00004872-199612000-00008",{"id":24,"text":3488,"url":24,"identifiers":3489},"21. Japanese Society for Detection of Asymptomatic Brain Diseases: The guidelines for brain MRI mass screening. The Society 2003, available at http:\u002F\u002Fwww.snh.or.jp\u002Fjsbd\u002Fpdf\u002Fguideline2003.pdf [accessed November 11, 2006].",{},{"id":24,"text":3491,"url":24,"identifiers":3492},"22. Chambless LE, Heiss G, Folsom AR, \u003Ci>et al\u003C\u002Fi>: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987−1993. \u003Ci>Am J Epidemiol\u003C\u002Fi> 1997; \u003Cb>146\u003C\u002Fb>: 483-494.",{"doi":3493},"10.1093\u002Foxfordjournals.aje.a009302",{"id":24,"text":3495,"url":24,"identifiers":3496},"23. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr, Cardiovascular Health Study Collaborative Research Group: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. \u003Ci>N Engl J Med\u003C\u002Fi> 1999; \u003Cb>340\u003C\u002Fb>: 14-22.",{"doi":1862},{"id":24,"text":3498,"url":24,"identifiers":3499},"24. Yamashita H, Fujikawa T, Yanai I, \u003Ci>et al\u003C\u002Fi>: Cognitive dysfunction in recovered depressive patients with silent cerebral infarction. \u003Ci>Neuropsychobiology\u003C\u002Fi> 2002; \u003Cb>45\u003C\u002Fb>: 12-18.",{"doi":3500},"10.1159\u002F000048667",{"id":24,"text":3502,"url":24,"identifiers":3503},"25. Maeshima S, Moriwaki H, Ozaki F, \u003Ci>et al\u003C\u002Fi>: Silent cerebral infarction and cognitive function in middle-aged neurologically healthy subjects. \u003Ci>Acta Neurol Scand\u003C\u002Fi> 2002; \u003Cb>105\u003C\u002Fb>: 179-184.",{"doi":3504},"10.1034\u002Fj.1600-0404.2002.1o068.x",{"id":24,"text":3506,"url":24,"identifiers":3507},"26. Fujikawa T, Yamawaki S, Touhouda Y: Background factors and clinical symptoms of major depression with silent cerebral infarction. \u003Ci>Stroke\u003C\u002Fi> 1994; \u003Cb>25\u003C\u002Fb>: 798-801.",{"doi":3508},"10.1161\u002F01.STR.25.4.798",{"id":24,"text":3510,"url":24,"identifiers":3511},"27. Yanai I, Fujikawa T, Horiguchi J, \u003Ci>et al\u003C\u002Fi>: The 3-year course and outcome of patients with major depression and silent cerebral infarction. \u003Ci>J Affect Disord\u003C\u002Fi> 1998; \u003Cb>47\u003C\u002Fb>: 25-30.",{"doi":3512},"10.1016\u002FS0165-0327(97)00148-1",{"id":24,"text":3514,"url":24,"identifiers":3515},"10.1016\u002Fj.jstrokecerebrovasdis.2006.08.001",{"doi":3514},{"id":24,"text":3517,"url":24,"identifiers":3518},"29. Manolio T, Kronmal R, Burke G, \u003Ci>et al\u003C\u002Fi>: Magnetic resonance abnormalities and cardiovascular disease in older adults: the cardiovascular health study. \u003Ci>Stroke\u003C\u002Fi> 1994; \u003Cb>25\u003C\u002Fb>: 318-327.",{"doi":3519},"10.1161\u002F01.STR.25.2.318",{"id":24,"text":3521,"url":24,"identifiers":3522},"30. Korogi Y, Takahashi M, Mabuchi N, \u003Ci>et al\u003C\u002Fi>: Intracranial vascular stenosis and occlusion: diagnostic accuracy of three-dimensional, Fourier transform, time-of-flight MR angiography. \u003Ci>Radiology\u003C\u002Fi> 1994; \u003Cb>193\u003C\u002Fb>: 187-193.",{"doi":3523},"10.1148\u002Fradiology.193.1.8090890",{"id":24,"text":3525,"url":24,"identifiers":3526},"31. Korogi Y, Takahashi M, Nakagawa T, \u003Ci>et al\u003C\u002Fi>: Intracranial vascular stenosis and occlusion: MR angiographic findings. \u003Ci>Am J Neuroradiol\u003C\u002Fi> 1997; \u003Cb>18\u003C\u002Fb>: 135-143.",{},{"id":24,"text":3528,"url":24,"identifiers":3529},"SAWADA Motoshi, 1994, 34, 682, 10.2176\u002Fnmc.34.682",{"doi":3530},"10.2176\u002Fnmc.34.682",{"id":24,"text":3532,"url":24,"identifiers":3533},"33. Wong KS, Li H, Chan YL, \u003Ci>et al\u003C\u002Fi>: Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. \u003Ci>Stroke\u003C\u002Fi> 2000; \u003Cb>31\u003C\u002Fb>: 2641-2647.",{"doi":3534},"10.1161\u002F01.STR.31.11.2641",{"id":24,"text":3536,"url":24,"identifiers":3537},"34. Thomas GN, Lin JW, Lam WW, \u003Ci>et al\u003C\u002Fi>: Increasing severity of cardiovascular risk factors with increasing middle cerebral artery stenotic involvement in type 2 diabetic Chinese patients with asymptomatic cerebrovascular disease. \u003Ci>Diabetes Care\u003C\u002Fi> 2004; \u003Cb>27\u003C\u002Fb>: 1121-1126.",{"doi":3538},"10.2337\u002Fdiacare.27.5.1121",{"id":24,"text":3540,"url":24,"identifiers":3541},"35. Mattace-Raso FU, van der Cammen TJ, Hofman A, \u003Ci>et al\u003C\u002Fi>: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. \u003Ci>Circulation\u003C\u002Fi> 2006; \u003Cb>113\u003C\u002Fb>: 601-603.",{"doi":3542},"10.1161\u002FCIRCULATIONAHA.105.555235",{"id":24,"text":3544,"url":24,"identifiers":3545},"36. Stork S, van den Beld AW, von Schacky C, \u003Ci>et al\u003C\u002Fi>: Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study. \u003Ci>Circulation\u003C\u002Fi> 2004; \u003Cb>110\u003C\u002Fb>: 344-348.",{"doi":3546},"10.1161\u002F01.CIR.0000134966.10793.C9",{"id":24,"text":3548,"url":24,"identifiers":3549},"10.1161\u002FCIRCULATIONAHA.104.483628",{"doi":3548},{"id":24,"text":3005,"url":24,"identifiers":3551},{"doi":3005},{"id":24,"text":3553,"url":24,"identifiers":3554},"10.1016\u002FS0895-7061(03)00918-X",{"doi":3553},{"id":24,"text":3556,"url":24,"identifiers":3557},"10.1016\u002Fj.jocn.2005.02.012",{"doi":3556},{"id":24,"text":3559,"url":24,"identifiers":3560},"10.1016\u002Fj.atherosclerosis.2003.10.013",{"doi":3559},{"id":24,"text":3562,"url":24,"identifiers":3563},"10.1291\u002Fhypres.26.163",{"doi":3562},{"id":24,"text":3565,"url":24,"identifiers":3566},"10.1291\u002Fhypres.29.309",{"doi":3565},{"id":24,"text":3568,"url":24,"identifiers":3569},"10.1291\u002Fhypres.28.125",{"doi":3568},{"id":24,"text":3571,"url":24,"identifiers":3572},"45. Bokura H, Kobayashi S, Yamaguchi S: Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. \u003Ci>J Neurol\u003C\u002Fi> 1998; \u003Cb>245\u003C\u002Fb>: 116-122.",{"doi":3573},"10.1007\u002Fs004150050189",{"id":24,"text":3575,"url":24,"identifiers":3576},"46. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW: Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. \u003Ci>Am J Roentgenol\u003C\u002Fi> 1988; \u003Cb>151\u003C\u002Fb>: 551-558.",{"doi":3577},"10.2214\u002Fajr.151.3.551",{"id":24,"text":3579,"url":24,"identifiers":3580},"47. Takao M, Koto A, Tanahashi N, \u003Ci>et al\u003C\u002Fi>: Pathologic findings of silent, small hyperintense foci in the basal ganglia and thalamus on MRI. \u003Ci>Neurology\u003C\u002Fi> 1999; \u003Cb>52\u003C\u002Fb>: 666-668.",{"doi":3581},"10.1212\u002FWNL.52.3.666",{"id":24,"text":3583,"url":24,"identifiers":3584},"48. Yamada N, Yaginuma T, Iwasa H, \u003Ci>et al\u003C\u002Fi>: Brain dock report: evaluation of risk factors and higher cerebral function in nonsymptomatic cerebral infarction. \u003Ci>Jichi Med Sch J\u003C\u002Fi> 1998; \u003Cb>21\u003C\u002Fb>: 223-237.",{},{"id":3586,"createTime":3587,"updateTime":3587,"relativeEntities":3588,"slug":3589,"properties":3590,"entityType":139,"verifyStatus":140,"verifyTime":3587,"verifyNote":141,"syncStatus":23,"languages":3603,"translateLanguages":24,"viewCount":25,"primaryUrl":3604,"fullTextUrl":24,"authors":3605,"publicationType":288,"publisherRelationship":3717,"citationCount":639,"citationInfo":3749,"publishDate":3751,"publishYear":3752,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":3753,"isForceReanalyzing":539},"25a784e9-77c0-4753-a4eb-f5b33d72a502","2024-09-25T16:34:20.564+00:00",[],"Cyclin-Dependent-Kinase-Inhibitor-p21Waf1-Regulates-Vascular-Smooth-Muscle-Cell-Hypertrophy",{"mag":3591,"keywords":3593,"openalex":3594,"abstract":3596,"title":3597,"pm":3599,"doi":3601},{"VOID":3592},"2081653837",{},{"VOID":3595},"W2081653837",{},{"EN":3598},"Cyclin-Dependent Kinase Inhibitor, p21Waf1, Regulates Vascular Smooth Muscle Cell Hypertrophy",{"VOID":3600},"15127886",{"VOID":3602},"10.1291\u002Fhypres.27.283",[143],"http:\u002F\u002Fwww.jstage.jst.go.jp\u002Farticle\u002Fhypres\u002F27\u002F4\u002F27_4_283\u002F_article",[3606,3627,3642,3659,3674,3694],{"id":3607,"sortIndex":206,"researcher":24,"roles":3608,"affiliations":3609,"properties":3620},"2e91a1b2-6fab-4180-9486-4ed0082dbdd1",[],[3610],{"id":3611,"sortIndex":25,"affiliation":3612,"properties":24},"254d0975-8576-4e70-9a8c-033add4d47a6",{"id":3613,"createTime":3614,"updateTime":3614,"relativeEntities":3615,"slug":3616,"properties":3617,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"ca433d55-7b26-4a71-b094-dc0d76594996","2024-09-25T16:34:20.579+00:00",[],"Department-of-Pathology-Kurume-University-School-of-Medicine",{"title":3618},{"EN":3619},"Department of Pathology, Kurume University, School of Medicine",{"openalex":3621,"orcid":3623,"title":3625},{"VOID":3622},"A5068419055",{"VOID":3624},"https:\u002F\u002Forcid.org\u002F0000-0002-0084-5500",{"EN":3626},"Nobuyuki Arima",{"id":3628,"sortIndex":171,"researcher":24,"roles":3629,"affiliations":3630,"properties":3637},"b5d8cc4d-09ca-4826-87a7-597a13767d30",[],[3631],{"id":3632,"sortIndex":25,"affiliation":3633,"properties":24},"1bb619b3-9e8d-4e78-95c1-86cd7957c1ec",{"id":3613,"createTime":3614,"updateTime":3614,"relativeEntities":3634,"slug":3616,"properties":3635,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3636},{"EN":3619},{"openalex":3638,"title":3640},{"VOID":3639},"A5011723752",{"EN":3641},"Minoru Morimatsu",{"id":3643,"sortIndex":238,"researcher":24,"roles":3644,"affiliations":3645,"properties":3652},"2b3a9df3-3a77-485d-8dfe-ba9be78bd522",[],[3646],{"id":3647,"sortIndex":25,"affiliation":3648,"properties":24},"70c872b2-8554-41f9-9031-31f4a06fb900",{"id":3613,"createTime":3614,"updateTime":3614,"relativeEntities":3649,"slug":3616,"properties":3650,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3651},{"EN":3619},{"openalex":3653,"orcid":3655,"title":3657},{"VOID":3654},"A5060887563",{"VOID":3656},"https:\u002F\u002Forcid.org\u002F0000-0002-8267-2454",{"EN":3658},"Seiya Kato",{"id":3660,"sortIndex":148,"researcher":24,"roles":3661,"affiliations":3662,"properties":3669},"b9d03b3b-7bf5-483f-a831-aa7e09c11f2f",[],[3663],{"id":3664,"sortIndex":25,"affiliation":3665,"properties":24},"97444010-5eda-4e12-a24a-13b9cc700fd2",{"id":3613,"createTime":3614,"updateTime":3614,"relativeEntities":3666,"slug":3616,"properties":3667,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3668},{"EN":3619},{"openalex":3670,"title":3672},{"VOID":3671},"A5028688995",{"EN":3673},"Teruhiko Fujii",{"id":3675,"sortIndex":274,"researcher":24,"roles":3676,"affiliations":3677,"properties":3688},"647466d4-5988-4282-b741-b747f3148578",[],[3678],{"id":3679,"sortIndex":25,"affiliation":3680,"properties":24},"85f256f7-a4ac-45fe-966f-e74cd4437369",{"id":3681,"createTime":3682,"updateTime":3682,"relativeEntities":3683,"slug":3684,"properties":3685,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"7660ae8f-de24-489f-836f-ed8608faae86","2024-09-25T16:34:20.576+00:00",[],"Department-of-Internal-Medicine-III-and-the-Cardiovascular-Research-Institute-Kurume-University-School-of-Medicine",{"title":3686},{"EN":3687},"Department of Internal Medicine III, and the Cardiovascular Research Institute, Kurume University, School of Medicine",{"openalex":3689,"orcid":3691,"title":3693},{"VOID":3690},"A5082234778",{"VOID":3692},"https:\u002F\u002Forcid.org\u002F0000-0003-3831-7241",{"EN":2715},{"id":3695,"sortIndex":25,"researcher":24,"roles":3696,"affiliations":3697,"properties":3710},"d7888806-7fc8-4f17-be22-b4a381a7bfa0",[],[3698,3704],{"id":3699,"sortIndex":238,"affiliation":3700,"properties":24},"b46f106e-3f64-4190-92ef-dd8447d4a22d",{"id":3613,"createTime":3614,"updateTime":3614,"relativeEntities":3701,"slug":3616,"properties":3702,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3703},{"EN":3619},{"id":3705,"sortIndex":25,"affiliation":3706,"properties":24},"30711586-64ce-4eb8-a19c-bcf3670c274c",{"id":3681,"createTime":3682,"updateTime":3682,"relativeEntities":3707,"slug":3684,"properties":3708,"entityType":61,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":3709},{"EN":3687},{"openalex":3711,"orcid":3713,"title":3715},{"VOID":3712},"A5062677017",{"VOID":3714},"https:\u002F\u002Forcid.org\u002F0000-0001-9527-2444",{"EN":3716},"Kenichi Okamoto",{"url":24,"publisher":3718,"properties":3743},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":3719,"slug":10,"properties":3720,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":3726,"manageAffiliations":3727,"indexDatabases":3728,"url":116,"thumbnailPath":24,"statistic":24,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":3721,"issn":3722,"introduce":3723,"eissn":3724,"title":3725},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[3729,3736],{"id":77,"indexDatabase":3730,"url":92,"indexYears":24,"academicFieldIds":3735,"indexDatabaseRanking":24},{"id":79,"createTime":80,"updateTime":81,"relativeEntities":3731,"label":3732,"description":3733,"key":88,"publicationTags":3734,"standard":24},[],{"EN":84,"VI":84},{"VI":86,"EN":87},[90,91],[94],{"id":96,"indexDatabase":3737,"url":109,"indexYears":110,"academicFieldIds":3742,"indexDatabaseRanking":115},{"id":98,"createTime":99,"updateTime":100,"relativeEntities":3738,"label":3739,"description":3740,"key":106,"publicationTags":3741,"standard":24},[],{"EN":103,"VI":103},{"EN":103,"VI":105},[108],[112,113,114],{"volume":3744,"pages":3746,"issue":3748},{"VOID":3745},"27",{"VOID":3747},"283-291",{"VOID":2977},{"total":639,"publishYear":24,"statisticByYear":3750},{"2012":238},"2004-01-01",2004,[3754,3758,3762,3766,3770,3773,3777,3781,3784,3787,3790,3793,3796,3800,3803,3806,3809,3813,3817,3820,3824,3827,3830,3833,3837,3841,3845,3848,3851,3855,3859,3862,3866,3869,3873],{"id":24,"text":3755,"url":24,"identifiers":3756},"Owens GK, Rabinovitch PS, Schwartz, 1981, Proc Natl Acad Sci U S A, 78, 7759, 10.1073\u002Fpnas.78.12.7759",{"doi":3757},"10.1073\u002Fpnas.78.12.7759",{"id":24,"text":3759,"url":24,"identifiers":3760},"Geisterfer AAT, Peach MJ, Owens GK, 1998, Circ Res, 62, 749, 10.1161\u002F01.RES.62.4.749",{"doi":3761},"10.1161\u002F01.RES.62.4.749",{"id":24,"text":3763,"url":24,"identifiers":3764},"Itoh H, Mukoyama M, Pratt RE, Gibbo, 1993, J Clin Invest, 91, 2268, 10.1172\u002FJCI116454",{"doi":3765},"10.1172\u002FJCI116454",{"id":24,"text":3767,"url":24,"identifiers":3768},"Simons M, 1996, J Lab Clin Med, 128, 361, 10.1016\u002FS0022-2143(96)80007-2",{"doi":3769},"10.1016\u002FS0022-2143(96)80007-2",{"id":24,"text":3771,"url":24,"identifiers":3772},"10.1126\u002Fscience.7824950",{"doi":3771},{"id":24,"text":3774,"url":24,"identifiers":3775},"1995, Proc Natl Acad Sci U S A, 92, 5855, 10.1073\u002Fpnas.92.13.5855",{"doi":3776},"10.1073\u002Fpnas.92.13.5855",{"id":24,"text":3778,"url":24,"identifiers":3779},"Tanner FV, Boehm M, Akyüre, 2000, Circulation, 101, 2022, 10.1161\u002F01.CIR.101.17.2022",{"doi":3780},"10.1161\u002F01.CIR.101.17.2022",{"id":24,"text":3782,"url":24,"identifiers":3783},"10.1016\u002F0092-8674(93)90500-P",{"doi":3782},{"id":24,"text":3785,"url":24,"identifiers":3786},"10.1038\u002F366701a0",{"doi":3785},{"id":24,"text":3788,"url":24,"identifiers":3789},"10.1016\u002F0092-8674(93)90499-G",{"doi":3788},{"id":24,"text":3791,"url":24,"identifiers":3792},"10.1006\u002Fexcr.1994.1063",{"doi":3791},{"id":24,"text":3794,"url":24,"identifiers":3795},"1994, Cancer Res, 54, 1169",{},{"id":24,"text":3797,"url":24,"identifiers":3798},"Parker SB, Eichele G, Zhang P, et a, 1995, Science, 267, 1024, 10.1126\u002Fscience.7863329",{"doi":3799},"10.1126\u002Fscience.7863329",{"id":24,"text":3801,"url":24,"identifiers":3802},"1994, Cancer Res, 54, 3391",{},{"id":24,"text":3804,"url":24,"identifiers":3805},"10.1038\u002F369574a0",{"doi":3804},{"id":24,"text":3807,"url":24,"identifiers":3808},"10.1073\u002Fpnas.93.15.7905",{"doi":3807},{"id":24,"text":3810,"url":24,"identifiers":3811},"Chang MW, Barr E, Lu MM, Barton K,, 1995, J Clin Invest, 96, 2260, 10.1172\u002FJCI118281",{"doi":3812},"10.1172\u002FJCI118281",{"id":24,"text":3814,"url":24,"identifiers":3815},"Ueno H, Masuda S, Nishio S, Juan-Ju, 1997, Ann NY Acad Sci, 811, 401, 10.1111\u002Fj.1749-6632.1997.tb52020.x",{"doi":3816},"10.1111\u002Fj.1749-6632.1997.tb52020.x",{"id":24,"text":3818,"url":24,"identifiers":3819},"10.1074\u002Fjbc.272.15.10050",{"doi":3818},{"id":24,"text":3821,"url":24,"identifiers":3822},"Marra DE, Simoncini T, Liao JK, 2000, Circulation, 102, 2124, 10.1161\u002F01.CIR.102.17.2124",{"doi":3823},"10.1161\u002F01.CIR.102.17.2124",{"id":24,"text":3825,"url":24,"identifiers":3826},"10.1016\u002FS0092-8674(00)81801-2",{"doi":3825},{"id":24,"text":3828,"url":24,"identifiers":3829},"10.1006\u002Fexmp.1999.2235",{"doi":3828},{"id":24,"text":3831,"url":24,"identifiers":3832},"10.1074\u002Fjbc.275.14.10285",{"doi":3831},{"id":24,"text":3834,"url":24,"identifiers":3835},"Timmermans PBMWM, 1999, Hypertens Res, 22, 147, 10.1291\u002Fhypres.22.147",{"doi":3836},"10.1291\u002Fhypres.22.147",{"id":24,"text":3838,"url":24,"identifiers":3839},"Watson MH, Venance SL, Pang SC, Mak, 1993, Circ Res, 73, 109, 10.1161\u002F01.RES.73.1.109",{"doi":3840},"10.1161\u002F01.RES.73.1.109",{"id":24,"text":3842,"url":24,"identifiers":3843},"Braun-Dullaeus RC, Mann MJ, Ziegler, 1999, J Clin Invest, 104, 815, 10.1172\u002FJCI5339",{"doi":3844},"10.1172\u002FJCI5339",{"id":24,"text":3846,"url":24,"identifiers":3847},"10.1083\u002Fjcb.107.2.771",{"doi":3846},{"id":24,"text":3849,"url":24,"identifiers":3850},"10.1016\u002F0092-8674(77)90209-4",{"doi":3849},{"id":24,"text":3852,"url":24,"identifiers":3853},"RAO G N, 1999, Biochim Biophys Acta, 1448, 525, 10.1016\u002FS0167-4889(98)00149-9",{"doi":3854},"10.1016\u002FS0167-4889(98)00149-9",{"id":24,"text":3856,"url":24,"identifiers":3857},"Fukui R, Shibata N, Kohbayashi E, e, 1997, Atherosclerosis, 132, 53, 10.1016\u002FS0021-9150(97)00086-5",{"doi":3858},"10.1016\u002FS0021-9150(97)00086-5",{"id":24,"text":3860,"url":24,"identifiers":3861},"1998, Hypertension, 31, 493",{},{"id":24,"text":3863,"url":24,"identifiers":3864},"Naftilan AJ, 1994, Curr Opin Nephrol Hypertens, 3, 218, 10.1097\u002F00041552-199403000-00014",{"doi":3865},"10.1097\u002F00041552-199403000-00014",{"id":24,"text":3867,"url":24,"identifiers":3868},"10.1291\u002Fhypres.24.189",{"doi":3867},{"id":24,"text":3870,"url":24,"identifiers":3871},"YAMAGUCHI M, 1998, Heart Vessels, 13, 246, 10.1007\u002FBF03257248",{"doi":3872},"10.1007\u002FBF03257248",{"id":24,"text":3874,"url":24,"identifiers":3875},"Ihling C, Menzel G, Wellens E, M, 1997, Arterioscler Thromb Vasc Biol, 17, 2218, 10.1161\u002F01.ATV.17.10.2218",{"doi":3876},"10.1161\u002F01.ATV.17.10.2218"]